<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://onlinelibrarystatic.wiley.com/xslt/wol-journal-rss.xsl"
            type="text/xsl"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1111/(ISSN)1365-3156" xmlns="http://purl.org/rss/1.0/"><title>Tropical Medicine &amp; International Health</title><description> Wiley Online Library : Tropical Medicine &amp; International Health</description><link>http://dx.doi.org/10.1111%2F%28ISSN%291365-3156</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">© Blackwell Publishing Ltd</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1360-2276</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1365-3156</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">February 2012</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">17</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">143</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">261</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1111/tmi.2012.17.issue-2/asset/cover.gif?v=1&amp;s=8c99549018fb2879e8e32bc00fccc428b8f6b5cc"/><items><rdf:Seq><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02946.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02940.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02952.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02951.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02944.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02941.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02953.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02950.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02949.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02945.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02935.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02938.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02936.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02921.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02927.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02931.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02920.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02916.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02926.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02934.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02923.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02932.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02933.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02922.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02930.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02915.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02919.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02918.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02917.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02909.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2010.02607.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2007.01802.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02948.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02910.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02904.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02913.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02906.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02912.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02896.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02907.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02897.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02898.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02895.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02901.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02905.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02899.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02900.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02902.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02911.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02908_1.x"/><rdf:li rdf:resource="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02908_2.x"/></rdf:Seq></items></channel><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02946.x" xmlns="http://purl.org/rss/1.0/"><title>Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi*</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02946.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi*</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Peter MacPherson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David G. Lalloo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Augustine T. Choko</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gillian H. Mann</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stephen Bertel Squire</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Daniel Mwale</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eddie Manda</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Simon D. Makombe</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nicola Desmond</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Robert Heyderman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elizabeth L. Corbett</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T05:06:03.707654-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02946.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02946.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02946.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective: </b> To understand reasons for suboptimal and delayed uptake of antiretroviral therapy (ART) by describing the patterns of HIV testing and counselling (HTC) and outcomes of ART eligibility assessments in primary clinic attendees.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods: </b> All clinic attendances and episodes of HTC were recorded at two clinics in Blantyre. A cohort of newly diagnosed HIV-positive adults (&gt;15 years) was recruited and exit interviews undertaken. Logistic regression models were constructed to investigate factors associated with referral to start ART. Qualitative interviews were conducted with providers and patients.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results: </b> There were 2398 episodes of HTC during 18 021 clinic attendances (13.3%) between January and April 2011. The proportion of clinic attendees undergoing HTC was lowest in non-pregnant women (6.3%) and men (8.5%), compared with pregnant women (47.2%). Men had more advanced HIV infection than women (79.7% WHO stage 3 or 4 <em>vs.</em> 56.4%). Problems with WHO staging and access to CD4 counts affected ART eligibility assessments; only 48% completed ART eligibility assessment, and 54% of those reporting WHO stage 3/4 illnesses were not referred to start ART promptly. On multivariate analysis, HIV-positive pregnant women were significantly less likely to be referred directly for ART initiation (adjusted OR: 0.29, 95% CI: 0.13–0.63).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions: </b> These data show that provider-initiated testing and counselling (PITC) has not yet been fully implemented at primary care clinics. Suboptimal ART eligibility assessments and referral (reflecting the difficulties of WHO staging in primary care) mean that simplified eligibility assessment tools are required to reduce unnecessary delay and attrition in the pre-ART period. Simplified initiation criteria for pregnant women, as being introduced in Malawi, should improve linkage to ART.</p></div>]]></content:encoded><description>Objective:  To understand reasons for suboptimal and delayed uptake of antiretroviral therapy (ART) by describing the patterns of HIV testing and counselling (HTC) and outcomes of ART eligibility assessments in primary clinic attendees.Methods:  All clinic attendances and episodes of HTC were recorded at two clinics in Blantyre. A cohort of newly diagnosed HIV-positive adults (&gt;15 years) was recruited and exit interviews undertaken. Logistic regression models were constructed to investigate factors associated with referral to start ART. Qualitative interviews were conducted with providers and patients.Results:  There were 2398 episodes of HTC during 18 021 clinic attendances (13.3%) between January and April 2011. The proportion of clinic attendees undergoing HTC was lowest in non-pregnant women (6.3%) and men (8.5%), compared with pregnant women (47.2%). Men had more advanced HIV infection than women (79.7% WHO stage 3 or 4 vs. 56.4%). Problems with WHO staging and access to CD4 counts affected ART eligibility assessments; only 48% completed ART eligibility assessment, and 54% of those reporting WHO stage 3/4 illnesses were not referred to start ART promptly. On multivariate analysis, HIV-positive pregnant women were significantly less likely to be referred directly for ART initiation (adjusted OR: 0.29, 95% CI: 0.13–0.63).Conclusions:  These data show that provider-initiated testing and counselling (PITC) has not yet been fully implemented at primary care clinics. Suboptimal ART eligibility assessments and referral (reflecting the difficulties of WHO staging in primary care) mean that simplified eligibility assessment tools are required to reduce unnecessary delay and attrition in the pre-ART period. Simplified initiation criteria for pregnant women, as being introduced in Malawi, should improve linkage to ART.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02940.x" xmlns="http://purl.org/rss/1.0/"><title>Correlation of Pfg377 ortholog gene expression of Plasmodium vivax and mosquito infection</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02940.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Correlation of Pfg377 ortholog gene expression of Plasmodium vivax and mosquito infection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Chansamut</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Buates</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Takhampunya</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Udomsangpetch</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Bantuchai</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Sattabongkot</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T05:05:55.127575-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02940.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02940.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02940.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To determine the expression of Pfg377 ortholog gene in <em>Plasmodium vivax</em>, and examine its correlation with mosquito infection.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Seventy clinical blood samples positive for <em>P. vivax</em> by microscopy, were used for the mosquito infectivity assay. Infectivity to female <em>Anopheles dirus</em> was determined from oocyst counts. The transcripts of Pfg377 ortholog gene of <em>P. vivax</em> from blood samples infective and non-infective to mosquitoes were examined using quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Of 70 <em>P. vivax</em> positive blood samples, 50 (71.4%) samples were mosquito-infective and 20 (28.6%) were not. In infective samples, the expression level of Pfg377 ortholog gene was significantly higher than in the non-infective group (<em>P </em>&lt;<em> </em>0.05). In infective samples, the expression level of Pfg377 ortholog gene at ≥100 copies/ml of blood cut-off point correlated with ≥10 oocysts/mosquito cut-off point of average oocyst numbers and with ≥50% cut-off point of per cent infected mosquitoes (Pearson’s chi-square correlation, <em>P </em>=<em> </em>0.014 and <em>P </em>=<em> </em>0.026, respectively).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The cut-off point of the expression level of Pfg377 ortholog gene could be used to predict the infectiousness of <em>P. vivax</em> gametocytes leading to mosquito infection and parasite transmission in the field.</p></div>]]></content:encoded><description>Objective  To determine the expression of Pfg377 ortholog gene in Plasmodium vivax, and examine its correlation with mosquito infection.Methods  Seventy clinical blood samples positive for P. vivax by microscopy, were used for the mosquito infectivity assay. Infectivity to female Anopheles dirus was determined from oocyst counts. The transcripts of Pfg377 ortholog gene of P. vivax from blood samples infective and non-infective to mosquitoes were examined using quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR).Results  Of 70 P. vivax positive blood samples, 50 (71.4%) samples were mosquito-infective and 20 (28.6%) were not. In infective samples, the expression level of Pfg377 ortholog gene was significantly higher than in the non-infective group (P &lt; 0.05). In infective samples, the expression level of Pfg377 ortholog gene at ≥100 copies/ml of blood cut-off point correlated with ≥10 oocysts/mosquito cut-off point of average oocyst numbers and with ≥50% cut-off point of per cent infected mosquitoes (Pearson’s chi-square correlation, P = 0.014 and P = 0.026, respectively).Conclusion  The cut-off point of the expression level of Pfg377 ortholog gene could be used to predict the infectiousness of P. vivax gametocytes leading to mosquito infection and parasite transmission in the field.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02952.x" xmlns="http://purl.org/rss/1.0/"><title>Low mortality risk but high loss to follow-up among patients in the Tanzanian national HIV care and treatment programme</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02952.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Low mortality risk but high loss to follow-up among patients in the Tanzanian national HIV care and treatment programme</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. Somi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. C. Keogh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Todd</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. Kilama</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Wringe</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. van den Hombergh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. Malima</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Josiah</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Urassa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Swai</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. Zaba</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T04:59:51.621226-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02952.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02952.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02952.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To analyse survival and retention rates of the Tanzanian care and treatment programme.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Routine patient-level data were available from 101 of 909 clinics. Kaplan–Meier probabilities of mortality and attrition after ART initiation were calculated. Mortality risks were corrected for biases from loss to follow-up using Egger’s nomogram. Smoothed hazard rates showed mortality and attrition peaks. Cox regression identified factors associated with death and attrition. Median CD4 counts were calculated at 6 month intervals.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> In 88,875 adults, 18% were lost to follow up 12 months after treatment initiation, and 36% after 36 months. Cumulative mortality reached 10% by 12 months (15% after correcting for loss to follow-up) and 14% by 36 months. Mortality and attrition rates both peaked within the first six months, and were higher among males, those under 45 kg and those with CD4 counts below 50 cells/μl at ART initiation. In the first year on ART, median CD4 count increased by 126 cells/μl, with similar changes in both sexes.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Earlier diagnoses through expanded HIV testing may reduce high mortality and attrition rates if combined with better patient tracing systems. Further research is needed to explore reasons for attrition.</p></div>]]></content:encoded><description>Objective  To analyse survival and retention rates of the Tanzanian care and treatment programme.Methods  Routine patient-level data were available from 101 of 909 clinics. Kaplan–Meier probabilities of mortality and attrition after ART initiation were calculated. Mortality risks were corrected for biases from loss to follow-up using Egger’s nomogram. Smoothed hazard rates showed mortality and attrition peaks. Cox regression identified factors associated with death and attrition. Median CD4 counts were calculated at 6 month intervals.Results  In 88,875 adults, 18% were lost to follow up 12 months after treatment initiation, and 36% after 36 months. Cumulative mortality reached 10% by 12 months (15% after correcting for loss to follow-up) and 14% by 36 months. Mortality and attrition rates both peaked within the first six months, and were higher among males, those under 45 kg and those with CD4 counts below 50 cells/μl at ART initiation. In the first year on ART, median CD4 count increased by 126 cells/μl, with similar changes in both sexes.Conclusion  Earlier diagnoses through expanded HIV testing may reduce high mortality and attrition rates if combined with better patient tracing systems. Further research is needed to explore reasons for attrition.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02951.x" xmlns="http://purl.org/rss/1.0/"><title>Training community care workers to provide comprehensive TB/HIV/PMTCT integrated care in KwaZulu-Natal: lessons learnt</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02951.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Training community care workers to provide comprehensive TB/HIV/PMTCT integrated care in KwaZulu-Natal: lessons learnt</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Uwimana</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Zarowsky</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. Hausler</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Jackson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T04:59:30.893523-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02951.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02951.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02951.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To describe a participatory approach to implement and evaluate ways to integrate and train community care workers (CCWs) to enhance collaborative TB/HIV/PMTCT activities, and home-based HIV counseling and testing (HCT) at community level.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> The intervention study was conducted in Sisonke, a rural district of KwaZulu Natal, South Africa. A baseline household (HH) survey was conducted in 11 villages. Six villages were randomly selected into intervention and control clusters. Training was provided first to CCWs from the intervention cluster (IC) followed by the control cluster (CC). Routine monthly data from CCWs were collected from March–December 2010. The data was subjected to bivariate tests.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The baseline HH survey revealed that of 3012 HH members visited by CCWs in 2008, 21% were screened for TB symptoms, 7% were visited for TB adherence support and 2% for ART adherence, and 1.5% were counselled on infant feeding options. A total of 89 CCWs were trained. Data show that during the study period in IC, 684 adults were offered HCT by CCWs, 92% accepted HCT and tested and 7% tested HIV-positive and were referred to the clinic for further care. Of 3556 adults served in IC, 44% were screened for TB symptoms and 32% for symptoms of sexually transmitted infections (STIs) and 37% of children were traced as TB contact. Out of 6226 adults served in CC, 10% were screened for TB symptoms and 7% for STI symptoms. The differences in uptake of services between IC and CC were statistically significant (<em>p</em> &lt; 0.05).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The findings of this study suggest higher uptake of TB and STI symptoms screening, TB contact tracing and home based HCT in the intervention clusters. This study suggests that up-skilling CCWs could be one avenue to enhance TB/HIV case finding, TB contact tracing and linkages to care.</p></div>]]></content:encoded><description>Objective  To describe a participatory approach to implement and evaluate ways to integrate and train community care workers (CCWs) to enhance collaborative TB/HIV/PMTCT activities, and home-based HIV counseling and testing (HCT) at community level.Methods  The intervention study was conducted in Sisonke, a rural district of KwaZulu Natal, South Africa. A baseline household (HH) survey was conducted in 11 villages. Six villages were randomly selected into intervention and control clusters. Training was provided first to CCWs from the intervention cluster (IC) followed by the control cluster (CC). Routine monthly data from CCWs were collected from March–December 2010. The data was subjected to bivariate tests.Results  The baseline HH survey revealed that of 3012 HH members visited by CCWs in 2008, 21% were screened for TB symptoms, 7% were visited for TB adherence support and 2% for ART adherence, and 1.5% were counselled on infant feeding options. A total of 89 CCWs were trained. Data show that during the study period in IC, 684 adults were offered HCT by CCWs, 92% accepted HCT and tested and 7% tested HIV-positive and were referred to the clinic for further care. Of 3556 adults served in IC, 44% were screened for TB symptoms and 32% for symptoms of sexually transmitted infections (STIs) and 37% of children were traced as TB contact. Out of 6226 adults served in CC, 10% were screened for TB symptoms and 7% for STI symptoms. The differences in uptake of services between IC and CC were statistically significant (p &lt; 0.05).Conclusion  The findings of this study suggest higher uptake of TB and STI symptoms screening, TB contact tracing and home based HCT in the intervention clusters. This study suggests that up-skilling CCWs could be one avenue to enhance TB/HIV case finding, TB contact tracing and linkages to care.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02944.x" xmlns="http://purl.org/rss/1.0/"><title>Evaluation of the diagnostic accuracy of the Haemoglobin Colour Scale to detect anaemia in young children attending primary healthcare clinics in Zanzibar</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02944.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Evaluation of the diagnostic accuracy of the Haemoglobin Colour Scale to detect anaemia in young children attending primary healthcare clinics in Zanzibar</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Catherine Aldridge</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hamish M. E. Foster</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marco Albonico</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shaali M. Ame</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Antonio Montresor</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T04:56:27.477968-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02944.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02944.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02944.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> This study evaluates the diagnostic accuracy of Haemoglobin Colour Scale (HCS), compared with clinical diagnosis, to detect anaemia and severe anaemia in preschool-age children attending primary healthcare clinics in rural Zanzibar.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> In all participants, haemoglobin (Hb) concentration was independently estimated by clinical examination for palmar pallor, HCS and HemoCue™. HemoCue was considered the reference method. Data collection was integrated into the usual health services and performed by local healthcare workers (HCWs). Sensitivity, specificity, positive and negative predictive values were calculated for HCS and clinical examination for palmar pallor. The limits of agreement between HCS and HemoCue, and inter-observer variability for HCS, were also defined.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> A total of 799 children age 2–59 months were recruited to the study. The prevalence of anaemia (Hb &lt; 11 g/dl) and severe anaemia (&lt;5 g/dl) were 71% and 0.8% respectively. The sensitivity of HCS to detect anaemia was 33% [95% confidence interval (CI) 29–36] and specificity was 87% (83–91). The sensitivity of HCS to detect severe anaemia was 14% (95% CI 0–58) and specificity was 100% (99–100). The sensitivity of palmar pallor to detect anaemia was low, but superior to HCS (58%<em>vs</em>. 33%, <em>P</em> &lt; 0.001); specificity was inferior to HCS (55%<em>vs</em>. 87%, <em>P</em> &lt; 0.001). There was no evidence of a difference in either sensitivity (<em>P</em> &gt; 0.1) or specificity (<em>P</em> &gt; 0.1) between HCS and palmar pallor to detect severe anaemia.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Haemoglobin Colour Scale does not improve the capacity of HCWs to diagnose anaemia in this population. Accuracy is limited by considerable variability in the performances of test operators. However, optimizing the training protocol for those using the test may improve performance.</p></div>]]></content:encoded><description>Objectives  This study evaluates the diagnostic accuracy of Haemoglobin Colour Scale (HCS), compared with clinical diagnosis, to detect anaemia and severe anaemia in preschool-age children attending primary healthcare clinics in rural Zanzibar.Methods  In all participants, haemoglobin (Hb) concentration was independently estimated by clinical examination for palmar pallor, HCS and HemoCue™. HemoCue was considered the reference method. Data collection was integrated into the usual health services and performed by local healthcare workers (HCWs). Sensitivity, specificity, positive and negative predictive values were calculated for HCS and clinical examination for palmar pallor. The limits of agreement between HCS and HemoCue, and inter-observer variability for HCS, were also defined.Results  A total of 799 children age 2–59 months were recruited to the study. The prevalence of anaemia (Hb &lt; 11 g/dl) and severe anaemia (&lt;5 g/dl) were 71% and 0.8% respectively. The sensitivity of HCS to detect anaemia was 33% [95% confidence interval (CI) 29–36] and specificity was 87% (83–91). The sensitivity of HCS to detect severe anaemia was 14% (95% CI 0–58) and specificity was 100% (99–100). The sensitivity of palmar pallor to detect anaemia was low, but superior to HCS (58%vs. 33%, P &lt; 0.001); specificity was inferior to HCS (55%vs. 87%, P &lt; 0.001). There was no evidence of a difference in either sensitivity (P &gt; 0.1) or specificity (P &gt; 0.1) between HCS and palmar pallor to detect severe anaemia.Conclusions  Haemoglobin Colour Scale does not improve the capacity of HCWs to diagnose anaemia in this population. Accuracy is limited by considerable variability in the performances of test operators. However, optimizing the training protocol for those using the test may improve performance.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02941.x" xmlns="http://purl.org/rss/1.0/"><title>Public health services, an essential determinant of health during crisis. Lessons from Cuba, 1989–2000</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02941.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Public health services, an essential determinant of health during crisis. Lessons from Cuba, 1989–2000</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pol De Vos</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anaí García-Fariñas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Adolfo Álvarez-Pérez</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Armando Rodríguez-Salvá</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mariano Bonet-Gorbea</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Patrick Van der Stuyft</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T04:56:23.462164-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02941.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02941.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02941.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>During the 1990s, Cuba was able to overcome a severe crisis, almost without negative health impacts. This national retrospective study covering the years 1989–2000 analyses the country’s strategy through essential social, demographic, health process and health outcome indicators. Gross domestic product (GDP) diminished by 34.76% between 1989 and 1993. In 1994 slow recuperation started. During the crisis, public health expenses increased. The number of family doctors rose from 9.22 to 27.03 per 104 inhabitants between 1989 and 2000. Infant mortality rate and life expectancy exemplify a series of health indicators that continued to improve during the crisis years, whereas low birth weight and tuberculosis incidence are among the few indicators that suffered deterioration. GDP is inversely related to tuberculosis incidence, whereas the average salary is inversely related to low birth weight. Infant mortality rate has a strong negative correlation with the health expenses per inhabitant, the number of maternal homes, the number of family doctors and the proportion of pregnant women receiving care in maternal homes. Life expectancy has a strong positive correlation with health expenses, the number of nursing personnel and the number of medical contacts per inhabitant. The Cuban strategy effectively resolved health risks during the crisis. In times of serious socio-economic constraints, a well conceptualized public health policy can play an important role in maintaining the overall well-being of a population.</p></div>]]></content:encoded><description>During the 1990s, Cuba was able to overcome a severe crisis, almost without negative health impacts. This national retrospective study covering the years 1989–2000 analyses the country’s strategy through essential social, demographic, health process and health outcome indicators. Gross domestic product (GDP) diminished by 34.76% between 1989 and 1993. In 1994 slow recuperation started. During the crisis, public health expenses increased. The number of family doctors rose from 9.22 to 27.03 per 104 inhabitants between 1989 and 2000. Infant mortality rate and life expectancy exemplify a series of health indicators that continued to improve during the crisis years, whereas low birth weight and tuberculosis incidence are among the few indicators that suffered deterioration. GDP is inversely related to tuberculosis incidence, whereas the average salary is inversely related to low birth weight. Infant mortality rate has a strong negative correlation with the health expenses per inhabitant, the number of maternal homes, the number of family doctors and the proportion of pregnant women receiving care in maternal homes. Life expectancy has a strong positive correlation with health expenses, the number of nursing personnel and the number of medical contacts per inhabitant. The Cuban strategy effectively resolved health risks during the crisis. In times of serious socio-economic constraints, a well conceptualized public health policy can play an important role in maintaining the overall well-being of a population.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02953.x" xmlns="http://purl.org/rss/1.0/"><title>Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02953.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Improved equity in measles vaccination from integrating insecticide-treated bednets in a vaccination campaign, Madagascar</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">James L. Goodson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Manisha A. Kulkarni</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jodi L. Vanden Eng</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kathleen A. Wannemuehler</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Annett H. Cotte</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rachelle E. Desrochers</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bakolalao Randriamanalina</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elizabeth T. Luman</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-24T23:53:00.71262-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02953.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02953.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02953.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To evaluate the effect of integrating ITN distribution on measles vaccination campaign coverage in Madagascar.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Nationwide cross-sectional survey to estimate measles vaccination coverage, nationally, and in districts with and without ITN integration. To evaluate the effect of ITN integration, propensity score matching was used to create comparable samples in ITN and non-ITN districts. Relative risks (RR) and 95% confidence intervals (CI) were estimated via log-binomial models. Equity ratios, defined as the coverage ratio between the lowest and highest household wealth quintile (<em>Q</em>), were used to assess equity in measles vaccination coverage.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> National measles vaccination coverage during the campaign was 66.9% (95% CI 63.0–70.7). Among the propensity score subset, vaccination campaign coverage was higher in ITN districts (70.8%) than non-ITN districts (59.1%) (RR = 1.3, 95% CI 1.1–1.6). Among children in the poorest wealth quintile, vaccination coverage was higher in ITN than in non-ITN districts (Q1; RR = 2.4, 95% CI 1.2–4.8) and equity for measles vaccination was greater in ITN districts (equity ratio = 1.0, 95% CI 0.8–1.3) than in non-ITN districts (equity ratio = 0.4, 95% CI 0.2–0.8).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Integration of ITN distribution with a vaccination campaign might improve measles vaccination coverage among the poor, thus providing protection for the most vulnerable and difficult to reach children.</p></div>]]></content:encoded><description>Objective  To evaluate the effect of integrating ITN distribution on measles vaccination campaign coverage in Madagascar.Methods  Nationwide cross-sectional survey to estimate measles vaccination coverage, nationally, and in districts with and without ITN integration. To evaluate the effect of ITN integration, propensity score matching was used to create comparable samples in ITN and non-ITN districts. Relative risks (RR) and 95% confidence intervals (CI) were estimated via log-binomial models. Equity ratios, defined as the coverage ratio between the lowest and highest household wealth quintile (Q), were used to assess equity in measles vaccination coverage.Results  National measles vaccination coverage during the campaign was 66.9% (95% CI 63.0–70.7). Among the propensity score subset, vaccination campaign coverage was higher in ITN districts (70.8%) than non-ITN districts (59.1%) (RR = 1.3, 95% CI 1.1–1.6). Among children in the poorest wealth quintile, vaccination coverage was higher in ITN than in non-ITN districts (Q1; RR = 2.4, 95% CI 1.2–4.8) and equity for measles vaccination was greater in ITN districts (equity ratio = 1.0, 95% CI 0.8–1.3) than in non-ITN districts (equity ratio = 0.4, 95% CI 0.2–0.8).Conclusion  Integration of ITN distribution with a vaccination campaign might improve measles vaccination coverage among the poor, thus providing protection for the most vulnerable and difficult to reach children.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02950.x" xmlns="http://purl.org/rss/1.0/"><title>The impact of gender and physical environment on the handwashing behaviour of university students in Ghana</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02950.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The impact of gender and physical environment on the handwashing behaviour of university students in Ghana</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Simon Mariwah</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kate Hampshire</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Adetayo Kasim</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-16T15:19:55.550381-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02950.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02950.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02950.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> To establish levels of handwashing after defecation among students at the University of Cape Coast in Ghana, and to test hypotheses that gender and washroom environment affect handwashing behaviour.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Data on students’ handwashing behaviour after defecation were collected by structured observations in washrooms. Eight hundred and six observations were made (360 female students and 446 males) in 56 washrooms over 496 observation periods. Observers recorded gender, duration of handwashing, use of soap, and physical characteristics of the washroom (cleanliness, availability of soap, tap flow and presence of handwashing posters).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Fewer than half the students observed washed their hands or bathed after defecation. Of these, only two-thirds washed both hands and a minority (20%) used soap; only 16 students (all men) washed their hands for the recommended 15 s or longer. Female students were more likely to wash their hands at all, and were more likely to wash both hands, than males. Cleanliness of the washroom was strongly associated with improved handwashing behaviour for both women and men, as was tap flow quality for female students.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Handwashing behaviour is generally poor among UCC students, mirroring results from North American Universities. The findings underline the plasticity of handwashing behaviour among this population, and highlight the need for ensuring that the physical environment in washrooms on university campuses is conducive to handwashing.</p></div>]]></content:encoded><description>Objectives  To establish levels of handwashing after defecation among students at the University of Cape Coast in Ghana, and to test hypotheses that gender and washroom environment affect handwashing behaviour.Methods  Data on students’ handwashing behaviour after defecation were collected by structured observations in washrooms. Eight hundred and six observations were made (360 female students and 446 males) in 56 washrooms over 496 observation periods. Observers recorded gender, duration of handwashing, use of soap, and physical characteristics of the washroom (cleanliness, availability of soap, tap flow and presence of handwashing posters).Results  Fewer than half the students observed washed their hands or bathed after defecation. Of these, only two-thirds washed both hands and a minority (20%) used soap; only 16 students (all men) washed their hands for the recommended 15 s or longer. Female students were more likely to wash their hands at all, and were more likely to wash both hands, than males. Cleanliness of the washroom was strongly associated with improved handwashing behaviour for both women and men, as was tap flow quality for female students.Conclusions  Handwashing behaviour is generally poor among UCC students, mirroring results from North American Universities. The findings underline the plasticity of handwashing behaviour among this population, and highlight the need for ensuring that the physical environment in washrooms on university campuses is conducive to handwashing.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02949.x" xmlns="http://purl.org/rss/1.0/"><title>Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001–2002</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02949.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among humans in Java, Indonesia, in 2001–2002</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Juliëtte A. Severin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Endang Sri Lestari</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wendy Kloezen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nicole Lemmens-den Toom</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ni Made Mertaniasih</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kuntaman Kuntaman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marijam Purwanta</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Offra Duerink</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Usman Hadi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alex van Belkum</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Henri A. Verbrugh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wil H. Goessens</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-16T15:19:38.233878-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02949.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02949.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02949.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To characterise commensal <em>Escherichia coli</em> and other Enterobacteriaceae with reduced susceptibility to cefotaxime that were collected in a large survey carried out among 3995 patients and healthy persons in two urban regions on Java, Indonesia, in 2001–2002.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> The putative extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae were analysed using double-disk synergy tests, isoelectric focusing, PCR assays, DNA sequencing, and pulsed-field gel electrophoresis (PFGE).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> On the day of discharge after five or more days of hospitalisation, at least 95 of 999 (9.5%) patients carried ESBL-positive Enterobacteriaceae as dominant faecal flora. Six patients were simultaneously colonised with <em>E. coli</em> and <em>Klebsiella pneumoniae</em> isolates with ESBL activity. On admission, only 6 of 998 (0.6%) patients were colonised. Faecal carriage of ESBL-producing Enterobacteriaceae among healthy persons or persons visiting a public health centre was not detected. The 107 ESBL-positive strains included 68 <em>E. coli</em>, 35 <em>K. pneumoniae</em>, and four other Enterobacteriaceae. <em>bla</em><sub>CTX-M-15</sub> was the most prevalent ESBL in both <em>E. coli</em> (47.1%) and <em>K. pneumoniae</em> (45.7%), but the <em>E. coli</em> O25b-ST131 clone was virtually absent. Other ESBL types found were: SHV-2, -2a, -5, -12, CTX-M-3, -9, -14, and TEM-19. PFGE revealed extensive genetic diversity among the isolates.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> In 2001–2002, faecal carriage of ESBL-producing Enterobacteriaceae as dominant flora in Indonesia was almost exclusively hospital-associated. The presence of various <em>bla</em><sub>ESBL</sub> genes and the extensive genetic diversity among isolates argue against a single/dominant strain outbreak.</p></div>]]></content:encoded><description>Objective  To characterise commensal Escherichia coli and other Enterobacteriaceae with reduced susceptibility to cefotaxime that were collected in a large survey carried out among 3995 patients and healthy persons in two urban regions on Java, Indonesia, in 2001–2002.Methods  The putative extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae were analysed using double-disk synergy tests, isoelectric focusing, PCR assays, DNA sequencing, and pulsed-field gel electrophoresis (PFGE).Results  On the day of discharge after five or more days of hospitalisation, at least 95 of 999 (9.5%) patients carried ESBL-positive Enterobacteriaceae as dominant faecal flora. Six patients were simultaneously colonised with E. coli and Klebsiella pneumoniae isolates with ESBL activity. On admission, only 6 of 998 (0.6%) patients were colonised. Faecal carriage of ESBL-producing Enterobacteriaceae among healthy persons or persons visiting a public health centre was not detected. The 107 ESBL-positive strains included 68 E. coli, 35 K. pneumoniae, and four other Enterobacteriaceae. blaCTX-M-15 was the most prevalent ESBL in both E. coli (47.1%) and K. pneumoniae (45.7%), but the E. coli O25b-ST131 clone was virtually absent. Other ESBL types found were: SHV-2, -2a, -5, -12, CTX-M-3, -9, -14, and TEM-19. PFGE revealed extensive genetic diversity among the isolates.Conclusions  In 2001–2002, faecal carriage of ESBL-producing Enterobacteriaceae as dominant flora in Indonesia was almost exclusively hospital-associated. The presence of various blaESBL genes and the extensive genetic diversity among isolates argue against a single/dominant strain outbreak.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02945.x" xmlns="http://purl.org/rss/1.0/"><title>Clusters of leprosy transmission and of late diagnosis in a highly endemic area in Brazil: focus on different spatial analysis approaches</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02945.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Clusters of leprosy transmission and of late diagnosis in a highly endemic area in Brazil: focus on different spatial analysis approaches</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Carlos H. Alencar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alberto N. Ramos</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Emerson S. dos Santos</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joachim Richter</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jorg Heukelbach</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-16T15:18:04.495-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02945.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02945.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02945.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> The Brazilian National Hansen’s Disease Control Program recently identified clusters with high disease transmission. Herein, we present different spatial analytical approaches to define highly vulnerable areas in one of these clusters.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method </b> The study area included 373 municipalities in the four Brazilian states Maranhão, Pará, Tocantins and Piauí. Spatial analysis was based on municipalities as the observation unit, considering the following disease indicators: (i) rate of new cases/100 000 population, (ii) rate of cases &lt;15 years/100 000 population, (iii) new cases with grade-2 disability/100 000 population and (iv) proportion of new cases with grade-2 disabilities. We performed descriptive spatial analysis, local empirical Bayesian analysis and spatial scan statistic.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> A total of 254 (68.0%) municipalities were classified as hyperendemic (mean annual detection rates &gt;40 cases/100 000 inhabitants). There was a concentration of municipalities with higher detection rates in Pará and in the center of Maranhão. Spatial scan statistic identified 23 likely clusters of new leprosy case detection rates, most of them localized in these two states. These clusters included only 32% of the total population, but 55.4% of new leprosy cases. We also identified 16 significant clusters for the detection rate &lt;15 years and 11 likely clusters of new cases with grade-2. Several clusters of new cases with grade-2/population overlap with those of new cases detection and detection of children &lt;15 years of age. The proportion of new cases with grade-2 did not reveal any significant clusters.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Several municipality clusters for high leprosy transmission and late diagnosis were identified in an endemic area using different statistical approaches. Spatial scan statistic is adequate to validate and confirm high-risk leprosy areas for transmission and late diagnosis, identified using descriptive spatial analysis and using local empirical Bayesian method. National and State leprosy control programs urgently need to intensify control actions in these highly vulnerable municipalities.</p></div>]]></content:encoded><description>Objective  The Brazilian National Hansen’s Disease Control Program recently identified clusters with high disease transmission. Herein, we present different spatial analytical approaches to define highly vulnerable areas in one of these clusters.Method  The study area included 373 municipalities in the four Brazilian states Maranhão, Pará, Tocantins and Piauí. Spatial analysis was based on municipalities as the observation unit, considering the following disease indicators: (i) rate of new cases/100 000 population, (ii) rate of cases &lt;15 years/100 000 population, (iii) new cases with grade-2 disability/100 000 population and (iv) proportion of new cases with grade-2 disabilities. We performed descriptive spatial analysis, local empirical Bayesian analysis and spatial scan statistic.Results  A total of 254 (68.0%) municipalities were classified as hyperendemic (mean annual detection rates &gt;40 cases/100 000 inhabitants). There was a concentration of municipalities with higher detection rates in Pará and in the center of Maranhão. Spatial scan statistic identified 23 likely clusters of new leprosy case detection rates, most of them localized in these two states. These clusters included only 32% of the total population, but 55.4% of new leprosy cases. We also identified 16 significant clusters for the detection rate &lt;15 years and 11 likely clusters of new cases with grade-2. Several clusters of new cases with grade-2/population overlap with those of new cases detection and detection of children &lt;15 years of age. The proportion of new cases with grade-2 did not reveal any significant clusters.Conclusions  Several municipality clusters for high leprosy transmission and late diagnosis were identified in an endemic area using different statistical approaches. Spatial scan statistic is adequate to validate and confirm high-risk leprosy areas for transmission and late diagnosis, identified using descriptive spatial analysis and using local empirical Bayesian method. National and State leprosy control programs urgently need to intensify control actions in these highly vulnerable municipalities.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02935.x" xmlns="http://purl.org/rss/1.0/"><title>Sulfadoxine–pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC)</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02935.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Sulfadoxine–pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joris L. Likwela</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Umberto D’Alessandro</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bernard L. Lokwa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sylvain Meuris</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michele W. Dramaix</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-30T03:29:45.286481-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02935.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02935.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02935.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To assess the effect of intermittent preventive treatment with sulfadoxine–pyrimethamine (IPTp-SP) on birth weight in sites with varying degrees of drug resistance.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Birth weight data from three regions in Democratic Republic of Congo with varying degrees of sulfadoxine–pyrimethamine (SP) resistance (1.6% in Mikalayi, 21.7% in Kisangani and 60.6% in Rutshuru) were analysed retrospectively by means of a logistic model that included the number of SP doses taken by the mother and other potentials confounding factors.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The IPTp-SP reduced the risk of low birth weight (LBW) in Kisangani (adjusted OR, 0.15; IC95%, 0.05–0.46) and in Mikalayi (adjusted OR, 0.12; IC95%, 0.01–0.89). In both sites, the average birth weight was higher for mothers having received two rather than one or no SP doses (<em>P</em> &lt; 0.001). In Rutshuru, IPTp-SP had an effect in primigravidae but not in multigravidae. However, after adjustment for other LBW risk factors, there was no difference in the proportion of LBW (adjusted OR 0.92; IC95%, 0.37–2.25) between women having taken at least 2 SP doses and those with only one dose or none.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> IPT-SP remains an effective strategy in Kisangani and Mikalayi where the therapeutic failure to SP in children with clinical malaria was 21.7% and 1.6%, respectively, while IPTp-SP effect seems lower in Rutshuru where the therapeutic failure to SP was 60.6%. The threshold value of SP resistance at which IPTp-SP fails to have a significant impact on birth weight and LBW is unknown. Considering that no alternative is currently available, additional studies on the efficacy of IPTp-SP in the areas of high SP resistance such as Rutshuru are needed so that the threshold at which this intervention fails to provide any benefit is determined with some precision.</p></div>]]></content:encoded><description>Objective  To assess the effect of intermittent preventive treatment with sulfadoxine–pyrimethamine (IPTp-SP) on birth weight in sites with varying degrees of drug resistance.Methods  Birth weight data from three regions in Democratic Republic of Congo with varying degrees of sulfadoxine–pyrimethamine (SP) resistance (1.6% in Mikalayi, 21.7% in Kisangani and 60.6% in Rutshuru) were analysed retrospectively by means of a logistic model that included the number of SP doses taken by the mother and other potentials confounding factors.Results  The IPTp-SP reduced the risk of low birth weight (LBW) in Kisangani (adjusted OR, 0.15; IC95%, 0.05–0.46) and in Mikalayi (adjusted OR, 0.12; IC95%, 0.01–0.89). In both sites, the average birth weight was higher for mothers having received two rather than one or no SP doses (P &lt; 0.001). In Rutshuru, IPTp-SP had an effect in primigravidae but not in multigravidae. However, after adjustment for other LBW risk factors, there was no difference in the proportion of LBW (adjusted OR 0.92; IC95%, 0.37–2.25) between women having taken at least 2 SP doses and those with only one dose or none.Conclusion  IPT-SP remains an effective strategy in Kisangani and Mikalayi where the therapeutic failure to SP in children with clinical malaria was 21.7% and 1.6%, respectively, while IPTp-SP effect seems lower in Rutshuru where the therapeutic failure to SP was 60.6%. The threshold value of SP resistance at which IPTp-SP fails to have a significant impact on birth weight and LBW is unknown. Considering that no alternative is currently available, additional studies on the efficacy of IPTp-SP in the areas of high SP resistance such as Rutshuru are needed so that the threshold at which this intervention fails to provide any benefit is determined with some precision.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02938.x" xmlns="http://purl.org/rss/1.0/"><title>Is HINARI appropriate for medical students in the developing world?</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02938.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Is HINARI appropriate for medical students in the developing world?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Caleb Van Essen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Peter Cartledge</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Patrick Kyamanywa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Achille Manirakiza</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-30T02:26:23.212568-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02938.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02938.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02938.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Viewpoint</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The Health InterNetwork Access to Research Initiative (HINARI), which arose in response to medical literature needs in developing countries, gives online access to scientific information to a variety of institutions throughout the world. This is a great resource; however, little research has been performed on the effectiveness and usefulness of HINARI, specifically to medical schools. Our study sought to find out whether the textbooks (e-books) available on HINARI could form a virtual library that would cover the curriculum of a medical school. After categorising and reviewing the medically relevant e-books on HINARI, we found that they were insufficient in providing adequate subject material relevant to medical school curricula from Rwanda, the United Kingdom and the United States. This literature gap could be closed by additional medical textbooks being made available from contributing publishers. An increase of only 14% in HINARI e-book resources would provide material for the entire medical school curriculum.</p></div>]]></content:encoded><description>The Health InterNetwork Access to Research Initiative (HINARI), which arose in response to medical literature needs in developing countries, gives online access to scientific information to a variety of institutions throughout the world. This is a great resource; however, little research has been performed on the effectiveness and usefulness of HINARI, specifically to medical schools. Our study sought to find out whether the textbooks (e-books) available on HINARI could form a virtual library that would cover the curriculum of a medical school. After categorising and reviewing the medically relevant e-books on HINARI, we found that they were insufficient in providing adequate subject material relevant to medical school curricula from Rwanda, the United Kingdom and the United States. This literature gap could be closed by additional medical textbooks being made available from contributing publishers. An increase of only 14% in HINARI e-book resources would provide material for the entire medical school curriculum.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02936.x" xmlns="http://purl.org/rss/1.0/"><title>Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02936.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Camila Aguiar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Angelica M. Batista</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tycha B. S. Pavan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eros A. Almeida</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Maria E. Guariento</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jamiro S. Wanderley</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sandra C. B. Costa</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-30T02:25:25.536996-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02936.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02936.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02936.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To evaluate the serological and parasitological status of patients with chronic Chagas disease (CD) after chemotherapy with benzonidazole.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Retrospective study of patients treated with benzonidazole (5 mg/kg/day for 60 days) between 1980 and 2010. Twenty-nine patients who had CD confirmed by two reagent immunological tests and/or one positive xenodiagnosis before treatment were included. Conventional serology (ELISA and IIF) and parasitological tests (haemoculture and N-PCR) were performed.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> At the time of treatment, the mean age of patients was 36 ± 7.24 years (20–39 years) and the time post-treatment varied from 1 to 29 years. After chemotherapy, all individuals had reagent ELISA and 93.1% had positive results for the IIF test. <em>T. cruzi</em> DNA was detected by N-PCR in 48.3%. Negative results were observed in 41.4% and inconclusive ones in 10.3%. Haemoculture was negative for all individuals.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Our results suggest that N-PCR may be useful in the early identification of therapeutic failure of CD. Although it is difficult to determine parasitological cure in negative N-PCR cases, we can infer that this condition represents a declination of parasitaemia as a favourable consequence of aetiological treatment.</p></div>]]></content:encoded><description>Objective  To evaluate the serological and parasitological status of patients with chronic Chagas disease (CD) after chemotherapy with benzonidazole.Methods  Retrospective study of patients treated with benzonidazole (5 mg/kg/day for 60 days) between 1980 and 2010. Twenty-nine patients who had CD confirmed by two reagent immunological tests and/or one positive xenodiagnosis before treatment were included. Conventional serology (ELISA and IIF) and parasitological tests (haemoculture and N-PCR) were performed.Results  At the time of treatment, the mean age of patients was 36 ± 7.24 years (20–39 years) and the time post-treatment varied from 1 to 29 years. After chemotherapy, all individuals had reagent ELISA and 93.1% had positive results for the IIF test. T. cruzi DNA was detected by N-PCR in 48.3%. Negative results were observed in 41.4% and inconclusive ones in 10.3%. Haemoculture was negative for all individuals.Conclusions  Our results suggest that N-PCR may be useful in the early identification of therapeutic failure of CD. Although it is difficult to determine parasitological cure in negative N-PCR cases, we can infer that this condition represents a declination of parasitaemia as a favourable consequence of aetiological treatment.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02921.x" xmlns="http://purl.org/rss/1.0/"><title>Effect of pregnancy on immunological and virological outcomes of women on ART: a prospective cohort study in rural Uganda, 2004–2009</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02921.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effect of pregnancy on immunological and virological outcomes of women on ART: a prospective cohort study in rural Uganda, 2004–2009</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Billy N. Mayanja</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Leigh Anne Shafer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lieve Van der Paal</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nassim Kyakuwa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nicaise Ndembi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Peter Hughes</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dermot Maher</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Heiner Grosskurth</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-30T01:20:59.56923-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02921.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02921.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02921.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> Before antiretroviral therapy (ART) introduction, pregnancy was associated with a sustained drop in CD4 cell count in HIV-infected women. We examined the effects of pregnancy on immunological and virological ART outcomes.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Between January 2004 and March 2009, we studied HIV-infected women receiving ART in a prospective open cohort study in rural Uganda. We used random effects regression models to compare the CD4 counts of women who became pregnant and those who did not, and among the pregnant women before and after pregnancy. CD4 count and proportions with detectable viral load (≥400 copies/ml) were compared between the two groups using the Mann–Whitney rank sum test and logistic regression respectively.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Of 88 women aged 20–40 years receiving ART, 23 became pregnant. At ART initiation, there were no significant differences between those who became pregnant and those who did not in clinical, immunological and virological parameters. Among women who became pregnant, CD4 cell count increased before pregnancy (average 75.9 cells/mm<sup>3</sup> per year), declined during pregnancy (average 106.0) but rose again in the first year after delivery (average 88.6). Among women who did not become pregnant, the average CD4 cell count rise per year for the first 3 years was 88.5. There was no significant difference in the proportions of women with detectable viral load at last clinic visit among those who became pregnant (8.7%) and those who did not (16.1%), <em>P</em> = 0.499.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Pregnancy had no lasting effect on the immunological and virological outcomes of HIV-infected women on ART.</p></div>]]></content:encoded><description>Objectives  Before antiretroviral therapy (ART) introduction, pregnancy was associated with a sustained drop in CD4 cell count in HIV-infected women. We examined the effects of pregnancy on immunological and virological ART outcomes.Methods  Between January 2004 and March 2009, we studied HIV-infected women receiving ART in a prospective open cohort study in rural Uganda. We used random effects regression models to compare the CD4 counts of women who became pregnant and those who did not, and among the pregnant women before and after pregnancy. CD4 count and proportions with detectable viral load (≥400 copies/ml) were compared between the two groups using the Mann–Whitney rank sum test and logistic regression respectively.Results  Of 88 women aged 20–40 years receiving ART, 23 became pregnant. At ART initiation, there were no significant differences between those who became pregnant and those who did not in clinical, immunological and virological parameters. Among women who became pregnant, CD4 cell count increased before pregnancy (average 75.9 cells/mm3 per year), declined during pregnancy (average 106.0) but rose again in the first year after delivery (average 88.6). Among women who did not become pregnant, the average CD4 cell count rise per year for the first 3 years was 88.5. There was no significant difference in the proportions of women with detectable viral load at last clinic visit among those who became pregnant (8.7%) and those who did not (16.1%), P = 0.499.Conclusion  Pregnancy had no lasting effect on the immunological and virological outcomes of HIV-infected women on ART.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02927.x" xmlns="http://purl.org/rss/1.0/"><title>Assessing the impact of a school-based water treatment, hygiene and sanitation programme on pupil absence in Nyanza Province, Kenya: a cluster-randomized trial</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02927.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Assessing the impact of a school-based water treatment, hygiene and sanitation programme on pupil absence in Nyanza Province, Kenya: a cluster-randomized trial</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Matthew C. Freeman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Leslie E. Greene</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Robert Dreibelbis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shadi Saboori</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Richard Muga</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Babette Brumback</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Richard Rheingans</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-18T22:48:19.608762-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02927.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02927.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02927.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> There has been increased attention to access to water, sanitation and hygiene (WASH) at schools in developing countries, but a dearth of empirical studies on the impact. We conducted a cluster-randomized trial of school-based WASH on pupil absence in Nyanza Province, Kenya, from 2007 to 2008.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Public primary schools nested in three geographical strata were randomly assigned and allocated to one of three study arms [water treatment and hygiene promotion (WT &amp; HP), additional sanitation improvement, or control] to assess the effects on pupil absence at 2-year follow-up.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> We found no overall effect of the intervention on absence. However, among schools in two of the geographical areas not affected by post-election violence, those that received WT and HP showed a 58% reduction in the odds of absence for girls (OR 0.42, CI 0.21–0.85). In the same strata, sanitation improvement in combination with WT and HP resulted in a comparable drop in absence, although results were marginally significant (OR 0.47, 0.21–1.05). Boys were not impacted by the intervention.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> School WASH improvements can improve school attendance for girls, and mechanisms for gendered impacts should be explored. Incomplete intervention compliance highlights the challenges of achieving consistent results across all settings.</p></div>]]></content:encoded><description>Objectives  There has been increased attention to access to water, sanitation and hygiene (WASH) at schools in developing countries, but a dearth of empirical studies on the impact. We conducted a cluster-randomized trial of school-based WASH on pupil absence in Nyanza Province, Kenya, from 2007 to 2008.Methods  Public primary schools nested in three geographical strata were randomly assigned and allocated to one of three study arms [water treatment and hygiene promotion (WT &amp; HP), additional sanitation improvement, or control] to assess the effects on pupil absence at 2-year follow-up.Results  We found no overall effect of the intervention on absence. However, among schools in two of the geographical areas not affected by post-election violence, those that received WT and HP showed a 58% reduction in the odds of absence for girls (OR 0.42, CI 0.21–0.85). In the same strata, sanitation improvement in combination with WT and HP resulted in a comparable drop in absence, although results were marginally significant (OR 0.47, 0.21–1.05). Boys were not impacted by the intervention.Conclusion  School WASH improvements can improve school attendance for girls, and mechanisms for gendered impacts should be explored. Incomplete intervention compliance highlights the challenges of achieving consistent results across all settings.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02931.x" xmlns="http://purl.org/rss/1.0/"><title>Stillbirths and early neonatal mortality in rural Northern Ghana</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02931.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Stillbirths and early neonatal mortality in rural Northern Ghana</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cyril Engmann</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul Walega</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raymond A. Aborigo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Philip Adongo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cheryl A. Moyer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Layla Lavasani</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">John Williams</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Carl Bose</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fred Binka</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Abraham Hodgson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-18T22:46:37.184252-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02931.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02931.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02931.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To calculate perinatal mortality (stillbirth and early neonatal death: END) rates in the Upper East region of Ghana and characterize community-based stillbirths and END in terms of timing, cause of death, and maternal and infant risk factors.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Birth outcomes were obtained from the Navrongo Health and Demographic Surveillance System over a 7-year period.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Twenty thousand four hundred and ninty seven pregnant women were registered in the study. The perinatal mortality rate was 39 deaths/1000 deliveries, stillbirth rate 23/1000 deliveries and END rates 16/1000 live births. Most stillbirths were 31 weeks gestation or less. Prematurity, first-time delivery and multiple gestation all significantly increased the odds of perinatal death. Approximately 70% of END occurred during the first 3 postnatal days, and the most common causes of death were birth asphyxia and injury, infections and prematurity.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Stillbirths and END remain a significant problem in Navrongo. The main causes of END occur during the first 3 days and may be modifiable with simple targeted perinatal policies.</p></div>]]></content:encoded><description>Objective  To calculate perinatal mortality (stillbirth and early neonatal death: END) rates in the Upper East region of Ghana and characterize community-based stillbirths and END in terms of timing, cause of death, and maternal and infant risk factors.Methods  Birth outcomes were obtained from the Navrongo Health and Demographic Surveillance System over a 7-year period.Results  Twenty thousand four hundred and ninty seven pregnant women were registered in the study. The perinatal mortality rate was 39 deaths/1000 deliveries, stillbirth rate 23/1000 deliveries and END rates 16/1000 live births. Most stillbirths were 31 weeks gestation or less. Prematurity, first-time delivery and multiple gestation all significantly increased the odds of perinatal death. Approximately 70% of END occurred during the first 3 postnatal days, and the most common causes of death were birth asphyxia and injury, infections and prematurity.Conclusion  Stillbirths and END remain a significant problem in Navrongo. The main causes of END occur during the first 3 days and may be modifiable with simple targeted perinatal policies.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02920.x" xmlns="http://purl.org/rss/1.0/"><title>Methodology matters: what type of research is suitable for evaluating community treatment supporters for HIV and tuberculosis treatment?</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02920.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Methodology matters: what type of research is suitable for evaluating community treatment supporters for HIV and tuberculosis treatment?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dermot Maher</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anthony D. Harries</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jean B. Nachega</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shabbar Jaffar</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-16T01:23:56.076058-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02920.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02920.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02920.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Viewpoint</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The choice of research method relevant to the evaluation of delivery of a health intervention is not always straightforward. We use the evaluation of HIV and tuberculosis community treatment supporters in promoting adherence to treatment in Africa as a case study to illustrate the pros and cons of operational research and randomised controlled trials. The choice of this intervention for the case study reflects the importance of maximising the benefits of unprecedented efforts to scale-up treatments of these two epidemics. International policy supporting the role of community treatment supporters in tuberculosis is largely based on the findings of operational research studies. This reflects the advantages that operational research is less costly than randomised controlled trials, provides more rapid answers to policy questions, enables standard evaluation of the intervention in ‘real life’ conditions in several diverse settings and has in-built potential to influence policy and practice, because the research is conducted within health programmes. Recent evidence on the role of community treatment supporters in HIV is largely based on randomised trials. This reflects the advantages that randomised trials compared to operational research are more rigorous and generate a more convincing result. Operational research and randomised trials may be viewed as providing complementary findings to inform new policies and practice aimed at improving programme performance and patient outcomes. However, in practice, insufficient funds are likely to be made available for randomised trials to answer all the current research questions on delivery of programme interventions. In deciding on the type of research to evaluate a particular health intervention, dialogue is necessary with policy-makers to weigh up explicitly the trade-offs between research rigour and other factors such as cost, speed of implementation of research and speed of policy uptake and of change in programme practice.</p></div>]]></content:encoded><description>The choice of research method relevant to the evaluation of delivery of a health intervention is not always straightforward. We use the evaluation of HIV and tuberculosis community treatment supporters in promoting adherence to treatment in Africa as a case study to illustrate the pros and cons of operational research and randomised controlled trials. The choice of this intervention for the case study reflects the importance of maximising the benefits of unprecedented efforts to scale-up treatments of these two epidemics. International policy supporting the role of community treatment supporters in tuberculosis is largely based on the findings of operational research studies. This reflects the advantages that operational research is less costly than randomised controlled trials, provides more rapid answers to policy questions, enables standard evaluation of the intervention in ‘real life’ conditions in several diverse settings and has in-built potential to influence policy and practice, because the research is conducted within health programmes. Recent evidence on the role of community treatment supporters in HIV is largely based on randomised trials. This reflects the advantages that randomised trials compared to operational research are more rigorous and generate a more convincing result. Operational research and randomised trials may be viewed as providing complementary findings to inform new policies and practice aimed at improving programme performance and patient outcomes. However, in practice, insufficient funds are likely to be made available for randomised trials to answer all the current research questions on delivery of programme interventions. In deciding on the type of research to evaluate a particular health intervention, dialogue is necessary with policy-makers to weigh up explicitly the trade-offs between research rigour and other factors such as cost, speed of implementation of research and speed of policy uptake and of change in programme practice.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02916.x" xmlns="http://purl.org/rss/1.0/"><title>Expanding and improving urban outreach immunization in Patna, India</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02916.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Expanding and improving urban outreach immunization in Patna, India</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Narottam Pradhan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tove K. Ryman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sherin Varkey</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alok Ranjan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Satish K. Gupta</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gopal Krishna</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. P. Swetanki</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Randall Young</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-14T09:05:58.884816-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02916.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02916.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02916.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> We conducted a case study of an urban immunization outreach strategy to determine the feasibility of the intervention and to measure administrative immunization coverage outcomes.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> A multipronged strategy for improving immunization coverage in Urban Patna, India, was implemented for 1 year (2009/2010). The strategy was designed to increase immunization sites, shift human resources, plan logistics, improve community mobilization, provide supervision, strengthen data flow and implement special vaccination drives.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Over 1 year, the coverage of all primary vaccines of the Universal Immunization Program improved by over 100%.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Coverage can be rapidly improved through outreach immunization in low socioeconomic areas if existing opportunities are carefully utilized.</p></div>]]></content:encoded><description>Objectives  We conducted a case study of an urban immunization outreach strategy to determine the feasibility of the intervention and to measure administrative immunization coverage outcomes.Methods  A multipronged strategy for improving immunization coverage in Urban Patna, India, was implemented for 1 year (2009/2010). The strategy was designed to increase immunization sites, shift human resources, plan logistics, improve community mobilization, provide supervision, strengthen data flow and implement special vaccination drives.Results  Over 1 year, the coverage of all primary vaccines of the Universal Immunization Program improved by over 100%.Conclusion  Coverage can be rapidly improved through outreach immunization in low socioeconomic areas if existing opportunities are carefully utilized.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02926.x" xmlns="http://purl.org/rss/1.0/"><title>Risk factors for pre-eclampsia in Mulago Hospital, Kampala, Uganda</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02926.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Risk factors for pre-eclampsia in Mulago Hospital, Kampala, Uganda</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul Kiondo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gakenia Wamuyu-Maina</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gabriel S. Bimenya</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nazarius Mbona Tumwesigye</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Julius Wandabwa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pius Okong</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-13T00:35:30.211347-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02926.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02926.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02926.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> Pre-eclampsia contributes significantly to maternal, foetal and neonatal morbidity and mortality. The risk factors for pre-eclampsia have not been well documented in Uganda. In this paper, we describe the risk factors for pre-eclampsia in women attending antenatal clinics at Mulago Hospital, Kampala.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> This casecontrol study was conducted from 1st May 2008 to 1st May 2009. 207 women with pre-eclampsia were the cases, and 352 women with normal pregnancy were the controls. The women were 15–39 years old, and their gestational ages were 20 weeks or more. They were interviewed about their socio-demographic characteristics, past medical history and, their past and present obstetric performances.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The risk factors were low plasma vitamin C (OR 3.19, 95% CI: 1.54–6.61), low education level (OR 1.67, 95% CI: 1.12–2.48), chronic hypertension (OR 2.29, 95% CI 1.12–4.66), family history of hypertension (OR 2.25, 95% CI: 1.53–3.31) and primiparity (OR 2.76, 95% CI: 1.84–4.15) and para≥5 (3.71, 95% CI:1.84–7.45).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The risk factors identified are similar to what has been found elsewhere. Health workers need to identify women at risk of pre-eclampsia and manage them appropriately so as to prevent the maternal and neonatal morbidity and mortality associated with this condition.</p></div>]]></content:encoded><description>Objective  Pre-eclampsia contributes significantly to maternal, foetal and neonatal morbidity and mortality. The risk factors for pre-eclampsia have not been well documented in Uganda. In this paper, we describe the risk factors for pre-eclampsia in women attending antenatal clinics at Mulago Hospital, Kampala.Methods  This casecontrol study was conducted from 1st May 2008 to 1st May 2009. 207 women with pre-eclampsia were the cases, and 352 women with normal pregnancy were the controls. The women were 15–39 years old, and their gestational ages were 20 weeks or more. They were interviewed about their socio-demographic characteristics, past medical history and, their past and present obstetric performances.Results  The risk factors were low plasma vitamin C (OR 3.19, 95% CI: 1.54–6.61), low education level (OR 1.67, 95% CI: 1.12–2.48), chronic hypertension (OR 2.29, 95% CI 1.12–4.66), family history of hypertension (OR 2.25, 95% CI: 1.53–3.31) and primiparity (OR 2.76, 95% CI: 1.84–4.15) and para≥5 (3.71, 95% CI:1.84–7.45).Conclusion  The risk factors identified are similar to what has been found elsewhere. Health workers need to identify women at risk of pre-eclampsia and manage them appropriately so as to prevent the maternal and neonatal morbidity and mortality associated with this condition.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02934.x" xmlns="http://purl.org/rss/1.0/"><title>Profile of gay men in Mexico City: results of a survey of meeting sites</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02934.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Profile of gay men in Mexico City: results of a survey of meeting sites</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Juan Pablo Gutiérrez</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-11T23:55:22.219784-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02934.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02934.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02934.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To describe the distribution, size and characteristics of formal and non-formal meeting places for gay men in Mexico City, the general characteristics of this population, and the factors influencing HIV status and sexual behaviour among gay men.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Meeting sites for gay men in Mexico City were mapped, and the results were used as a sampling frame for an individual-level survey. For the survey, a random sample of sites was selected using a selection probability proportional to size, with the aim of interviewing approximately 3000 gay men. Multivariate logistic models were constructed to analyse the correlations between the population profile, and characteristics and behaviours related to HIV status.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Mapping produced an estimated population attending these meeting places in Mexico City of about 6000–14 000 gay men, who were mostly young and economically active individuals with higher educational and socioeconomic levels than the average levels of the population as a whole. Approximately 67% of these men reported being tested for HIV at least once, and 30% of the men reported being HIV-positive.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion </b> Participants’ profile depicted the gay population in Mexico City as a highly educated community with a relatively high socioeconomic level. Despite their exposure to prevention efforts, members of this community reported unsafe behaviours consistent with the high prevalence of self-reported HIV infection.</p></div>]]></content:encoded><description>Objective  To describe the distribution, size and characteristics of formal and non-formal meeting places for gay men in Mexico City, the general characteristics of this population, and the factors influencing HIV status and sexual behaviour among gay men.Methods  Meeting sites for gay men in Mexico City were mapped, and the results were used as a sampling frame for an individual-level survey. For the survey, a random sample of sites was selected using a selection probability proportional to size, with the aim of interviewing approximately 3000 gay men. Multivariate logistic models were constructed to analyse the correlations between the population profile, and characteristics and behaviours related to HIV status.Results  Mapping produced an estimated population attending these meeting places in Mexico City of about 6000–14 000 gay men, who were mostly young and economically active individuals with higher educational and socioeconomic levels than the average levels of the population as a whole. Approximately 67% of these men reported being tested for HIV at least once, and 30% of the men reported being HIV-positive.Discussion  Participants’ profile depicted the gay population in Mexico City as a highly educated community with a relatively high socioeconomic level. Despite their exposure to prevention efforts, members of this community reported unsafe behaviours consistent with the high prevalence of self-reported HIV infection.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02923.x" xmlns="http://purl.org/rss/1.0/"><title>Compliance with focused antenatal care services: do health workers in rural Burkina Faso, Uganda and Tanzania perform all ANC procedures?</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02923.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Compliance with focused antenatal care services: do health workers in rural Burkina Faso, Uganda and Tanzania perform all ANC procedures?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul Conrad</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gerhrd Schmid</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Justin Tientrebeogo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Arinaitwe Moses</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Silvia Kirenga</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Florian Neuhann</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Olaf Müller</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Malabika Sarker</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-08T05:58:38.110016-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02923.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02923.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02923.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To assess health workers’ compliance with the procedures set in the focused antenatal care (ANC) guidelines in rural Uganda, Tanzania and Burkina Faso; to compare the compliance within and among the three study sites; and to appraise the logistic and supply of the respective health facilities (HF).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> The cross-sectional study was conducted in the rural HF in three African countries. This descriptive observational study took place in HF in Nouna, Burkina Faso (5), Iganga, Uganda (6) and Rufiji, Tanzania (7). In total, 788 ANC sessions and service provisions were observed, the duration of each ANC service provision was calculated, and the infrastructures of the respective HF were assessed.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Health workers in all HF performed most of the procedures but also omitted certain practices stipulated in the focused ANC guidelines. There was a substantial variation in provision of ANC services among HF within and among the country sites. The findings also revealed that the duration of first visits was &lt;15 min and health workers spent even less time in subsequent visits in all three sites. Reagents for laboratory tests and drugs as outlined in the focus ANC guidelines were often out of stock in most facilities.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Health workers in all three country sites failed to perform all procedures stipulated in the focused ANC guideline; this could not be always explained by the lack of supplies. It is crucial to point out the necessity of the core procedures of ANC repeatedly.</p></div>]]></content:encoded><description>Objective  To assess health workers’ compliance with the procedures set in the focused antenatal care (ANC) guidelines in rural Uganda, Tanzania and Burkina Faso; to compare the compliance within and among the three study sites; and to appraise the logistic and supply of the respective health facilities (HF).Methods  The cross-sectional study was conducted in the rural HF in three African countries. This descriptive observational study took place in HF in Nouna, Burkina Faso (5), Iganga, Uganda (6) and Rufiji, Tanzania (7). In total, 788 ANC sessions and service provisions were observed, the duration of each ANC service provision was calculated, and the infrastructures of the respective HF were assessed.Results  Health workers in all HF performed most of the procedures but also omitted certain practices stipulated in the focused ANC guidelines. There was a substantial variation in provision of ANC services among HF within and among the country sites. The findings also revealed that the duration of first visits was &lt;15 min and health workers spent even less time in subsequent visits in all three sites. Reagents for laboratory tests and drugs as outlined in the focus ANC guidelines were often out of stock in most facilities.Conclusion  Health workers in all three country sites failed to perform all procedures stipulated in the focused ANC guideline; this could not be always explained by the lack of supplies. It is crucial to point out the necessity of the core procedures of ANC repeatedly.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02932.x" xmlns="http://purl.org/rss/1.0/"><title>Anaemia during pregnancy: impact on birth outcome and infant haemoglobin level during the first 18 months of life</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02932.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Anaemia during pregnancy: impact on birth outcome and infant haemoglobin level during the first 18 months of life</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ghislain K. Koura</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Smaïla Ouedraogo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Agnès Le Port</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Laurence Watier</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gilles Cottrell</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">José Guerra</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Isabelle Choudat</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Antoine Rachas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Julie Bouscaillou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Achille Massougbodji</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">André Garcia</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-07T04:38:34.594329-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02932.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02932.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02932.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>To determine the effect of maternal anaemia on pregnancy outcome and describe its impact on infant haemoglobin level in the first 18 months of life, we conducted a prospective study of 617 pregnant women and their children in Benin. Prevalence of maternal anaemia at delivery was 39.5%, and 61.1% of newborns were anaemic at birth. Maternal anaemia was not associated with low birth weight [OR = 1.2 (0.6–2.2)] or preterm birth [OR = 1.3 (0.7–2.4)], whereas the newborn’s anaemia was related to maternal anaemia [OR = 1.8 (1.2–2.5)]. There was no association between an infant’s haemoglobin level until 18 months and maternal anaemia. However, malaria attacks during follow-up, male gender and sickle cell trait were all associated with a lower infant haemoglobin level until 18 months, whereas good infant feeding practices and a polygamous family were positively associated with a higher haemoglobin level during the first 18 months of life.</p></div>]]></content:encoded><description>To determine the effect of maternal anaemia on pregnancy outcome and describe its impact on infant haemoglobin level in the first 18 months of life, we conducted a prospective study of 617 pregnant women and their children in Benin. Prevalence of maternal anaemia at delivery was 39.5%, and 61.1% of newborns were anaemic at birth. Maternal anaemia was not associated with low birth weight [OR = 1.2 (0.6–2.2)] or preterm birth [OR = 1.3 (0.7–2.4)], whereas the newborn’s anaemia was related to maternal anaemia [OR = 1.8 (1.2–2.5)]. There was no association between an infant’s haemoglobin level until 18 months and maternal anaemia. However, malaria attacks during follow-up, male gender and sickle cell trait were all associated with a lower infant haemoglobin level until 18 months, whereas good infant feeding practices and a polygamous family were positively associated with a higher haemoglobin level during the first 18 months of life.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02933.x" xmlns="http://purl.org/rss/1.0/"><title>Increasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya*</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02933.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Increasing access to the MDR-TB surveillance programme through a collaborative model in western Kenya*</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul H. Park</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cornelius Magut</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Adrian Gardner</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dennis O. O’yiengo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lydia Kamle</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bernard K. Langat</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nathan G. Buziba</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Jane Carter</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-05T22:30:56.089182-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02933.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02933.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02933.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> Kenya, like many resource-constrained countries, has a single mycobacterial laboratory, centrally located in Nairobi, with capacity for drug-susceptibility testing (DST) – the gold standard in diagnosing drug-resistant tuberculosis. We describe and evaluate a novel operational design that attempts to overcome diagnostic delivery barriers.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Review of the public DST programme identified several barriers limiting access: lack of programme awareness amongst physicians, limited supplies, unreliable transport and no specimen tracking methods. Staff visited 19 clinic sites in western Kenya and trained healthcare providers in regard to the novel diagnostics model. Provincial laboratory registries were reviewed to assess utilization of DST services prior to and after programme modification.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Onsite training consisted of the inclusion criteria for re-treatment patients – the high-priority group for DST. Additionally, infrastructural support established a stable supply chain. An existing transport system was adapted to deliver sputum specimens. Task shifting created an accession and tracking system of specimens. During the 24 months post-implementation, the number of re-treatment specimens from the catchment area increased from 9.1 to 23.5 specimens per month. In comparing annual data pre- and post-implementation, the proportion of re-treatment cases receiving DST increased from 24.7% (<em>n</em> = 403) to 32.5% (<em>n</em> = 574) (<em>P</em> &lt; 0.001), and the number of multidrug-resistant (MDR) TB cases increased from 5 to 10 cases.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The delivery model significantly increased the proportion of re-treatment cases receiving DST. Barriers to accessing the national MDR-TB surveillance programme can be overcome through an operational model based on pragmatic use of existing services from multiple partners.</p></div>]]></content:encoded><description>Objective  Kenya, like many resource-constrained countries, has a single mycobacterial laboratory, centrally located in Nairobi, with capacity for drug-susceptibility testing (DST) – the gold standard in diagnosing drug-resistant tuberculosis. We describe and evaluate a novel operational design that attempts to overcome diagnostic delivery barriers.Methods  Review of the public DST programme identified several barriers limiting access: lack of programme awareness amongst physicians, limited supplies, unreliable transport and no specimen tracking methods. Staff visited 19 clinic sites in western Kenya and trained healthcare providers in regard to the novel diagnostics model. Provincial laboratory registries were reviewed to assess utilization of DST services prior to and after programme modification.Results  Onsite training consisted of the inclusion criteria for re-treatment patients – the high-priority group for DST. Additionally, infrastructural support established a stable supply chain. An existing transport system was adapted to deliver sputum specimens. Task shifting created an accession and tracking system of specimens. During the 24 months post-implementation, the number of re-treatment specimens from the catchment area increased from 9.1 to 23.5 specimens per month. In comparing annual data pre- and post-implementation, the proportion of re-treatment cases receiving DST increased from 24.7% (n = 403) to 32.5% (n = 574) (P &lt; 0.001), and the number of multidrug-resistant (MDR) TB cases increased from 5 to 10 cases.Conclusion  The delivery model significantly increased the proportion of re-treatment cases receiving DST. Barriers to accessing the national MDR-TB surveillance programme can be overcome through an operational model based on pragmatic use of existing services from multiple partners.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02922.x" xmlns="http://purl.org/rss/1.0/"><title>In vitro antiplasmodial activity and cytotoxicity of extracts and fractions of Vitex madiensis, medicinal plant of Gabon</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02922.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">In vitro antiplasmodial activity and cytotoxicity of extracts and fractions of Vitex madiensis, medicinal plant of Gabon</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. P. Ondo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. B. Lekana-Douki</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. B. Bongui</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. S. Zang Edou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Zatra</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. S. Toure-Ndouo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Elomri</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Lebibi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Seguin</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-05T22:28:12.637005-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02922.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02922.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02922.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Vitex madiensis</em> Oliv. (Lamiaceae) is traditionally used to treat malaria symptoms in Haut-Ogooué, Gabon. Leaves and stem barks extracts were obtained using dichloromethane (CH<sub>2</sub>Cl<sub>2</sub>), ethyl acetate (EtOAc) and methanol (MeOH) as extraction solvents and fractionated on silica gel column. The <em>in vitro</em> antiplasmodial activity of CH<sub>2</sub>Cl<sub>2</sub>, EtOAc and MeOH extracts and fractions was evaluated against the chloroquine-resistant FCB strain and field isolates of <em>Plasmodium falciparum</em> using the DELI test. The cytotoxicity of the extracts was tested on MRC-5 and THP1 cells using the tetrazolium salt MTT colorimetric assay, and the selectivity index (SI) of each extract was calculated. CH<sub>2</sub>Cl<sub>2</sub> extract, the EA1 fraction from EtOAc extract of stem barks and cyclohexane (L<sub>cycl</sub>), dichloromethane (L<sub>DM</sub>) and butanol (L<sub>but</sub>) fractions from MeOH/H<sub>2</sub>O extract of leaves exhibited the highest <em>in vitro</em> antiplasmodial activity on FCB strain and field isolates (IC<sub>50</sub> from 0.53 to 4.87 μg/ml) with high selectivity index (of 20.15–1800). These data support the use of <em>V. madiensis</em> in malaria treatment along with continued investigations within traditional medicines in the search of new antimalarial agents. The EA1, C<sub>6</sub>H<sub>12</sub> and CH<sub>2</sub>Cl<sub>2</sub> fractions could be selected for future investigation or/and for the treatment of malaria symptoms after standardization.</p></div>]]></content:encoded><description>Vitex madiensis Oliv. (Lamiaceae) is traditionally used to treat malaria symptoms in Haut-Ogooué, Gabon. Leaves and stem barks extracts were obtained using dichloromethane (CH2Cl2), ethyl acetate (EtOAc) and methanol (MeOH) as extraction solvents and fractionated on silica gel column. The in vitro antiplasmodial activity of CH2Cl2, EtOAc and MeOH extracts and fractions was evaluated against the chloroquine-resistant FCB strain and field isolates of Plasmodium falciparum using the DELI test. The cytotoxicity of the extracts was tested on MRC-5 and THP1 cells using the tetrazolium salt MTT colorimetric assay, and the selectivity index (SI) of each extract was calculated. CH2Cl2 extract, the EA1 fraction from EtOAc extract of stem barks and cyclohexane (Lcycl), dichloromethane (LDM) and butanol (Lbut) fractions from MeOH/H2O extract of leaves exhibited the highest in vitro antiplasmodial activity on FCB strain and field isolates (IC50 from 0.53 to 4.87 μg/ml) with high selectivity index (of 20.15–1800). These data support the use of V. madiensis in malaria treatment along with continued investigations within traditional medicines in the search of new antimalarial agents. The EA1, C6H12 and CH2Cl2 fractions could be selected for future investigation or/and for the treatment of malaria symptoms after standardization.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02930.x" xmlns="http://purl.org/rss/1.0/"><title>Response to: accuracy of circulating cathodic antigen tests for rapid mapping of Schistosoma mansoni and S. haematobium infections in Southern Sudan by RA Ashton et al. (2011) Trop Med Int Health16, pp. 1099–1103</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02930.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Response to: accuracy of circulating cathodic antigen tests for rapid mapping of Schistosoma mansoni and S. haematobium infections in Southern Sudan by RA Ashton et al. (2011) Trop Med Int Health16, pp. 1099–1103</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A.M. Deelder</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G.J. van Dam</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. van Lieshout</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-29T23:33:31.513555-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02930.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02930.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02930.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editors</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02915.x" xmlns="http://purl.org/rss/1.0/"><title>Acceptability of coupling Intermittent Preventive Treatment in infants with the Expanded Programme on Immunization in three francophone countries in Africa</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02915.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Acceptability of coupling Intermittent Preventive Treatment in infants with the Expanded Programme on Immunization in three francophone countries in Africa</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alexandra de Sousa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Leon P. Rabarijaona</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jean L. Ndiaye</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Doudou Sow</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mouhamed Ndyiae</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jacques Hassan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nilda Lambo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul Adovohekpe</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Flavia Guidetti</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Judith Recht</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alphonse Affo</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-29T08:26:55.335271-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02915.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02915.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02915.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> Intermittent preventive treatment in infants (IPTi) is a malaria control strategy currently recommended by WHO for implementation at scale in Africa, consisting of administration of sulphadoxine-pyrimethamine (SP) coupled with routine immunizations offered to children under 1 year. In this study, we analysed IPTi acceptability by communities and health staff.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Direct observation, in-depth interviews (IDIs) and focus group discussions (FGDs) were conducted in Benin, Madagascar and Senegal during IPTi pilot implementation. Villages were stratified by immunization coverage. Data were transcribed and analysed using NVivo7 software.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Communities’ knowledge of malaria aetiology and diagnosis was good, although generally villagers did not seek treatment at health centres as their first choice. Perceptions and attitudes towards IPTi were very positive among communities and health workers. A misconception that SP was an antipyretic that prevents post-vaccinal fever contributed to IPTi’s acceptability. No refusals or negative rumours related to IPTi coupling with immunizations were identified, and IPTi did not negatively influence attitudes towards other malaria control strategies. Healthcare decisions about children, normatively made by the father, are starting to shift to educated and financially independent mothers.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion </b> Intermittent preventive treatment in infants is well accepted by providers and communities, showing a synergic acceptability when coupled with routine immunizations. However, a misconception that SP alleviates fever should be addressed when scaling up implementation.</p></div>]]></content:encoded><description>Objective  Intermittent preventive treatment in infants (IPTi) is a malaria control strategy currently recommended by WHO for implementation at scale in Africa, consisting of administration of sulphadoxine-pyrimethamine (SP) coupled with routine immunizations offered to children under 1 year. In this study, we analysed IPTi acceptability by communities and health staff.Methods  Direct observation, in-depth interviews (IDIs) and focus group discussions (FGDs) were conducted in Benin, Madagascar and Senegal during IPTi pilot implementation. Villages were stratified by immunization coverage. Data were transcribed and analysed using NVivo7 software.Results  Communities’ knowledge of malaria aetiology and diagnosis was good, although generally villagers did not seek treatment at health centres as their first choice. Perceptions and attitudes towards IPTi were very positive among communities and health workers. A misconception that SP was an antipyretic that prevents post-vaccinal fever contributed to IPTi’s acceptability. No refusals or negative rumours related to IPTi coupling with immunizations were identified, and IPTi did not negatively influence attitudes towards other malaria control strategies. Healthcare decisions about children, normatively made by the father, are starting to shift to educated and financially independent mothers.Discussion  Intermittent preventive treatment in infants is well accepted by providers and communities, showing a synergic acceptability when coupled with routine immunizations. However, a misconception that SP alleviates fever should be addressed when scaling up implementation.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02919.x" xmlns="http://purl.org/rss/1.0/"><title>Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02919.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. D. Keenan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Moncada</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Gebre</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. Ayele</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. C. Chen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. N. Yu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. M. Emerson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. E. Stoller</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. E. McCulloch</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. D. Gaynor</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Schachter</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-28T10:19:27.222442-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02919.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02919.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02919.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> During mass antibiotic distributions for trachoma, certain individuals are difficult to locate and go untreated. These untreated individuals may serve as a source of community reinfection. The importance of this difficult-to-locate, untreated population is unclear. We sought to determine whether individuals who are difficult to locate were more likely to be infected with ocular chlamydia than those who were easier to locate.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> We monitored 12 Ethiopian communities 1 year after a third annual mass azithromycin treatment for trachoma. Conjunctival swabbing for chlamydial RNA was performed in a random sample of children from each community. If insufficient numbers of children were enrolled on the first monitoring day, we returned on subsequent days.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Of the 12 communities, 10 required more than one monitoring day. On average, 16.1% (95% CI 7.9–30.0) of children were enrolled after the initial day. Evidence of chlamydia was found in 7.1% (95% CI 2.7–17.4) of 0- to 9-year-old children. No ocular swabs collected after the initial day were positive for chlamydial RNA. Children examined after the initial monitoring day were significantly less likely to have ocular chlamydial infection than children seen on the initial day; Mantel–Haenszel common OR = 0 (95% CI 0–0.77).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> In a setting of repeated annual mass azithromycin treatments, after approximately 80% of individuals have been located in a community, extra efforts to find absent individuals may not yield significantly more cases of ocular chlamydia.</p></div>]]></content:encoded><description>Objectives  During mass antibiotic distributions for trachoma, certain individuals are difficult to locate and go untreated. These untreated individuals may serve as a source of community reinfection. The importance of this difficult-to-locate, untreated population is unclear. We sought to determine whether individuals who are difficult to locate were more likely to be infected with ocular chlamydia than those who were easier to locate.Methods  We monitored 12 Ethiopian communities 1 year after a third annual mass azithromycin treatment for trachoma. Conjunctival swabbing for chlamydial RNA was performed in a random sample of children from each community. If insufficient numbers of children were enrolled on the first monitoring day, we returned on subsequent days.Results  Of the 12 communities, 10 required more than one monitoring day. On average, 16.1% (95% CI 7.9–30.0) of children were enrolled after the initial day. Evidence of chlamydia was found in 7.1% (95% CI 2.7–17.4) of 0- to 9-year-old children. No ocular swabs collected after the initial day were positive for chlamydial RNA. Children examined after the initial monitoring day were significantly less likely to have ocular chlamydial infection than children seen on the initial day; Mantel–Haenszel common OR = 0 (95% CI 0–0.77).Conclusions  In a setting of repeated annual mass azithromycin treatments, after approximately 80% of individuals have been located in a community, extra efforts to find absent individuals may not yield significantly more cases of ocular chlamydia.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02918.x" xmlns="http://purl.org/rss/1.0/"><title>Malaria prevalence and treatment of febrile patients at health facilities and medicine retailers in Cameroon</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02918.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Malaria prevalence and treatment of febrile patients at health facilities and medicine retailers in Cameroon</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lindsay J. Mangham</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bonnie Cundill</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Olivia A. Achonduh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joel N. Ambebila</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Albertine K. Lele</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Theresia N. Metoh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sarah N. Ndive</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ignatius C. Ndong</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rachel L. Nguela</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Akindeh M. Nji</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Barnabas Orang-Ojong</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Virginia Wiseman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joelle Pamen-Ngako</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wilfred F. Mbacham</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-21T00:24:48.328431-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02918.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02918.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02918.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To investigate the quality of malaria case management in Cameroon 5 years after the adoption of artemisinin-based combination therapy (ACT). Treatment patterns were examined in different types of facility, and the factors associated with being prescribed or receiving an ACT were investigated.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> A cross-sectional cluster survey was conducted among individuals of all ages who left public and private health facilities and medicine retailers in Cameroon and who reported seeking treatment for a fever. Prevalence of malaria was determined by rapid diagnostic tests (RDTs) in consenting patients attending the facilities and medicine retailers.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Among the patients, 73% were prescribed or received an antimalarial, and 51% were prescribed or received an ACT. Treatment provided to patients significantly differed by type of facility: 65% of patients at public facilities, 55% of patients at private facilities and 45% of patients at medicine retailers were prescribed or received an ACT (<em>P</em> = 0.023). The odds of a febrile patient being prescribed or receiving an ACT were significantly higher for patients who asked for an ACT (OR = 24.1, <em>P</em> &lt; 0.001), were examined by the health worker (OR = 1.88, <em>P</em> = 0.021), had not previously sought an antimalarial for the illness (OR = 2.29, <em>P</em> = 0.001) and sought treatment at a public (OR = 3.55) or private facility (OR = 1.99, <em>P</em> = 0.003). Malaria was confirmed in 29% of patients and 70% of patients with a negative result were prescribed or received an antimalarial.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Malaria case management could be improved. Symptomatic diagnosis is inefficient because two-thirds of febrile patients do not have malaria. Government plans to extend malaria testing should promote rational use of ACT; though, the introduction of rapid diagnostic testing needs to be accompanied by updated clinical guidelines that provide clear guidance for the treatment of patients with negative test results.</p></div>]]></content:encoded><description>Objective  To investigate the quality of malaria case management in Cameroon 5 years after the adoption of artemisinin-based combination therapy (ACT). Treatment patterns were examined in different types of facility, and the factors associated with being prescribed or receiving an ACT were investigated.Methods  A cross-sectional cluster survey was conducted among individuals of all ages who left public and private health facilities and medicine retailers in Cameroon and who reported seeking treatment for a fever. Prevalence of malaria was determined by rapid diagnostic tests (RDTs) in consenting patients attending the facilities and medicine retailers.Results  Among the patients, 73% were prescribed or received an antimalarial, and 51% were prescribed or received an ACT. Treatment provided to patients significantly differed by type of facility: 65% of patients at public facilities, 55% of patients at private facilities and 45% of patients at medicine retailers were prescribed or received an ACT (P = 0.023). The odds of a febrile patient being prescribed or receiving an ACT were significantly higher for patients who asked for an ACT (OR = 24.1, P &lt; 0.001), were examined by the health worker (OR = 1.88, P = 0.021), had not previously sought an antimalarial for the illness (OR = 2.29, P = 0.001) and sought treatment at a public (OR = 3.55) or private facility (OR = 1.99, P = 0.003). Malaria was confirmed in 29% of patients and 70% of patients with a negative result were prescribed or received an antimalarial.Conclusions  Malaria case management could be improved. Symptomatic diagnosis is inefficient because two-thirds of febrile patients do not have malaria. Government plans to extend malaria testing should promote rational use of ACT; though, the introduction of rapid diagnostic testing needs to be accompanied by updated clinical guidelines that provide clear guidance for the treatment of patients with negative test results.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02917.x" xmlns="http://purl.org/rss/1.0/"><title>Critical review of the Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA): suggestions for harmonization, implementation and improvement</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02917.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Critical review of the Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA): suggestions for harmonization, implementation and improvement</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tjeerd A. M. Datema</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Linda Oskam</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stella M. van Beers</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul R. Klatser</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-11-18T04:13:21.215125-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02917.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02917.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02917.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> Clinical laboratories in low- and middle-income countries (LMIC) need fundamental improvement because quality laboratory services are essential for the decision-making capacity of clinicians, health workers and public health authorities. To this end, a tiered accreditation scheme Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA) was developed by WHO-AFRO, CDC and others for clinical laboratories in LMIC. One to five stars are accredited to laboratories based on the level of compliance with a checklist. Our aim was to evaluate the quality and applicability of this accreditation scheme compared with international quality standards.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> We performed a critical review of this scheme to formulate recommendations for implementation, harmonization and improvement. Two analyses were performed: one assessing its coverage of the ISO 15189:2007 standard and one to identify and evaluate priorities of the accreditation checklist.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Although the content of the checklist covers all aspects of total quality management, it strongly prioritizes resource management activities. We recommend identifying critical requirements for each tier of accreditation to assure a certain level of quality for each tier or instead using a pass/fail approach towards accreditation. In addition, the checklist should include more questions for assessing proper management, ethics and continuous improvement to meet ISO 15189.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Launching accreditation schemes for laboratories in LMIC should be encouraged. After further optimization of SLIPTA, clinical laboratories may certainly benefit, leading to more correctly diagnosed patients and less waste of resources.</p></div>]]></content:encoded><description>Objective  Clinical laboratories in low- and middle-income countries (LMIC) need fundamental improvement because quality laboratory services are essential for the decision-making capacity of clinicians, health workers and public health authorities. To this end, a tiered accreditation scheme Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA) was developed by WHO-AFRO, CDC and others for clinical laboratories in LMIC. One to five stars are accredited to laboratories based on the level of compliance with a checklist. Our aim was to evaluate the quality and applicability of this accreditation scheme compared with international quality standards.Methods  We performed a critical review of this scheme to formulate recommendations for implementation, harmonization and improvement. Two analyses were performed: one assessing its coverage of the ISO 15189:2007 standard and one to identify and evaluate priorities of the accreditation checklist.Results  Although the content of the checklist covers all aspects of total quality management, it strongly prioritizes resource management activities. We recommend identifying critical requirements for each tier of accreditation to assure a certain level of quality for each tier or instead using a pass/fail approach towards accreditation. In addition, the checklist should include more questions for assessing proper management, ethics and continuous improvement to meet ISO 15189.Conclusion  Launching accreditation schemes for laboratories in LMIC should be encouraged. After further optimization of SLIPTA, clinical laboratories may certainly benefit, leading to more correctly diagnosed patients and less waste of resources.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02909.x" xmlns="http://purl.org/rss/1.0/"><title>Scarcity of healthcare worker protection in eight low- and middle-income countries: surgery and the risk of HIV and other bloodborne pathogens</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02909.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Scarcity of healthcare worker protection in eight low- and middle-income countries: surgery and the risk of HIV and other bloodborne pathogens</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jeffrey J. Leow</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Reinou S. Groen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jin Yung Bae</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Charles A. Adisa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Peter Kingham</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Adam L. Kushner</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-10-31T03:16:16.109381-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02909.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02909.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02909.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> In view of the substantial incidence of bloodborne diseases and risk to surgical healthcare workers in low- and middle-income countries (LMICs), we evaluated the availability of eye protection, aprons, sterile gloves, sterilizers and suction pumps.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Review of studies using the WHO Tool for the Situational Analysis of Access to Emergency and Essential Surgical Care.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Eight papers documented data from 164 hospitals: Afghanistan (17), Gambia (18), Ghana (17), Liberia (16), Mongolia (44), Sierra Leone (12), Solomon Islands (9) and Sri Lanka (31). No country had a 100% supply of any item. Eye protection was available in only one hospital in Sri Lanka (4%) and most abundant in Liberia (56%). The availability of sterile gloves ranged from 24% in Afghanistan to 94% in Ghana.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Substantial deficiencies of basic protective supplies exist in low- and middle-income countries.</p></div>]]></content:encoded><description>Objective  In view of the substantial incidence of bloodborne diseases and risk to surgical healthcare workers in low- and middle-income countries (LMICs), we evaluated the availability of eye protection, aprons, sterile gloves, sterilizers and suction pumps.Methods  Review of studies using the WHO Tool for the Situational Analysis of Access to Emergency and Essential Surgical Care.Results  Eight papers documented data from 164 hospitals: Afghanistan (17), Gambia (18), Ghana (17), Liberia (16), Mongolia (44), Sierra Leone (12), Solomon Islands (9) and Sri Lanka (31). No country had a 100% supply of any item. Eye protection was available in only one hospital in Sri Lanka (4%) and most abundant in Liberia (56%). The availability of sterile gloves ranged from 24% in Afghanistan to 94% in Ghana.Conclusion  Substantial deficiencies of basic protective supplies exist in low- and middle-income countries.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2010.02607.x" xmlns="http://purl.org/rss/1.0/"><title>Per diems undermine health interventions, systems and research in Africa: burying our heads in the sand</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2010.02607.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Per diems undermine health interventions, systems and research in Africa: burying our heads in the sand</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Valéry Ridde</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2010-07-28T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2010.02607.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2010.02607.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2010.02607.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2007.01802.x" xmlns="http://purl.org/rss/1.0/"><title>Improved injection safety after targeted interventions in the Syrian Arab RepublicSûreté améliorée des injections après des interventions ciblées dans la République Arabe SyrienneMejora en la seguridad de las inyecciones después de intervenciones dirigidas en la República Árabe Siria</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2007.01802.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Improved injection safety after targeted interventions in the Syrian Arab RepublicSûreté améliorée des injections après des interventions ciblées dans la République Arabe SyrienneMejora en la seguridad de las inyecciones después de intervenciones dirigidas en la República Árabe Siria</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Carsten Mantel</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Selma Khamassi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Khaled Baradei</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Haifa Nasri</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ezzedine Mohsni</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Philippe Duclos</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2007-01-15T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2007.01802.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2007.01802.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2007.01802.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> Concerns about unsafe injection practices and possible infections with blood-borne pathogens in the Syrian Arab Republic motivated an assessment of the injection safety situation in the country in July 2001. In light of the recommendations from this assessment, the Ministry of Health of Syria, with the assistance of WHO, implemented a set of activities under the ‘Focus Project’, which aims to ensure immunization safety. The first phase of the project ran from May 2002 to February 2004, and consisted of the improved provision of injection safety equipment and supplies, the elaboration and wide distribution of national guidelines on injection safety and safe waste management, a behaviour change and communication campaign targeting the general public, and comprehensive training of healthcare workers. A follow-up survey was carried out in February 2004, 2 years after initiation of the project.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Two representative surveys were conducted using a standardized assessment tool. A cluster sampling strategy, with probability proportionate to the population size, led to the inclusion of 80 health facilities in eight districts in 2001 and of 120 health facilities in 12 districts in 2004.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Injection practices had significantly improved 2 years after the start of the project. The 2001 study had pointed to a low, but non-negligible risk to patients (2% unsafe injections), coupled with a high risk to healthcare workers (61% reported needle-stick injuries in the last 12 months) and to the communities owing to unsafe waste disposal (sharps waste found outside 37% of health facilities, waste disposal considered unsafe in 48% of them). The 2004 survey showed that 90% of Syrian healthcare workers had received training in injection safety. All injections observed were given safely (difference to 2001 not significant), although some problems in preparation and reconstitution prevailed. The risk to healthcare workers was significantly reduced as only 14% of the staff reported needle-stick injuries (<em>p</em> &lt; 0.001). The risk to the communities was notably decreased following improvements in sharps waste management (sharps were found in the surroundings of only 13% of health facilities, <em>p</em> &lt; 0.001).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> The example of Syria shows that rapid improvement in injection safety is possible and that the necessary tools and methods to monitor and evaluate progress are at our disposal. Challenges remain in transferring this successful programme from the well-structured immunization programme to the more diverse curative health services.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectifs</b> Evaluer la sûreté des injections en Syrie après une implémentation en mai 2002 d'un certain nombre de mesures visant à améliorer la sûreté des injections.</p></div><div class="para"><p><b>Méthodes</b> Deux surveillances représentatives ont été conduites à l'aide d'un outil standard d’évaluation. Une stratégie d’échantillonnage en grappe avec une probabilité proportionnée à la taille de la population a menéà l'inclusion de 80 services de santé dans 8 zones en 2001 et de 120 services de santé dans 12 zones en 2004.</p></div><div class="para"><p><b>Résultats</b> Les pratiques en matière d'injection se sont sensiblement améliorées deux ans après le début du projet. L’étude de 2001 a révélé un risque faible mais non négligeable pour les patients (2% d'injections peu sûres), couplés à un à risque élevé pour les agents de la santé (61% ont rapporté des blessures avec des aiguilles durant les 12 mois précédents) et pour les communautés à cause de la méthode d’élimination peu sûre des ordures (des déchets d'objets pointus ont été trouvés à l'extérieur de 37% des services de santé, 48% des déchets étaient considérées peu sûres). La surveillance de 2004 a démontré que 90% des agents de santé syriens avaient reçu une formation pour la sûreté des injections; toutes les injections observées ont été effectuées sans risque (à la différence avec 2001 n.s.), quand bien même quelques problèmes dans la préparation et la reconstitution des injectables aient été observés. Le risque pour les agents de santé a été sensiblement réduit car 14% seulement du personnel rapportait des blessures avec des aiguilles (p &lt; 0,001). Le risque pour les communautés était significativement inférieur après amélioration du traitement des déchets d'objets pointus (des objets pointus ont été retrouvés dans les environnements de seulement 13% des services de santé, p &lt; 0.001).</p></div><div class="para"><p><b>Conclusions </b> L'exemple de la Syrie prouve que l'amélioration rapide de la sûreté des injections est possible et que les outils et méthodes nécessaires pour surveiller et évaluer le progrès sont à notre disposition. Les défis demeurent dans le transfert de ce programme efficace à partir d'un programme d'immunisation bien structuré vers des services de santé curatifs plus diversifiés.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivos </b> Evaluar la seguridad de las inyecciones en Siria después de la implementación de un número de medidas para incrementar la seguridad de las inyecciones en Mayo del 2002.</p></div><div class="para"><p><b>Métodos </b> Se realizaron dos encuestas utilizando una herramienta estándar de valoración. Una estrategia de muestreo por conglomerados, con una probabilidad proporcional al tamaño de la población, llevó a la inclusión de 80 centros sanitarios en 8 distritos en el 2001 y de 120 centros sanitarios en 12 distritos en el 2004.</p></div><div class="para"><p><b>Resultados </b> Las prácticas con inyecciones han mejorado significativamente después de dos años del comienzo del Proyecto. El estudio del 2001 había mostrado que el riesgo para los pacientes era bajo, aunque no insignificante (2% de inyecciones no seguras), junto con un alto riesgo para los trabajadores sanitarios (61% de accidentes con agujas en los últimos 12 meses) y las comunidades, debido a una gestión insegura de residuos (se encontraron objetos corto punzantes afuera de un 37% de los centros sanitarios, con un 48% de los residuos sanitarios considerados como inseguros). La encuesta del 2004 demostró que un 90% de los trabajadores sanitarios sirios había recibido entrenamiento en el uso seguro de inyecciones. Todas las inyecciones observadas fueron puestas de forma segura (diferencia con el 2001 no significativa), aunque continuaba habiendo algunos problemas en la preparación y la reconstitución de las mismas. El riesgo de los trabajadores sanitarios se redujo significativamente, puesto que solo un 14% reportó haber tenido un accidente con agujas. El riesgo para las comunidades fue notablemente más bajo después de las mejoras en el manejo de los residuos corto-punzantes (encontrándose objetos corto punzantes en un 13% de los centros sanitarios p &lt; 0.001).</p></div><div class="para"><p><b>Conclusiones </b> El ejemplo de Siria demuestra que es posible obtener una mejoría rápida de la seguridad en el uso de inyecciones, y que los métodos y herramientas necesarias para monitorizar y evaluar el progreso están disponibles. Los retos continúan estando en la transferencia, de este programa exitoso, desde un programa de inmunización bien estructurado, a los servicios sanitarios en áreas más diversas de curación.</p></div></div>]]></content:encoded><description>Objectives  Concerns about unsafe injection practices and possible infections with blood-borne pathogens in the Syrian Arab Republic motivated an assessment of the injection safety situation in the country in July 2001. In light of the recommendations from this assessment, the Ministry of Health of Syria, with the assistance of WHO, implemented a set of activities under the ‘Focus Project’, which aims to ensure immunization safety. The first phase of the project ran from May 2002 to February 2004, and consisted of the improved provision of injection safety equipment and supplies, the elaboration and wide distribution of national guidelines on injection safety and safe waste management, a behaviour change and communication campaign targeting the general public, and comprehensive training of healthcare workers. A follow-up survey was carried out in February 2004, 2 years after initiation of the project.Methods  Two representative surveys were conducted using a standardized assessment tool. A cluster sampling strategy, with probability proportionate to the population size, led to the inclusion of 80 health facilities in eight districts in 2001 and of 120 health facilities in 12 districts in 2004.Results  Injection practices had significantly improved 2 years after the start of the project. The 2001 study had pointed to a low, but non-negligible risk to patients (2% unsafe injections), coupled with a high risk to healthcare workers (61% reported needle-stick injuries in the last 12 months) and to the communities owing to unsafe waste disposal (sharps waste found outside 37% of health facilities, waste disposal considered unsafe in 48% of them). The 2004 survey showed that 90% of Syrian healthcare workers had received training in injection safety. All injections observed were given safely (difference to 2001 not significant), although some problems in preparation and reconstitution prevailed. The risk to healthcare workers was significantly reduced as only 14% of the staff reported needle-stick injuries (p &lt; 0.001). The risk to the communities was notably decreased following improvements in sharps waste management (sharps were found in the surroundings of only 13% of health facilities, p &lt; 0.001).Conclusions  The example of Syria shows that rapid improvement in injection safety is possible and that the necessary tools and methods to monitor and evaluate progress are at our disposal. Challenges remain in transferring this successful programme from the well-structured immunization programme to the more diverse curative health services.Objectifs Evaluer la sûreté des injections en Syrie après une implémentation en mai 2002 d'un certain nombre de mesures visant à améliorer la sûreté des injections.Méthodes Deux surveillances représentatives ont été conduites à l'aide d'un outil standard d’évaluation. Une stratégie d’échantillonnage en grappe avec une probabilité proportionnée à la taille de la population a menéà l'inclusion de 80 services de santé dans 8 zones en 2001 et de 120 services de santé dans 12 zones en 2004.Résultats Les pratiques en matière d'injection se sont sensiblement améliorées deux ans après le début du projet. L’étude de 2001 a révélé un risque faible mais non négligeable pour les patients (2% d'injections peu sûres), couplés à un à risque élevé pour les agents de la santé (61% ont rapporté des blessures avec des aiguilles durant les 12 mois précédents) et pour les communautés à cause de la méthode d’élimination peu sûre des ordures (des déchets d'objets pointus ont été trouvés à l'extérieur de 37% des services de santé, 48% des déchets étaient considérées peu sûres). La surveillance de 2004 a démontré que 90% des agents de santé syriens avaient reçu une formation pour la sûreté des injections; toutes les injections observées ont été effectuées sans risque (à la différence avec 2001 n.s.), quand bien même quelques problèmes dans la préparation et la reconstitution des injectables aient été observés. Le risque pour les agents de santé a été sensiblement réduit car 14% seulement du personnel rapportait des blessures avec des aiguilles (p &lt; 0,001). Le risque pour les communautés était significativement inférieur après amélioration du traitement des déchets d'objets pointus (des objets pointus ont été retrouvés dans les environnements de seulement 13% des services de santé, p &lt; 0.001).Conclusions  L'exemple de la Syrie prouve que l'amélioration rapide de la sûreté des injections est possible et que les outils et méthodes nécessaires pour surveiller et évaluer le progrès sont à notre disposition. Les défis demeurent dans le transfert de ce programme efficace à partir d'un programme d'immunisation bien structuré vers des services de santé curatifs plus diversifiés.Objetivos  Evaluar la seguridad de las inyecciones en Siria después de la implementación de un número de medidas para incrementar la seguridad de las inyecciones en Mayo del 2002.Métodos  Se realizaron dos encuestas utilizando una herramienta estándar de valoración. Una estrategia de muestreo por conglomerados, con una probabilidad proporcional al tamaño de la población, llevó a la inclusión de 80 centros sanitarios en 8 distritos en el 2001 y de 120 centros sanitarios en 12 distritos en el 2004.Resultados  Las prácticas con inyecciones han mejorado significativamente después de dos años del comienzo del Proyecto. El estudio del 2001 había mostrado que el riesgo para los pacientes era bajo, aunque no insignificante (2% de inyecciones no seguras), junto con un alto riesgo para los trabajadores sanitarios (61% de accidentes con agujas en los últimos 12 meses) y las comunidades, debido a una gestión insegura de residuos (se encontraron objetos corto punzantes afuera de un 37% de los centros sanitarios, con un 48% de los residuos sanitarios considerados como inseguros). La encuesta del 2004 demostró que un 90% de los trabajadores sanitarios sirios había recibido entrenamiento en el uso seguro de inyecciones. Todas las inyecciones observadas fueron puestas de forma segura (diferencia con el 2001 no significativa), aunque continuaba habiendo algunos problemas en la preparación y la reconstitución de las mismas. El riesgo de los trabajadores sanitarios se redujo significativamente, puesto que solo un 14% reportó haber tenido un accidente con agujas. El riesgo para las comunidades fue notablemente más bajo después de las mejoras en el manejo de los residuos corto-punzantes (encontrándose objetos corto punzantes en un 13% de los centros sanitarios p &lt; 0.001).Conclusiones  El ejemplo de Siria demuestra que es posible obtener una mejoría rápida de la seguridad en el uso de inyecciones, y que los métodos y herramientas necesarias para monitorizar y evaluar el progreso están disponibles. Los retos continúan estando en la transferencia, de este programa exitoso, desde un programa de inmunización bien estructurado, a los servicios sanitarios en áreas más diversas de curación.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02948.x" xmlns="http://purl.org/rss/1.0/"><title>Feature page</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02948.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Feature page</dc:title><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02948.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02948.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02948.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">143</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">143</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02910.x" xmlns="http://purl.org/rss/1.0/"><title>Transfer of evidence-based medical guidelines to low- and middle-income countries</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02910.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Transfer of evidence-based medical guidelines to low- and middle-income countries</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stephan Ehrhardt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christian G. Meyer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02910.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02910.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02910.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Editorial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">144</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">146</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02904.x" xmlns="http://purl.org/rss/1.0/"><title>Preliminary enquiry into the availability, price and quality of malaria rapid diagnostic tests in the private health sector of six malaria-endemic countriesEnquête préliminaire sur la disponibilité, le prix et la qualité des Tests de Diagnostic Rapide du paludisme dans le secteur privé de santé dans six pays endémiquesPrimera encuesta sobre la disponibilidad, precio y calidad de las pruebas de diagnóstico rápido para la malaria en el sector sanitario privado en seis países endémicos</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02904.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Preliminary enquiry into the availability, price and quality of malaria rapid diagnostic tests in the private health sector of six malaria-endemic countriesEnquête préliminaire sur la disponibilité, le prix et la qualité des Tests de Diagnostic Rapide du paludisme dans le secteur privé de santé dans six pays endémiquesPrimera encuesta sobre la disponibilidad, precio y calidad de las pruebas de diagnóstico rápido para la malaria en el sector sanitario privado en seis países endémicos</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Albertini</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Djalle</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. Faye</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Gamboa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Luchavez</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. L. Mationg</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. Mwangoka</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">W. Oyibo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Bennett</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Incardona</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Lee</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02904.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02904.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02904.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">147</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">152</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> This enquiry aimed to provide a snap-shot of availability, price and quality of malaria rapid diagnostic tests (RDTs) in private health facilities at selected sites in six malaria-endemic countries in Africa, South East Asia and South America.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> In each study site, data collectors surveyed private healthcare facilities which were selected based on accessibility from their home institution. Using a questionnaire, information was recorded about the facility itself and the malaria RDT(s) available. Where possible, a small number of RDTs were procured and quality control tested using a standardized procedure.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Of the 324 private healthcare facilities visited, 35 outlets (mainly private clinics and hospitals) were found to supply 10 different types of RDTs products. RDT prices across the six countries ranged from US$1.00 to $16.81. Five of the 14 malaria RDTs collected failed quality control testing.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> In the private outlets sampled, the availability of RDTs was limited. Some of the RDTs whose quality we tested demonstrated inadequate sensitivity. This presents a number of risks. Given the more widespread distribution of antimalarials currently planned for private sector facilities, parasite-based diagnosis in this sector will be essential to adhere to the WHO guidelines for effective case management of malaria. Considerable regulation and quality control are also necessary to assure the availability of accurate and reliable RDTs, as well as adequate case management and provider adherence to RDT results. Public sector engagement is likely to be essential in this process.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectifs: </b> Cette enquête visait à fournir une vue rapide sur la disponibilité, le prix et la qualité des tests de diagnostic rapide (TDR) du paludisme dans les établissements de santé privés dans des sites sélectionnés dans six pays endémiques pour le paludisme en Afrique, en Asie du sud-est et en Amérique du sud.</p></div><div class="para"><p><b>Méthodes: </b> Dans chaque site d’étude, les collecteurs de données ont enquêté sur les établissements de santé privés, choisis en fonction de l’accessibilitéà partir de leur institution d’origine. En utilisant un questionnaire, les informations ont été enregistrées sur l’installation elle-même et la disponibilité du TDR du paludisme. Lorsque possible, un petit nombre de TDR a été acquis et un contrôle de qualité a été effectué en utilisant une procédure standardisée.</p></div><div class="para"><p><b>Résultats: </b> Sur les 324 établissements de santé privés visités, 35 points (essentiellement des cliniques et hôpitaux privés) ont été trouvés, fournissant 10 différents types de produits TDR. Le prix des TDR dans les six pays variait de 1,00 $ US à 16,81 $ US. Cinq TDR du paludisme sur 14 collectés ont échoué au test de contrôle de qualité.</p></div><div class="para"><p><b>Conclusions: </b> Dans les points d’accès privés échantillonnés, la disponibilité des TDR était limitée. Certains TDR pour lesquels la qualité a été testée ont démontré une sensibilité inadéquate. Cela pose un certain nombre de risques. Compte tenu de la distribution plus étendue des antipaludiques prévue actuellement dans les établissements du secteur privé, le diagnostic parasitologique dans ce secteur devrait être essentiel afin de se conformer aux directives de l’OMS pour la prise en charge efficace des cas de paludisme. Une réglementation considérable et un contrôle de qualité sont également nécessaires pour assurer la disponibilité de TDR précis et fiables, ainsi qu’une prise en charge adéquate des cas et l’adhésion du prestataire aux résultats des TDR. L’engagement du secteur public est probablement essentiel dans ce processus.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivos: </b> Esta encuesta tenía por objetivo proveer una fotografía sobre la disponibilidad, el precio y la calidad de las pruebas de diagnóstico rápido (PDRs) de malaria en centros sanitarios privados de seis lugares seleccionados en seis países endémicos para malaria en África, el sudeste Asiático y Sudamérica.</p></div><div class="para"><p><b>Métodos: </b> En cada lugar de estudio, los recolectores de datos encuestaron centros sanitarios privados seleccionados basándose en la accesibilidad desde sus hogares. Utilizando un cuestionario, se obtuvo información sobre el centro sanitario así como sobre la disponibilidad de PDR(s). En donde era posible, se recogieron un pequeño número de PDRs y se realizaron pruebas de control de calidad utilizando un procedimiento estándar.</p></div><div class="para"><p><b>Resultados: </b> De los 324 centros sanitarios privados visitados, se hallaron 35 puntos de venta (principalmente clínicas privadas y hospitales) que proveían 10 tipos diferentes de PDRs. Los precios de las PDR en los seis países estaban entre US$1.00 y $16.81. Cinco de las 14 PDRs para malaria recolectadas no pasaron las pruebas de control de calidad.</p></div><div class="para"><p><b>Conclusiones: </b> En los puntos de venta privados muestreados, la disponibilidad de las PDRs era limitada. Algunas de las PDRs a las que se les realizó un control de calidad, demostraron tener una sensibilidad inadecuada. Esto presenta una serie de riesgos. Dada la mayor distribución de antipalúdicos actualmente planeada para los centros privados, el diagnóstico basado en el parásito en este sector sería esencial para adherirse a las guías de la OMS para realizar un manejo efectivo de casos de malaria. Es necesaria una regulación considerable y un control de calidad para asegurar la disponibilidad de PDRs precisas y fiables, al igual que un manejo adecuado de los casos y la adherencia del proveedor a los resultados de las PDRs. El compromiso del sector público será probablemente esencial en este proceso.</p></div></div>]]></content:encoded><description>Objectives  This enquiry aimed to provide a snap-shot of availability, price and quality of malaria rapid diagnostic tests (RDTs) in private health facilities at selected sites in six malaria-endemic countries in Africa, South East Asia and South America.Methods  In each study site, data collectors surveyed private healthcare facilities which were selected based on accessibility from their home institution. Using a questionnaire, information was recorded about the facility itself and the malaria RDT(s) available. Where possible, a small number of RDTs were procured and quality control tested using a standardized procedure.Results  Of the 324 private healthcare facilities visited, 35 outlets (mainly private clinics and hospitals) were found to supply 10 different types of RDTs products. RDT prices across the six countries ranged from US$1.00 to $16.81. Five of the 14 malaria RDTs collected failed quality control testing.Conclusions  In the private outlets sampled, the availability of RDTs was limited. Some of the RDTs whose quality we tested demonstrated inadequate sensitivity. This presents a number of risks. Given the more widespread distribution of antimalarials currently planned for private sector facilities, parasite-based diagnosis in this sector will be essential to adhere to the WHO guidelines for effective case management of malaria. Considerable regulation and quality control are also necessary to assure the availability of accurate and reliable RDTs, as well as adequate case management and provider adherence to RDT results. Public sector engagement is likely to be essential in this process.Objectifs:  Cette enquête visait à fournir une vue rapide sur la disponibilité, le prix et la qualité des tests de diagnostic rapide (TDR) du paludisme dans les établissements de santé privés dans des sites sélectionnés dans six pays endémiques pour le paludisme en Afrique, en Asie du sud-est et en Amérique du sud.Méthodes:  Dans chaque site d’étude, les collecteurs de données ont enquêté sur les établissements de santé privés, choisis en fonction de l’accessibilitéà partir de leur institution d’origine. En utilisant un questionnaire, les informations ont été enregistrées sur l’installation elle-même et la disponibilité du TDR du paludisme. Lorsque possible, un petit nombre de TDR a été acquis et un contrôle de qualité a été effectué en utilisant une procédure standardisée.Résultats:  Sur les 324 établissements de santé privés visités, 35 points (essentiellement des cliniques et hôpitaux privés) ont été trouvés, fournissant 10 différents types de produits TDR. Le prix des TDR dans les six pays variait de 1,00 $ US à 16,81 $ US. Cinq TDR du paludisme sur 14 collectés ont échoué au test de contrôle de qualité.Conclusions:  Dans les points d’accès privés échantillonnés, la disponibilité des TDR était limitée. Certains TDR pour lesquels la qualité a été testée ont démontré une sensibilité inadéquate. Cela pose un certain nombre de risques. Compte tenu de la distribution plus étendue des antipaludiques prévue actuellement dans les établissements du secteur privé, le diagnostic parasitologique dans ce secteur devrait être essentiel afin de se conformer aux directives de l’OMS pour la prise en charge efficace des cas de paludisme. Une réglementation considérable et un contrôle de qualité sont également nécessaires pour assurer la disponibilité de TDR précis et fiables, ainsi qu’une prise en charge adéquate des cas et l’adhésion du prestataire aux résultats des TDR. L’engagement du secteur public est probablement essentiel dans ce processus.Objetivos:  Esta encuesta tenía por objetivo proveer una fotografía sobre la disponibilidad, el precio y la calidad de las pruebas de diagnóstico rápido (PDRs) de malaria en centros sanitarios privados de seis lugares seleccionados en seis países endémicos para malaria en África, el sudeste Asiático y Sudamérica.Métodos:  En cada lugar de estudio, los recolectores de datos encuestaron centros sanitarios privados seleccionados basándose en la accesibilidad desde sus hogares. Utilizando un cuestionario, se obtuvo información sobre el centro sanitario así como sobre la disponibilidad de PDR(s). En donde era posible, se recogieron un pequeño número de PDRs y se realizaron pruebas de control de calidad utilizando un procedimiento estándar.Resultados:  De los 324 centros sanitarios privados visitados, se hallaron 35 puntos de venta (principalmente clínicas privadas y hospitales) que proveían 10 tipos diferentes de PDRs. Los precios de las PDR en los seis países estaban entre US$1.00 y $16.81. Cinco de las 14 PDRs para malaria recolectadas no pasaron las pruebas de control de calidad.Conclusiones:  En los puntos de venta privados muestreados, la disponibilidad de las PDRs era limitada. Algunas de las PDRs a las que se les realizó un control de calidad, demostraron tener una sensibilidad inadecuada. Esto presenta una serie de riesgos. Dada la mayor distribución de antipalúdicos actualmente planeada para los centros privados, el diagnóstico basado en el parásito en este sector sería esencial para adherirse a las guías de la OMS para realizar un manejo efectivo de casos de malaria. Es necesaria una regulación considerable y un control de calidad para asegurar la disponibilidad de PDRs precisas y fiables, al igual que un manejo adecuado de los casos y la adherencia del proveedor a los resultados de las PDRs. El compromiso del sector público será probablemente esencial en este proceso.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02913.x" xmlns="http://purl.org/rss/1.0/"><title>Genetic diversity and genotype multiplicity of Plasmodium falciparum infections in symptomatic individuals in the maritime region of TogoDiversité génétique et multiplicité génotypique des infections àPlasmodium falciparum chez les sujets symptomatiques dans la région maritime du TogoDiversidad genética y multiplicidad de genotipos en las infecciones por Plasmodium falciparum de individuos sintomáticos en la región marítima de Togo</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02913.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Genetic diversity and genotype multiplicity of Plasmodium falciparum infections in symptomatic individuals in the maritime region of TogoDiversité génétique et multiplicité génotypique des infections àPlasmodium falciparum chez les sujets symptomatiques dans la région maritime du TogoDiversidad genética y multiplicidad de genotipos en las infecciones por Plasmodium falciparum de individuos sintomáticos en la región marítima de Togo</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kwami L. Awaga</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tagnon D. Missihoun</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Simplice D. Karou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Koffi E. Djadou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nicodème W. Chabi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Afoua Akati</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Afi Lawson-Hukportie</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kokou Amevo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kodjovi Djegno</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jean L. Guéant</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ambaliou Sanni</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sabiba K. E. Amouzou</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02913.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02913.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02913.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">153</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">160</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To assess the genotype prevalence and the multiplicity of <em>Plasmodium falciparum</em> infections in the maritime region of Togo.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> We enrolled 309 symptomatic individuals aged from 6 months to 15 years from Bè/Lomé and Tsévié, two malaria endemic zones. The number and the proportions of merozoite surface proteins 1, 2 and 3 genotypes in patients were determined using capillary electrophoresis genotyping. We further investigated the possible association between transaminases and homocysteine, and the severity of the disease.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Of the 309 samples genotyped, 210 tested positive to msp-1, 227 to msp-2 and 193 to msp-3. The nested PCR revealed 22 different alleles for the allelic family msp-1, 33 for msp-2 and 13 for msp-3. At each locus, the family distribution was 54.58% of K1, 25% of MAD20 and 20.42% of RO33 for msp-1, and 51.71% and 48.29% of FC27 and 3D7, respectively, for msp-2. For all these allelic variants, the distribution was associated with neither the severity of malaria nor the zone of habitation. Pearson correlation coefficients between either the levels of homocysteine or the transaminase and the severity of the disease were very low.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The severity of malaria was not associated with higher multiplicity of infections and did not appear restricted to particular genotypes. More comprehensive explorations including immunity, genetic factors, nutritional and sociologic status of the population could clarify the situation.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectif: </b> Evaluer la prévalence génotypique et la multiplicité des infections à<em>Plasmodium falciparum</em> dans la région maritime du Togo.</p></div><div class="para"><p><b>Méthodes: </b> Nous avons recruté 309 enfants symptomatiques âgés de 6 mois à 15 ans à Bè/Lomé et à Tsévié, deux zones endémiques pour le paludisme. Le nombre et les proportions des génotypes des protéines de surface du mérozoïte (msp) -1, 2 et 3 chez les patients ont été déterminés en utilisant le génotypage par électrophorèse en capillaire. Nous avons également étudié l’association possible entre les transaminases et l’homocystéine avec la sévérité de la maladie.</p></div><div class="para"><p><b>Résultats: </b> Sur les 309 échantillons génotypés, 210 se sont révélés positifs pour msp-1, 227 positifs pour msp-2 et 193 positifs pour msp-3. La PCR nichée a révélé 22 allèles différents pour la famille allélique msp-1, 39 pour msp-2 et 13 pour msp-3. À chaque locus, la distribution de la famille était de 54,58% de K1, 25% de MAD20 et 20,42% de RO33 pour msp-1; 51,71% de FC27 et 48,29% de 3D7 pour msp-2. Pour toutes ces variantes alléliques, la distribution n’a été associée ni à la sévérité du paludisme ni à la zone d’habitation. Les coefficients de corrélation de Pearson entre soit les taux d’homocystéine ou de transaminase et la gravité de la maladie étaient très faibles.</p></div><div class="para"><p><b>Conclusion: </b> La sévérité du paludisme n’était pas été associée à des infections multiples et ne semblait pas limitée à des génotypes particuliers. Des investigations plus complètes, y compris de l’immunité, des facteurs génétiques, de l’état nutritionnel et sociologique de la population pourraient clarifier la situation.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivo: </b> Evaluar la prevalencia de genotipos y la multiplicidad de infecciones por <em>Plasmodium falciparum</em> en la región marítima de Togo.</p></div><div class="para"><p><b>Métodos: </b> Se incluyeron 309 niños sintomáticos con edades comprendidas entre los 6 meses y los 15 años en Bè/Lomé y Tsévié, dos áreas endémicas para malaria. El número y las proporciones de los genotipos 1, 2 y 3 de la proteína de superficie del merozoito se determinaron mediante genotipado por electroforesis capilar. Se investigó también la posible asociación entre las transaminasas y la homocisteína y la severidad de la enfermedad.</p></div><div class="para"><p><b>Resultados: </b> De las 309 muestras genotipadas, 210 dieron positivas para msp-1, 227 para msp-2 y 193 para msp-3. La PCR anidada reveló 22 alelos diferentes para la familia alélica msp-1, 39 para msp-2 y 13 para msp-3. En cada locus, la distribución de la familia era un 54.58% de K1, 25% de MAD20 y 20.42% de RO33 para msp-1, y 51.71% y 48.29% de FC27 y 3D7, respectivamente, para msp-2. Debido a todos estos variantes alélicos la distribución no estaba ni asociada con la severidad de la malaria ni con la zona de habitación. Los coeficientes de correlación de Pearson entre los niveles de homocisteína o de la transaminasa y la severidad de la enfermedad eran muy bajos.</p></div><div class="para"><p><b>Conclusión: </b> La severidad de la malaria no estaba asociada con una mayor multiplicidad de infección y no parecía estar restringida a genotipos particulares. Se requieren estudios más integrales que incluyan inmunidad, factores genéticos, estatus nutricional y sociológico de la población para clarificar la situación.</p></div></div>]]></content:encoded><description>Objective  To assess the genotype prevalence and the multiplicity of Plasmodium falciparum infections in the maritime region of Togo.Methods  We enrolled 309 symptomatic individuals aged from 6 months to 15 years from Bè/Lomé and Tsévié, two malaria endemic zones. The number and the proportions of merozoite surface proteins 1, 2 and 3 genotypes in patients were determined using capillary electrophoresis genotyping. We further investigated the possible association between transaminases and homocysteine, and the severity of the disease.Results  Of the 309 samples genotyped, 210 tested positive to msp-1, 227 to msp-2 and 193 to msp-3. The nested PCR revealed 22 different alleles for the allelic family msp-1, 33 for msp-2 and 13 for msp-3. At each locus, the family distribution was 54.58% of K1, 25% of MAD20 and 20.42% of RO33 for msp-1, and 51.71% and 48.29% of FC27 and 3D7, respectively, for msp-2. For all these allelic variants, the distribution was associated with neither the severity of malaria nor the zone of habitation. Pearson correlation coefficients between either the levels of homocysteine or the transaminase and the severity of the disease were very low.Conclusion  The severity of malaria was not associated with higher multiplicity of infections and did not appear restricted to particular genotypes. More comprehensive explorations including immunity, genetic factors, nutritional and sociologic status of the population could clarify the situation.Objectif:  Evaluer la prévalence génotypique et la multiplicité des infections àPlasmodium falciparum dans la région maritime du Togo.Méthodes:  Nous avons recruté 309 enfants symptomatiques âgés de 6 mois à 15 ans à Bè/Lomé et à Tsévié, deux zones endémiques pour le paludisme. Le nombre et les proportions des génotypes des protéines de surface du mérozoïte (msp) -1, 2 et 3 chez les patients ont été déterminés en utilisant le génotypage par électrophorèse en capillaire. Nous avons également étudié l’association possible entre les transaminases et l’homocystéine avec la sévérité de la maladie.Résultats:  Sur les 309 échantillons génotypés, 210 se sont révélés positifs pour msp-1, 227 positifs pour msp-2 et 193 positifs pour msp-3. La PCR nichée a révélé 22 allèles différents pour la famille allélique msp-1, 39 pour msp-2 et 13 pour msp-3. À chaque locus, la distribution de la famille était de 54,58% de K1, 25% de MAD20 et 20,42% de RO33 pour msp-1; 51,71% de FC27 et 48,29% de 3D7 pour msp-2. Pour toutes ces variantes alléliques, la distribution n’a été associée ni à la sévérité du paludisme ni à la zone d’habitation. Les coefficients de corrélation de Pearson entre soit les taux d’homocystéine ou de transaminase et la gravité de la maladie étaient très faibles.Conclusion:  La sévérité du paludisme n’était pas été associée à des infections multiples et ne semblait pas limitée à des génotypes particuliers. Des investigations plus complètes, y compris de l’immunité, des facteurs génétiques, de l’état nutritionnel et sociologique de la population pourraient clarifier la situation.Objetivo:  Evaluar la prevalencia de genotipos y la multiplicidad de infecciones por Plasmodium falciparum en la región marítima de Togo.Métodos:  Se incluyeron 309 niños sintomáticos con edades comprendidas entre los 6 meses y los 15 años en Bè/Lomé y Tsévié, dos áreas endémicas para malaria. El número y las proporciones de los genotipos 1, 2 y 3 de la proteína de superficie del merozoito se determinaron mediante genotipado por electroforesis capilar. Se investigó también la posible asociación entre las transaminasas y la homocisteína y la severidad de la enfermedad.Resultados:  De las 309 muestras genotipadas, 210 dieron positivas para msp-1, 227 para msp-2 y 193 para msp-3. La PCR anidada reveló 22 alelos diferentes para la familia alélica msp-1, 39 para msp-2 y 13 para msp-3. En cada locus, la distribución de la familia era un 54.58% de K1, 25% de MAD20 y 20.42% de RO33 para msp-1, y 51.71% y 48.29% de FC27 y 3D7, respectivamente, para msp-2. Debido a todos estos variantes alélicos la distribución no estaba ni asociada con la severidad de la malaria ni con la zona de habitación. Los coeficientes de correlación de Pearson entre los niveles de homocisteína o de la transaminasa y la severidad de la enfermedad eran muy bajos.Conclusión:  La severidad de la malaria no estaba asociada con una mayor multiplicidad de infección y no parecía estar restringida a genotipos particulares. Se requieren estudios más integrales que incluyan inmunidad, factores genéticos, estatus nutricional y sociológico de la población para clarificar la situación.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02906.x" xmlns="http://purl.org/rss/1.0/"><title>The role of sexually transmitted infections in the evolution of the South African HIV epidemicRôle des infections sexuellement transmissibles dans l’évolution de l’épidémie du VIH en Afrique du sudEl papel de las infecciones de transmisión sexual en la evolución de la epidemia de VIH en Sudáfrica</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02906.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The role of sexually transmitted infections in the evolution of the South African HIV epidemicRôle des infections sexuellement transmissibles dans l’évolution de l’épidémie du VIH en Afrique du sudEl papel de las infecciones de transmisión sexual en la evolución de la epidemia de VIH en Sudáfrica</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Leigh F. Johnson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rob E. Dorrington</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Debbie Bradshaw</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David J. Coetzee</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02906.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02906.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02906.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">161</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">168</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> To assess the extent to which sexually transmitted infections (STIs) have contributed to the spread of HIV in South Africa and to estimate the extent to which improvements in STI treatment have reduced HIV incidence.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> A mathematical model was used to simulate interactions between HIV and six other STIs (genital herpes, syphilis, chancroid, gonorrhoea, chlamydial infection and trichomoniasis) as well as bacterial vaginosis and vaginal candidiasis. The effects of STIs on HIV transmission probabilities were assumed to be consistent with meta-analytic reviews of observational studies, and the model was fitted to South African HIV prevalence data.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The proportion of new HIV infections in adults that were attributable to curable STIs reduced from 39% (uncertainty range: 24–50%) in 1990 to 14% (8–18%) in 2010, while the proportion of new infections attributable to genital herpes increased. Syndromic management programmes are estimated to have reduced adult HIV incidence by 6.6% (3.3–10.3%) between 1994 and 2004, by which time syndromic management coverage was 52%. Had syndromic management been introduced in 1986, with immediate achievement of 100% coverage and a doubling of the rate of health seeking, HIV incidence would have reduced by 64% (36–82%) over the next decade, but had the same intervention been delayed until 2004, HIV incidence would have reduced by only 5.5% (2.8–9.0%).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Sexually transmitted infections have contributed significantly to the spread of HIV in South Africa, but STI control efforts have had limited impact on HIV incidence because of their late introduction and suboptimal coverage.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectifs: </b> Evaluer la mesure dans laquelle les infections sexuellement transmissibles (IST) ont contribuéà la propagation du VIH en Afrique du sud et estimer dans quelle mesure des améliorations dans le traitement des IST ont réduit l’incidence du VIH.</p></div><div class="para"><p><b>Méthodes: </b> Un modèle mathématique a été utilisé pour simuler les interactions entre le VIH et six autres IST (herpès génital, syphilis, chancre mou, blennorragie, infection à Chlamydia et à Trichomonas) ainsi que la vaginose bactérienne et la candidose vaginale. Les effets des IST sur les probabilités de transmission du VIH ont été supposés être compatibles avec les résultats de méta-analyse d’études observationnelles et le modèle a été ajusté aux données de prévalence du VIH en Afrique du sud.</p></div><div class="para"><p><b>Résultats: </b> La proportion de nouvelles infections VIH chez les adultes, attribuables à des IST curables a diminué, allant de 39% (marge d’incertitude: 24–50%) en 1990 à 14% (8–18%) en 2010, tandis que la proportion de nouvelles infections attribuables à l’herpès génital a augmenté. Les programmes de prise en charge syndromique sont supposés avoir réduit l’incidence du VIH chez les adultes de 6,6% (3,3 à 10,3%) entre 1994 et 2004, où la couverture de la prise en charge syndromique était de 52%. Si la prise en charge syndromique avait été introduite en 1986, avec la réalisation immédiate d’une couverture de 100% et un doublement du taux des recours à la santé, l’incidence du VIH aurait été réduite de 64% (36–82%) au cours de la décennie suivante. Mais si la même intervention avait été retardée jusqu’en 2004, l’incidence du VIH aurait diminué de seulement 5,5% (2,8 à 9,0%).</p></div><div class="para"><p><b>Conclusions: </b> Les IST ont contribué de façon importante à la propagation du VIH en Afrique du sud, mais les efforts de contrôle des IST ont eu un impact limité sur l’incidence du VIH en raison de leur introduction tardive et de la couverture sous-optimale.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivos: </b> Evaluar hasta donde han contribuido las infecciones de transmisión sexual (ITSs) a la dispersión del VIH en Sudáfrica, y calcular hasta que punto las mejoras en el tratamiento de las ITSs han reducido la incidencia del VIH.</p></div><div class="para"><p><b>Métodos: </b> Se utilizó un modelo matemático para simular interacciones entre el VIH y otras seis ITSs (herpes genital, sífilis, chancro, gonorrea, infección por clamidias y tricomonas) al igual que la vaginosis bacteriana y la candidiasis vaginal. Se asumió que los efectos de las ITSs sobre la probabilidad de transmisión del VIH eran consistentes con las revisiones meta-analíticas de estudios observacionales, y el modelo se ajustó a datos de prevalencia del VIH en Sudáfrica.</p></div><div class="para"><p><b>Resultados: </b> La proporción de nuevas infecciones de VIH en adultos atribuibles a ITSs curables se redujo del 39% (rango de incertidumbre: 24–50%) en 1990 al 14% (8–18%) en 2010, mientras que la proporción de nuevas infecciones atribuibles al herpes genital aumentó. Se estima que los programas de manejo sindrómico han reducido la incidencia del VIH en un 6.6% (3.3–10.3%) entre 1994 y 2004, momento en el cual la cobertura del manejo sindrómico era del 52%. Si el manejo sindrómico se hubiese introducido en 1986, con un alcance inmediato del 100% de cobertura, y la tasa de búsqueda de salud se hubiese doblado, la incidencia del VIH se habría reducido en un 64% (36–82%) en la década siguiente; pero si la misma intervención se hubiese retrasado hasta el 2004, la incidencia del VIH se habría reducido solo en un 5.5% (2.8–9.0%).</p></div><div class="para"><p><b>Conclusiones: </b> Las ITSs han contribuido significativamente a la dispersión del VIH en Sudáfrica, pero los esfuerzos por controlar las ITS han tenido un impacto limitado sobre la incidencia del VIH por su introducción tardía y una ucobertura subóptima.</p></div></div>]]></content:encoded><description>Objectives  To assess the extent to which sexually transmitted infections (STIs) have contributed to the spread of HIV in South Africa and to estimate the extent to which improvements in STI treatment have reduced HIV incidence.Methods  A mathematical model was used to simulate interactions between HIV and six other STIs (genital herpes, syphilis, chancroid, gonorrhoea, chlamydial infection and trichomoniasis) as well as bacterial vaginosis and vaginal candidiasis. The effects of STIs on HIV transmission probabilities were assumed to be consistent with meta-analytic reviews of observational studies, and the model was fitted to South African HIV prevalence data.Results  The proportion of new HIV infections in adults that were attributable to curable STIs reduced from 39% (uncertainty range: 24–50%) in 1990 to 14% (8–18%) in 2010, while the proportion of new infections attributable to genital herpes increased. Syndromic management programmes are estimated to have reduced adult HIV incidence by 6.6% (3.3–10.3%) between 1994 and 2004, by which time syndromic management coverage was 52%. Had syndromic management been introduced in 1986, with immediate achievement of 100% coverage and a doubling of the rate of health seeking, HIV incidence would have reduced by 64% (36–82%) over the next decade, but had the same intervention been delayed until 2004, HIV incidence would have reduced by only 5.5% (2.8–9.0%).Conclusions  Sexually transmitted infections have contributed significantly to the spread of HIV in South Africa, but STI control efforts have had limited impact on HIV incidence because of their late introduction and suboptimal coverage.Objectifs:  Evaluer la mesure dans laquelle les infections sexuellement transmissibles (IST) ont contribuéà la propagation du VIH en Afrique du sud et estimer dans quelle mesure des améliorations dans le traitement des IST ont réduit l’incidence du VIH.Méthodes:  Un modèle mathématique a été utilisé pour simuler les interactions entre le VIH et six autres IST (herpès génital, syphilis, chancre mou, blennorragie, infection à Chlamydia et à Trichomonas) ainsi que la vaginose bactérienne et la candidose vaginale. Les effets des IST sur les probabilités de transmission du VIH ont été supposés être compatibles avec les résultats de méta-analyse d’études observationnelles et le modèle a été ajusté aux données de prévalence du VIH en Afrique du sud.Résultats:  La proportion de nouvelles infections VIH chez les adultes, attribuables à des IST curables a diminué, allant de 39% (marge d’incertitude: 24–50%) en 1990 à 14% (8–18%) en 2010, tandis que la proportion de nouvelles infections attribuables à l’herpès génital a augmenté. Les programmes de prise en charge syndromique sont supposés avoir réduit l’incidence du VIH chez les adultes de 6,6% (3,3 à 10,3%) entre 1994 et 2004, où la couverture de la prise en charge syndromique était de 52%. Si la prise en charge syndromique avait été introduite en 1986, avec la réalisation immédiate d’une couverture de 100% et un doublement du taux des recours à la santé, l’incidence du VIH aurait été réduite de 64% (36–82%) au cours de la décennie suivante. Mais si la même intervention avait été retardée jusqu’en 2004, l’incidence du VIH aurait diminué de seulement 5,5% (2,8 à 9,0%).Conclusions:  Les IST ont contribué de façon importante à la propagation du VIH en Afrique du sud, mais les efforts de contrôle des IST ont eu un impact limité sur l’incidence du VIH en raison de leur introduction tardive et de la couverture sous-optimale.Objetivos:  Evaluar hasta donde han contribuido las infecciones de transmisión sexual (ITSs) a la dispersión del VIH en Sudáfrica, y calcular hasta que punto las mejoras en el tratamiento de las ITSs han reducido la incidencia del VIH.Métodos:  Se utilizó un modelo matemático para simular interacciones entre el VIH y otras seis ITSs (herpes genital, sífilis, chancro, gonorrea, infección por clamidias y tricomonas) al igual que la vaginosis bacteriana y la candidiasis vaginal. Se asumió que los efectos de las ITSs sobre la probabilidad de transmisión del VIH eran consistentes con las revisiones meta-analíticas de estudios observacionales, y el modelo se ajustó a datos de prevalencia del VIH en Sudáfrica.Resultados:  La proporción de nuevas infecciones de VIH en adultos atribuibles a ITSs curables se redujo del 39% (rango de incertidumbre: 24–50%) en 1990 al 14% (8–18%) en 2010, mientras que la proporción de nuevas infecciones atribuibles al herpes genital aumentó. Se estima que los programas de manejo sindrómico han reducido la incidencia del VIH en un 6.6% (3.3–10.3%) entre 1994 y 2004, momento en el cual la cobertura del manejo sindrómico era del 52%. Si el manejo sindrómico se hubiese introducido en 1986, con un alcance inmediato del 100% de cobertura, y la tasa de búsqueda de salud se hubiese doblado, la incidencia del VIH se habría reducido en un 64% (36–82%) en la década siguiente; pero si la misma intervención se hubiese retrasado hasta el 2004, la incidencia del VIH se habría reducido solo en un 5.5% (2.8–9.0%).Conclusiones:  Las ITSs han contribuido significativamente a la dispersión del VIH en Sudáfrica, pero los esfuerzos por controlar las ITS han tenido un impacto limitado sobre la incidencia del VIH por su introducción tardía y una ucobertura subóptima.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02912.x" xmlns="http://purl.org/rss/1.0/"><title>Practices to improve identification of adult antiretroviral therapy failure at the Lighthouse Trust clinic in Lilongwe, MalawiPratiques visant à améliorer l’identification de l’échec thérapeutique antirétrovirale chez les adultes dans la clinique du Lighthouse Trust à Lilongwe, MalawiPrácticas que mejoran la identificación del fallo de la terapia antirretroviral en adultos en la clínica Lighthouse Trust en Lilongwe, Malawi</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02912.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Practices to improve identification of adult antiretroviral therapy failure at the Lighthouse Trust clinic in Lilongwe, MalawiPratiques visant à améliorer l’identification de l’échec thérapeutique antirétrovirale chez les adultes dans la clinique du Lighthouse Trust à Lilongwe, MalawiPrácticas que mejoran la identificación del fallo de la terapia antirretroviral en adultos en la clínica Lighthouse Trust en Lilongwe, Malawi</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Charles K. Vorkas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hannock Tweya</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dalitso Mzinganjira</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">George Dickie</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ralf Weigel</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sam Phiri</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mina C. Hosseinipour</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02912.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02912.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02912.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">169</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">176</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> Evaluating treatment failure is critical when deciding to modify antiretroviral therapy (ART). Virologic Assessment Forms (VAFs) were implemented in July 2008 as a prerequisite for ordering viral load. The form requires assessment of clinical and immunologic status.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Using the Electronic Medical Record (EMR), we retrospectively evaluated patients who met 2006 WHO guidelines for immunologic failure (≥15 years old; on ART ≥6 months; CD4 count &lt;baseline OR CD4 count &gt;50% drop from peak OR CD4 persistently &lt;100 cells) at the Lighthouse Trust clinic from December 2007 to December 2009. We compared virologic screening, VAF implementation and ART modification during the same period using Fisher’s exact tests and unpaired <em>t</em>-tests as appropriate.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Of 7000 enrolled ART patients ≥15 years old with at least two CD4 counts, 10% had immunologic failure with a median follow-up time on ART of 1.4 years (IQR: 0.8–2.3). Forty (6%) viral loads were ordered: 14 (35%) were detectable (&gt;400 HIV RNA copies/mL) and one (7%) patient was switched to second-line therapy. Overall, 259 VAFs were completed: 67% for immunologic failure and 33% for WHO Stage 4 condition. Before VAF implementation, 1% of patients had viral loads drawn during routine care, whereas afterwards, 8% did (<em>P</em> &lt; 0.0001; 95% CI: 0.03–0.08).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Clinicians did not identify a large proportion of immunologic failure patients for screening. Implementation of VAFs produced little improvement in virologic screening during routine care. Better training and monitoring systems are needed.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Contexte: </b> Evaluer l’échec du traitement est cruciale lorsqu’il s’agit de décider de modifier un traitement antirétroviral (ART). Des formulaires d’évaluation virologique (FEV) ont été introduits en juillet 2008 comme préalable à la demande d’un test de la charge virale. Le formulaire exige une évaluation de l’état clinique et immunologique.</p></div><div class="para"><p><b>Méthodes: </b> En utilisant le dossier médical électronique, nous avons rétrospectivement évalué les patients répondant aux directives 2006 de l’OMS pour l’échec immunologique (≥ 15 ans; sous ART ≥ 6 mois; taux des CD4 &lt; valeur initiale ou taux des CD4 &gt; 50% de la chute de la valeur pic ou taux des CD4 constamment &lt;100 cellules), à la clinique du Lighthouse Trust, de décembre 2007 à décembre 2009. Nous avons comparé le dépistage virologique, l’implémentation des FEV et la modification de l’ART durant la même période en utilisant les tests exacts de Fisher et le cas échéant, les tests t non appariés.</p></div><div class="para"><p><b>Résultats: </b> Sur 7000 patients recrutés ≥ 15 ans et sous ART avec au moins deux mesures des taux de CD4, 10% avaient un échec immunologique avec une durée de suivi médian de 1,4 ans sous ART (IIQ: 0,8 à 2,3). Des mesures de la charge virale ont été demandées pour 40 (6%) patients: 14 (35%) avaient des taux détectables (&gt; 400 copies de l’ARN du VIH/ml) et 1 (7%) des patients a été mis sous traitement de seconde ligne. En tout, 259 FEV ont été remplis: 67% pour l’échec immunologique et 33% pour la condition de stade 4 de l’OMS. Avant l’implémentation des FEV, 1% des patients avaient une charge virale mesurée au cours des soins de routine, mais après, ce taux est passéà 8% (p &lt;0,0001; IC95%: 0,03 à 0,08).</p></div><div class="para"><p><b>Conclusions: </b> Les cliniciens n’ont pas identifié une large proportion de patients avec un échec immunologique pour le dépistage. L’implémentation des FEV a apporté peu d’amélioration dans le dépistage virologique au cours des soins de routine. Une formation et des systèmes de surveillance meilleurs sont nécessaires.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Antecedentes: </b> Evaluar el fallo en el tratamiento es crítico a la hora de decidir modificar la terapia antirretroviral (TAR). Se implementaron los formularios de evaluación virológica (FEV) en Julio 2008 como un prerrequisito para pedir la carga viral. El formulario requiere la evaluación del estatus clínico e inmunológico.</p></div><div class="para"><p><b>Métodos: </b> En la clínica Lighthouse Trust, entre 12/2007-12/2009, y utilizando la Historia Clínica Electrónica (HCE), hemos evaluado de forma retrospectiva a los pacientes que alcanzaron la definición de fallo inmunológico según las guías de la OMS del 2006 (≥15 años; recibiendo TAR ≥ 6 meses; conteo de CD4 &lt; el inicial <b>O</b> conteo CD4 &gt;50% caida del pico máximo <b>O</b> CD4 persistentemente &lt;100 células). Hemos comparado las pruebas virológicas, la implementación del FEV y la modificación del TAR durante el mismo periodo utilizando las pruebas exactas de Fisher y pruebas t no pareadas según conveniencia.</p></div><div class="para"><p><b>Resultados: </b> De los 7,000 pacientes en TAR, ≥15 años y con al menos dos conteos de CD4, un 10% tenían un fallo inmunológico con una mediana de tiempo de seguimiento en TAR de 1.4 años (IQR: 0.8–2.3). Se ordenaron cuarenta (6%) cargas virales: 14 (35%) eran detectables (&gt;400 VIH copias/mL ARN) y a 1 (7%) paciente se le cambió a la segunda línea de tratamiento. En general, se completaron 259FEVs : un 67% por fallo inmunológico y 33% por estar en el Estadío 4 según la OMS. Antes de la implementación del FEV, un 1% de los pacientes tenían cargas virales tomadas durante cuidados rutinarios, mientras que después, lo tenía un 8% (p&lt;0.0001; 95% IC 0.03-0.08).</p></div><div class="para"><p><b>Conclusiones: </b> Los clínicos no identificaron una gran proporción de pacientes con fallo inmunológico a ser incluidos en las pruebas. La implementación de los FEV produjo poca mejoría en la detección virológica durante los cuidados rutinarios. Se requiere una mejora en la formación y en los sistemas de monitorización.</p></div></div>]]></content:encoded><description>Objectives  Evaluating treatment failure is critical when deciding to modify antiretroviral therapy (ART). Virologic Assessment Forms (VAFs) were implemented in July 2008 as a prerequisite for ordering viral load. The form requires assessment of clinical and immunologic status.Methods  Using the Electronic Medical Record (EMR), we retrospectively evaluated patients who met 2006 WHO guidelines for immunologic failure (≥15 years old; on ART ≥6 months; CD4 count &lt;baseline OR CD4 count &gt;50% drop from peak OR CD4 persistently &lt;100 cells) at the Lighthouse Trust clinic from December 2007 to December 2009. We compared virologic screening, VAF implementation and ART modification during the same period using Fisher’s exact tests and unpaired t-tests as appropriate.Results  Of 7000 enrolled ART patients ≥15 years old with at least two CD4 counts, 10% had immunologic failure with a median follow-up time on ART of 1.4 years (IQR: 0.8–2.3). Forty (6%) viral loads were ordered: 14 (35%) were detectable (&gt;400 HIV RNA copies/mL) and one (7%) patient was switched to second-line therapy. Overall, 259 VAFs were completed: 67% for immunologic failure and 33% for WHO Stage 4 condition. Before VAF implementation, 1% of patients had viral loads drawn during routine care, whereas afterwards, 8% did (P &lt; 0.0001; 95% CI: 0.03–0.08).Conclusions  Clinicians did not identify a large proportion of immunologic failure patients for screening. Implementation of VAFs produced little improvement in virologic screening during routine care. Better training and monitoring systems are needed.Contexte:  Evaluer l’échec du traitement est cruciale lorsqu’il s’agit de décider de modifier un traitement antirétroviral (ART). Des formulaires d’évaluation virologique (FEV) ont été introduits en juillet 2008 comme préalable à la demande d’un test de la charge virale. Le formulaire exige une évaluation de l’état clinique et immunologique.Méthodes:  En utilisant le dossier médical électronique, nous avons rétrospectivement évalué les patients répondant aux directives 2006 de l’OMS pour l’échec immunologique (≥ 15 ans; sous ART ≥ 6 mois; taux des CD4 &lt; valeur initiale ou taux des CD4 &gt; 50% de la chute de la valeur pic ou taux des CD4 constamment &lt;100 cellules), à la clinique du Lighthouse Trust, de décembre 2007 à décembre 2009. Nous avons comparé le dépistage virologique, l’implémentation des FEV et la modification de l’ART durant la même période en utilisant les tests exacts de Fisher et le cas échéant, les tests t non appariés.Résultats:  Sur 7000 patients recrutés ≥ 15 ans et sous ART avec au moins deux mesures des taux de CD4, 10% avaient un échec immunologique avec une durée de suivi médian de 1,4 ans sous ART (IIQ: 0,8 à 2,3). Des mesures de la charge virale ont été demandées pour 40 (6%) patients: 14 (35%) avaient des taux détectables (&gt; 400 copies de l’ARN du VIH/ml) et 1 (7%) des patients a été mis sous traitement de seconde ligne. En tout, 259 FEV ont été remplis: 67% pour l’échec immunologique et 33% pour la condition de stade 4 de l’OMS. Avant l’implémentation des FEV, 1% des patients avaient une charge virale mesurée au cours des soins de routine, mais après, ce taux est passéà 8% (p &lt;0,0001; IC95%: 0,03 à 0,08).Conclusions:  Les cliniciens n’ont pas identifié une large proportion de patients avec un échec immunologique pour le dépistage. L’implémentation des FEV a apporté peu d’amélioration dans le dépistage virologique au cours des soins de routine. Une formation et des systèmes de surveillance meilleurs sont nécessaires.Antecedentes:  Evaluar el fallo en el tratamiento es crítico a la hora de decidir modificar la terapia antirretroviral (TAR). Se implementaron los formularios de evaluación virológica (FEV) en Julio 2008 como un prerrequisito para pedir la carga viral. El formulario requiere la evaluación del estatus clínico e inmunológico.Métodos:  En la clínica Lighthouse Trust, entre 12/2007-12/2009, y utilizando la Historia Clínica Electrónica (HCE), hemos evaluado de forma retrospectiva a los pacientes que alcanzaron la definición de fallo inmunológico según las guías de la OMS del 2006 (≥15 años; recibiendo TAR ≥ 6 meses; conteo de CD4 &lt; el inicial O conteo CD4 &gt;50% caida del pico máximo O CD4 persistentemente &lt;100 células). Hemos comparado las pruebas virológicas, la implementación del FEV y la modificación del TAR durante el mismo periodo utilizando las pruebas exactas de Fisher y pruebas t no pareadas según conveniencia.Resultados:  De los 7,000 pacientes en TAR, ≥15 años y con al menos dos conteos de CD4, un 10% tenían un fallo inmunológico con una mediana de tiempo de seguimiento en TAR de 1.4 años (IQR: 0.8–2.3). Se ordenaron cuarenta (6%) cargas virales: 14 (35%) eran detectables (&gt;400 VIH copias/mL ARN) y a 1 (7%) paciente se le cambió a la segunda línea de tratamiento. En general, se completaron 259FEVs : un 67% por fallo inmunológico y 33% por estar en el Estadío 4 según la OMS. Antes de la implementación del FEV, un 1% de los pacientes tenían cargas virales tomadas durante cuidados rutinarios, mientras que después, lo tenía un 8% (p&lt;0.0001; 95% IC 0.03-0.08).Conclusiones:  Los clínicos no identificaron una gran proporción de pacientes con fallo inmunológico a ser incluidos en las pruebas. La implementación de los FEV produjo poca mejoría en la detección virológica durante los cuidados rutinarios. Se requiere una mejora en la formación y en los sistemas de monitorización.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02896.x" xmlns="http://purl.org/rss/1.0/"><title>Incidence of severe acute maternal morbidity associated with abortion: a systematic reviewIncidence de la morbidité maternelle aiguë sévère associée à l’avortement: une revue systématiqueIncidencia de la morbilidad materna aguda y severa asociada al aborto: revisión sistemática</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02896.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Incidence of severe acute maternal morbidity associated with abortion: a systematic reviewIncidence de la morbidité maternelle aiguë sévère associée à l’avortement: une revue systématiqueIncidencia de la morbilidad materna aguda y severa asociada al aborto: revisión sistemática</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. J. Adler</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">V. Filippi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. L. Thomas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Ronsmans</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02896.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02896.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02896.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Systematic Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">177</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">190</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To systematically review articles describing complications of abortion in settings where abortions are thought to be unsafe and to determine the incidence of severe acute maternal morbidity (SAMM) attributed to abortion at the population level.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> We searched relevant databases using search terms related to abortion and complications. We included population-representative studies that listed complications of abortion. We extracted data on the definitions and numbers of severe complications and SAMM, and we report abortion complication rates (per 100 000 women of reproductive age) and ratios (per 100 000 live births) for SAMM, severe complications and any complications.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> We included 15 studies representing eleven countries (six in Africa, four in Asia and one in Latin America). We found a median abortion ratio of SAMM of 237 (range 91–1892) per 100 000 live births and a median abortion ratio of severe complications of 596 (range 435–5298). There was a great degree of heterogeneity between definitions and study populations.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> The burden of SAMM attributed to abortion is much greater than what is reported for deaths caused by abortion. However, the great heterogeneity in definitions makes it difficult to draw firm conclusions. We call for future work on the burden of unsafe abortion to use strict definitions of SAMM.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectif: </b> Analyser systématiquement les articles décrivant les complications de l’avortement dans des contextes où l’avortement est considéréà risque et déterminer l’incidence de la morbidité maternelle sévère aiguë (MMSA) due à l’avortement à l’échelle des populations.</p></div><div class="para"><p><b>Méthodes: </b> Nous avons effectué des recherches dans des bases de données pertinentes en utilisant des termes de recherche liés à l’avortement et aux complications. Nous avons inclus des études représentatives de populations qui ont énuméré les complications liées à l’avortement. Nous avons extrait les données sur les définitions et le nombre de complications sévères et la MMSA et nous rapportons un taux de complications liées à l’avortement (pour 100.000 femmes en âge de procréer) et le ratio (pour 100.000 naissances vivantes) pour la MMSA, les complications sévères et toutes formes de complications</p></div><div class="para"><p><b>Résultats: </b> Nous avons inclus 15 études représentant onze pays (six en Afrique, quatre en Asie et un en Amérique latine). Nous avons trouvé un ratio médian d’avortements à MMSA de 237 (intervalle de 91 à 1892) pour 100.000 naissances vivantes et un ratio médian d’avortement à complications sévères de 596 (intervalle de 435 à 5298). Il y avait une hétérogénéité importante entre les définitions et les populations étudiées.</p></div><div class="para"><p><b>Conclusion: </b> La charge de MMSA due à l’avortement est beaucoup plus grande que ce qui est rapporté pour les décès dus à l’avortement. Cependant, la grande hétérogénéité dans les définitions rend difficile de tirer des conclusions claires. Nous lançons un appel aux futures études sur la charge de l’avortement à risque, d’utiliser des définitions strictes de la MMSA.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivo: </b> Realizar una revisión sistemática de las publicaciones en las que se describen complicaciones debidas a un aborto en lugares en los que estos se consideran inseguros, y determinar la incidencia de la morbilidad materna aguda y severa (MMAS) por abortos a nivel de la población.</p></div><div class="para"><p><b>Métodos: </b> Hemos realizado una búsqueda en bases de datos relevantes, utilizando términos de búsqueda relacionados con abortos y complicaciones. Hemos incluido estudios poblacionales representativos en los que se enumeran las complicaciones debidas al aborto. Extrajimos datos sobre las definiciones y números de complicaciones severas y MMAS y reportamos la tasa de complicaciones por aborto (por 100,000 mujeres en edad reproductiva) y la tasa (por 100,000 nacidos vivos) de MMAS, complicaciones severas y cualquier complicación.</p></div><div class="para"><p><b>Resultados: </b> Hemos incluido 15 estudios que representan a once países (seis en África, cuatro en Asia y uno en América Latina). Encontramos una tasa media de MMAS por aborto de 237 (rango 91 a 1892) por 100,000 nacidos vivos y un tasa media de complicaciones severas por aborto de 596 (rango 435 a 5298). Había un alto grado de heterogeneidad en las definiciones y poblaciones de estudio.</p></div><div class="para"><p><b>Conclusiones: </b> La carga de MMAS debida al aborto es mucho mayor de lo que se reporta por muertes atribuibles al aborto. Sin embargo, la gran heterogeneidad de las definiciones hace que sea difícil poder sacar conclusiones sólidas. Hacemos un llamamiento para que en trabajos futuros sobre la carga por abortos inseguros se utilicen definiciones estrictas de MMAS.</p></div></div>]]></content:encoded><description>Objective  To systematically review articles describing complications of abortion in settings where abortions are thought to be unsafe and to determine the incidence of severe acute maternal morbidity (SAMM) attributed to abortion at the population level.Methods  We searched relevant databases using search terms related to abortion and complications. We included population-representative studies that listed complications of abortion. We extracted data on the definitions and numbers of severe complications and SAMM, and we report abortion complication rates (per 100 000 women of reproductive age) and ratios (per 100 000 live births) for SAMM, severe complications and any complications.Results  We included 15 studies representing eleven countries (six in Africa, four in Asia and one in Latin America). We found a median abortion ratio of SAMM of 237 (range 91–1892) per 100 000 live births and a median abortion ratio of severe complications of 596 (range 435–5298). There was a great degree of heterogeneity between definitions and study populations.Conclusions  The burden of SAMM attributed to abortion is much greater than what is reported for deaths caused by abortion. However, the great heterogeneity in definitions makes it difficult to draw firm conclusions. We call for future work on the burden of unsafe abortion to use strict definitions of SAMM.Objectif:  Analyser systématiquement les articles décrivant les complications de l’avortement dans des contextes où l’avortement est considéréà risque et déterminer l’incidence de la morbidité maternelle sévère aiguë (MMSA) due à l’avortement à l’échelle des populations.Méthodes:  Nous avons effectué des recherches dans des bases de données pertinentes en utilisant des termes de recherche liés à l’avortement et aux complications. Nous avons inclus des études représentatives de populations qui ont énuméré les complications liées à l’avortement. Nous avons extrait les données sur les définitions et le nombre de complications sévères et la MMSA et nous rapportons un taux de complications liées à l’avortement (pour 100.000 femmes en âge de procréer) et le ratio (pour 100.000 naissances vivantes) pour la MMSA, les complications sévères et toutes formes de complicationsRésultats:  Nous avons inclus 15 études représentant onze pays (six en Afrique, quatre en Asie et un en Amérique latine). Nous avons trouvé un ratio médian d’avortements à MMSA de 237 (intervalle de 91 à 1892) pour 100.000 naissances vivantes et un ratio médian d’avortement à complications sévères de 596 (intervalle de 435 à 5298). Il y avait une hétérogénéité importante entre les définitions et les populations étudiées.Conclusion:  La charge de MMSA due à l’avortement est beaucoup plus grande que ce qui est rapporté pour les décès dus à l’avortement. Cependant, la grande hétérogénéité dans les définitions rend difficile de tirer des conclusions claires. Nous lançons un appel aux futures études sur la charge de l’avortement à risque, d’utiliser des définitions strictes de la MMSA.Objetivo:  Realizar una revisión sistemática de las publicaciones en las que se describen complicaciones debidas a un aborto en lugares en los que estos se consideran inseguros, y determinar la incidencia de la morbilidad materna aguda y severa (MMAS) por abortos a nivel de la población.Métodos:  Hemos realizado una búsqueda en bases de datos relevantes, utilizando términos de búsqueda relacionados con abortos y complicaciones. Hemos incluido estudios poblacionales representativos en los que se enumeran las complicaciones debidas al aborto. Extrajimos datos sobre las definiciones y números de complicaciones severas y MMAS y reportamos la tasa de complicaciones por aborto (por 100,000 mujeres en edad reproductiva) y la tasa (por 100,000 nacidos vivos) de MMAS, complicaciones severas y cualquier complicación.Resultados:  Hemos incluido 15 estudios que representan a once países (seis en África, cuatro en Asia y uno en América Latina). Encontramos una tasa media de MMAS por aborto de 237 (rango 91 a 1892) por 100,000 nacidos vivos y un tasa media de complicaciones severas por aborto de 596 (rango 435 a 5298). Había un alto grado de heterogeneidad en las definiciones y poblaciones de estudio.Conclusiones:  La carga de MMAS debida al aborto es mucho mayor de lo que se reporta por muertes atribuibles al aborto. Sin embargo, la gran heterogeneidad de las definiciones hace que sea difícil poder sacar conclusiones sólidas. Hacemos un llamamiento para que en trabajos futuros sobre la carga por abortos inseguros se utilicen definiciones estrictas de MMAS.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02907.x" xmlns="http://purl.org/rss/1.0/"><title>Plasma vitamin C assay in women of reproductive age in Kampala, Uganda, using a colorimetric methodDosage de la vitamine C plasmatique chez les femmes en âge de reproduction à Kampala, en Ouganda, par une méthode colorimétriqueEnsayo de vitamina C en plasma en mujeres en edad reproductiva en Kampala, Uganda, utilizando un método colorimétrico</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02907.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Plasma vitamin C assay in women of reproductive age in Kampala, Uganda, using a colorimetric methodDosage de la vitamine C plasmatique chez les femmes en âge de reproduction à Kampala, en Ouganda, par une méthode colorimétriqueEnsayo de vitamina C en plasma en mujeres en edad reproductiva en Kampala, Uganda, utilizando un método colorimétrico</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paul Kiondo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nazarius M. Tumwesigye</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Julius Wandabwa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gakenia Wamuyu-Maina</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gabriel S. Bimenya</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pius Okong</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02907.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02907.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02907.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">191</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">196</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> Vitamin C alone or in combination with vitamin E has been proposed to prevent pre-eclampsia. In this study, we assayed the plasma vitamin C in women of reproductive age in Kampala and assessed its association with pre-eclampsia.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Participants in this study were 215 women with pre-eclampsia, 400 women with normal pregnancy attending antenatal clinic and 200 non-pregnant women attending family planning clinic at Mulago Hospital’s Department of Obstetrics and Gynaecology from 1st May 2008 to 1st May 2009. Plasma vitamin C was assayed using the acid phosphotungstate method; differences in the means of plasma vitamin C were determined by <span class="smallCaps">anova</span>.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Mean plasma vitamin C levels were 1.72 (SD 0.68) × 10<sup>3</sup> μg/l in women with pre-eclampsia, 1.89 (SD 0.73) × 10<sup>3</sup> μg/l in women with normal pregnancy and 2.64 (SD 0.97) × 10<sup>3</sup> μg/l in non-pregnant women. Plasma vitamin C was lower in women with pre-eclampsia than in women with normal pregnancy (<em>P</em> = 0.005) and non-pregnant women (<em>P</em> &lt; 0.001).</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Health workers need to advise women of reproductive age on foods that are rich in vitamin C, as this may improve the vitamin status and possibly reduce the occurrence of pre-eclampsia.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectif: </b> La vitamine C seule ou en combinaison avec la vitamine E a été proposée pour prévenir la pré-éclampsie. Dans cet article, nous avons dosé la vitamine C plasmatique chez les femmes en âge de reproduction, à Kampala et avons évalué son association avec la pré-éclampsie.</p></div><div class="para"><p><b>Méthodes: </b> Les participantes étaient composées de 215 femmes atteintes de pré-éclampsie, 400 femmes avec une grossesse normale visitant la clinique de consultation prénatale et 200 femmes non enceintes visitant la clinique de planification familiale dans le département d’obstétrique et de gynécologie de l’hôpital de Mulago, du 1er mai 2008 au 1er mai 2009. La vitamine C plasmatique a été dosée par la méthode à l’acide phosphotungstique. Les différences entre les concentrations plasmatiques moyennes en vitamine C ont été déterminées par ANOVA.</p></div><div class="para"><p><b>Résultats: </b> Les taux plasmatiques moyens de vitamine C étaient de 1,72 (SD: 0,68) × 10<sup>3</sup> μg/L chez les femmes avec une pré-éclampsie, 1,89 (SD: 0,73) × 10<sup>3</sup> μg/L chez les femmes ayant une grossesse normale et 2,64 (SD 0,97) × 10<sup>3 </sup>μg/L chez les femmes non enceintes. La teneur plasmatique en vitamine C était plus faible chez les femmes avec une pré-éclampsie que chez les femmes avec une grossesse normale (P = 0,005) et chez les femmes non enceintes (P &lt; 0,001).</p></div><div class="para"><p><b>Conclusion: </b> Les agents de la santé devraient conseiller les femmes en âge de reproduction sur les aliments riches en vitamine C car cela peut améliorer le statut vitaminique et éventuellement réduire l’apparition de la pré-éclampsie.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivo: </b> Se ha propuesto la vitamina C, sola o en combinación con la vitamina E, para prevenir la pre-eclampsia. En este artículo, hemos evaluado los niveles de vitamina C en plasma en mujeres en edad reproductiva en Kampala, así como su asociación con la pre-eclampsia.</p></div><div class="para"><p><b>Métodos: </b> Las participantes en este estudio eran 215 mujeres con pre-eclampsia, 400 mujeres con un embarazo normal atendidas en la clínica prenatal y 200 mujeres no embarazadas que visitaban la clínica de planificación familiar, atendidas en el hospital de Mulago dentro del Departamento de Obstetricia y Ginecología entre el 1 Mayo 2008 y el 1 Mayo 2009. La vitamina C en plasma se evaluó utilizando el método del ácido fosfotungstato; las diferencias en las medias de vitamina C en plasma se determinaron mediante ANOVA.</p></div><div class="para"><p><b>Resultados: </b> Los niveles medios de vitamina C en plasma eran 1.72(SD 0.68) × 10<sup>3</sup> μg/L en mujeres con pre-eclampsia, 1.89(SD 0.73) × 10<sup>3</sup> μg/L en mujeres con embarazos normales y 2.64(SD 0.97) × 10<sup>3</sup>μg/L en mujeres no embarazadas. La vitamina C en plasma era menor en mujeres con pre-eclampsia que en mujeres con un embarazo normal (P = 0.005) y mujeres no embarazadas (P &lt; 0.001).</p></div><div class="para"><p><b>Conclusión: </b> Los trabajadores sanitarios deben recomendar a las mujeres en edad reproductiva que consuman alimentos ricos en vitamina C, puesto que ello puede mejorar el estatus de vitamina y posiblemente reducir la incidencia de pre-eclampsia.</p></div></div>]]></content:encoded><description>Objective  Vitamin C alone or in combination with vitamin E has been proposed to prevent pre-eclampsia. In this study, we assayed the plasma vitamin C in women of reproductive age in Kampala and assessed its association with pre-eclampsia.Methods  Participants in this study were 215 women with pre-eclampsia, 400 women with normal pregnancy attending antenatal clinic and 200 non-pregnant women attending family planning clinic at Mulago Hospital’s Department of Obstetrics and Gynaecology from 1st May 2008 to 1st May 2009. Plasma vitamin C was assayed using the acid phosphotungstate method; differences in the means of plasma vitamin C were determined by anova.Results  Mean plasma vitamin C levels were 1.72 (SD 0.68) × 103 μg/l in women with pre-eclampsia, 1.89 (SD 0.73) × 103 μg/l in women with normal pregnancy and 2.64 (SD 0.97) × 103 μg/l in non-pregnant women. Plasma vitamin C was lower in women with pre-eclampsia than in women with normal pregnancy (P = 0.005) and non-pregnant women (P &lt; 0.001).Conclusion  Health workers need to advise women of reproductive age on foods that are rich in vitamin C, as this may improve the vitamin status and possibly reduce the occurrence of pre-eclampsia.Objectif:  La vitamine C seule ou en combinaison avec la vitamine E a été proposée pour prévenir la pré-éclampsie. Dans cet article, nous avons dosé la vitamine C plasmatique chez les femmes en âge de reproduction, à Kampala et avons évalué son association avec la pré-éclampsie.Méthodes:  Les participantes étaient composées de 215 femmes atteintes de pré-éclampsie, 400 femmes avec une grossesse normale visitant la clinique de consultation prénatale et 200 femmes non enceintes visitant la clinique de planification familiale dans le département d’obstétrique et de gynécologie de l’hôpital de Mulago, du 1er mai 2008 au 1er mai 2009. La vitamine C plasmatique a été dosée par la méthode à l’acide phosphotungstique. Les différences entre les concentrations plasmatiques moyennes en vitamine C ont été déterminées par ANOVA.Résultats:  Les taux plasmatiques moyens de vitamine C étaient de 1,72 (SD: 0,68) × 103 μg/L chez les femmes avec une pré-éclampsie, 1,89 (SD: 0,73) × 103 μg/L chez les femmes ayant une grossesse normale et 2,64 (SD 0,97) × 103 μg/L chez les femmes non enceintes. La teneur plasmatique en vitamine C était plus faible chez les femmes avec une pré-éclampsie que chez les femmes avec une grossesse normale (P = 0,005) et chez les femmes non enceintes (P &lt; 0,001).Conclusion:  Les agents de la santé devraient conseiller les femmes en âge de reproduction sur les aliments riches en vitamine C car cela peut améliorer le statut vitaminique et éventuellement réduire l’apparition de la pré-éclampsie.Objetivo:  Se ha propuesto la vitamina C, sola o en combinación con la vitamina E, para prevenir la pre-eclampsia. En este artículo, hemos evaluado los niveles de vitamina C en plasma en mujeres en edad reproductiva en Kampala, así como su asociación con la pre-eclampsia.Métodos:  Las participantes en este estudio eran 215 mujeres con pre-eclampsia, 400 mujeres con un embarazo normal atendidas en la clínica prenatal y 200 mujeres no embarazadas que visitaban la clínica de planificación familiar, atendidas en el hospital de Mulago dentro del Departamento de Obstetricia y Ginecología entre el 1 Mayo 2008 y el 1 Mayo 2009. La vitamina C en plasma se evaluó utilizando el método del ácido fosfotungstato; las diferencias en las medias de vitamina C en plasma se determinaron mediante ANOVA.Resultados:  Los niveles medios de vitamina C en plasma eran 1.72(SD 0.68) × 103 μg/L en mujeres con pre-eclampsia, 1.89(SD 0.73) × 103 μg/L en mujeres con embarazos normales y 2.64(SD 0.97) × 103μg/L en mujeres no embarazadas. La vitamina C en plasma era menor en mujeres con pre-eclampsia que en mujeres con un embarazo normal (P = 0.005) y mujeres no embarazadas (P &lt; 0.001).Conclusión:  Los trabajadores sanitarios deben recomendar a las mujeres en edad reproductiva que consuman alimentos ricos en vitamina C, puesto que ello puede mejorar el estatus de vitamina y posiblemente reducir la incidencia de pre-eclampsia.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02897.x" xmlns="http://purl.org/rss/1.0/"><title>The cost of outpatient pneumonia in children &lt;5 years of age in FijiLe coût de la pneumonie ambulatoire chez les enfants de moins de cinq ans à FidjiEl coste del manejo ambulatorio de la neumonía en niños menores de cinco años de edad en Fiyi</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02897.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The cost of outpatient pneumonia in children &lt;5 years of age in FijiLe coût de la pneumonie ambulatoire chez les enfants de moins de cinq ans à FidjiEl coste del manejo ambulatorio de la neumonía en niños menores de cinco años de edad en Fiyi</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Beth Temple</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ulla Kou Griffiths</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Edward Kim Mulholland</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Felisita Tupou Ratu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lisi Tikoduadua</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Fiona Mary Russell</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02897.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02897.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02897.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">197</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">203</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> Pneumonia is the most common reason for visiting an outpatient facility among children &lt;5 years old in Fiji. The objective of this study is to describe for the first time the costs associated with an episode of outpatient pneumonia in Fiji, in terms of cost both to the government health sector and to the household.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Costs were estimated for 400 clinically diagnosed pneumonia cases from two outpatient facilities, one in the capital, Suva, and one in a peri-urban and rural area, Nausori. Household expenses relating to transport costs, treatment costs and indirect costs were determined primarily through structured interview with the caregiver. Unit costs were collected from a variety of sources. Patient-specific costs were summarised as average costs per facility.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The overall average societal cost associated with an episode of outpatient pneumonia was $18.98, ranging from $14.33 in Nausori to $23.67 in Suva. Household expenses represent a significant proportion of the societal cost (29% in Nausori and 45% in Suva), with transport costs the most important household cost item. Health sector expenses were dominated by personnel costs at both sites. Both the average total household expenses and the average total health sector expenses were significantly greater in Suva than Nausori.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> A single episode of outpatient pneumonia represents a significant cost both to the government health sector and to affected households. Given the high incidence of this disease in Fiji, this places a considerable burden on society.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectifs: </b> La pneumonie est la raison la plus courante pour les visites dans un service de soins ambulatoires pour les enfants de moins de cinq ans à Fidji. L’objectif de cet article est de décrire pour la première fois les coûts associés à un épisode de pneumonie ambulatoire à Fidji, à la fois en termes de coût pour le secteur de la santé du gouvernement et de coût pour le ménage.</p></div><div class="para"><p><b>Méthodes: </b> Les coûts ont été estimés pour 400 cas de pneumonie diagnostiquée cliniquement dans deux services de soins ambulatoires, l’un à Suva la capitale et l’autre à Nausori, une zone périurbaine et rurale. Les dépenses des ménages relatives aux frais de transport, du traitement et aux coûts indirects ont été déterminées principalement à travers des interviews structurées avec le soignant. Les coûts unitaires ont été recueillis auprès de diverses sources. Les coûts spécifiques du patient ont été résumés comme coûts moyens par établissement.</p></div><div class="para"><p><b>Résultats: </b> Le coût moyen global associéà un épisode de pneumonie ambulatoire pour la sociétéétait de 18,98 $ US, allant de 14,33 $ US à Nausori à 23,67 $ US à Suva. Les dépenses des ménages représentent une proportion importante du coût sociétal (29%à Nausori et 45%à Suva), avec les coûts de transport représentant le plus important des coûts pour les ménages. Les dépenses du secteur de la santéétaient dominées par les frais du personnel dans les deux sites. Autant les dépenses totales moyennes des ménages que les dépenses totales moyennes du secteur de la santéétaient significativement plus élevées à Suva qu’à Nausori.</p></div><div class="para"><p><b>Conclusions: </b> Un seul épisode de pneumonie ambulatoire représente un coût important à la fois pour le secteur de la santé gouvernemental et pour les ménages touchés. Compte tenu de l’incidence élevée de cette maladie à Fidji, il s’agit alors d’une charge considérable sur la société.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivos: </b> La neumonía es la causa más común de visita a las consultas externas entre niños menores de cinco años en Fiyi. El objetivo de este artículo es describir por primera vez los costes asociados a un episodio de neumonía con manejo ambulatorio en Fiyi, tanto en términos del coste al sector sanitario gubernamental como del coste a los hogares.</p></div><div class="para"><p><b>Métodos: </b> Los costes se estimaron para 400 casos de neumonía con diagnóstico clínico, uno en la capital, Suva, y uno en un área peri-urbana y área rural, Nausori. Los gastos de los hogares relacionados con los costes de transporte, tratamiento y costes indirectos se determinaron principalmente mediante una entrevista estructurada con el cuidador. Los costes unitarios se recolectaron de una variedad de fuentes. Los costes específicos del paciente se resumieron como costes promedio por instalación.</p></div><div class="para"><p><b>Resultados: </b> El coste social promedio asociado a un episodio de neumonía con manejo ambulatorio era de $18.98, con rangos entre $14.33 en Nausori y $23.67 en Suva. Los gastos para el hogar representan una proporción significativa de los costes sociales (29% en Nausori y 45% en Suva), siendo los costes de transporte el ítem más importante para los hogares. Los gastos del sector salud estaban dominados por los costes de personal en ambos lugares. Tanto el promedio total de gastos del hogar como el promedio total de los gastos del sector salud eran significativamente mayores en Suva que en Nausori.</p></div><div class="para"><p><b>Conclusiones: </b> Un solo episodio de neumonía con manejo ambulatorio representa un coste significativo tanto para el sector gubernamental como para los hogares afectados. Por la alta incidencia que tiene esta enfermedad en Fiyi, la carga social para la sociedad es considerable .</p></div></div>]]></content:encoded><description>Objectives  Pneumonia is the most common reason for visiting an outpatient facility among children &lt;5 years old in Fiji. The objective of this study is to describe for the first time the costs associated with an episode of outpatient pneumonia in Fiji, in terms of cost both to the government health sector and to the household.Methods  Costs were estimated for 400 clinically diagnosed pneumonia cases from two outpatient facilities, one in the capital, Suva, and one in a peri-urban and rural area, Nausori. Household expenses relating to transport costs, treatment costs and indirect costs were determined primarily through structured interview with the caregiver. Unit costs were collected from a variety of sources. Patient-specific costs were summarised as average costs per facility.Results  The overall average societal cost associated with an episode of outpatient pneumonia was $18.98, ranging from $14.33 in Nausori to $23.67 in Suva. Household expenses represent a significant proportion of the societal cost (29% in Nausori and 45% in Suva), with transport costs the most important household cost item. Health sector expenses were dominated by personnel costs at both sites. Both the average total household expenses and the average total health sector expenses were significantly greater in Suva than Nausori.Conclusions  A single episode of outpatient pneumonia represents a significant cost both to the government health sector and to affected households. Given the high incidence of this disease in Fiji, this places a considerable burden on society.Objectifs:  La pneumonie est la raison la plus courante pour les visites dans un service de soins ambulatoires pour les enfants de moins de cinq ans à Fidji. L’objectif de cet article est de décrire pour la première fois les coûts associés à un épisode de pneumonie ambulatoire à Fidji, à la fois en termes de coût pour le secteur de la santé du gouvernement et de coût pour le ménage.Méthodes:  Les coûts ont été estimés pour 400 cas de pneumonie diagnostiquée cliniquement dans deux services de soins ambulatoires, l’un à Suva la capitale et l’autre à Nausori, une zone périurbaine et rurale. Les dépenses des ménages relatives aux frais de transport, du traitement et aux coûts indirects ont été déterminées principalement à travers des interviews structurées avec le soignant. Les coûts unitaires ont été recueillis auprès de diverses sources. Les coûts spécifiques du patient ont été résumés comme coûts moyens par établissement.Résultats:  Le coût moyen global associéà un épisode de pneumonie ambulatoire pour la sociétéétait de 18,98 $ US, allant de 14,33 $ US à Nausori à 23,67 $ US à Suva. Les dépenses des ménages représentent une proportion importante du coût sociétal (29%à Nausori et 45%à Suva), avec les coûts de transport représentant le plus important des coûts pour les ménages. Les dépenses du secteur de la santéétaient dominées par les frais du personnel dans les deux sites. Autant les dépenses totales moyennes des ménages que les dépenses totales moyennes du secteur de la santéétaient significativement plus élevées à Suva qu’à Nausori.Conclusions:  Un seul épisode de pneumonie ambulatoire représente un coût important à la fois pour le secteur de la santé gouvernemental et pour les ménages touchés. Compte tenu de l’incidence élevée de cette maladie à Fidji, il s’agit alors d’une charge considérable sur la société.Objetivos:  La neumonía es la causa más común de visita a las consultas externas entre niños menores de cinco años en Fiyi. El objetivo de este artículo es describir por primera vez los costes asociados a un episodio de neumonía con manejo ambulatorio en Fiyi, tanto en términos del coste al sector sanitario gubernamental como del coste a los hogares.Métodos:  Los costes se estimaron para 400 casos de neumonía con diagnóstico clínico, uno en la capital, Suva, y uno en un área peri-urbana y área rural, Nausori. Los gastos de los hogares relacionados con los costes de transporte, tratamiento y costes indirectos se determinaron principalmente mediante una entrevista estructurada con el cuidador. Los costes unitarios se recolectaron de una variedad de fuentes. Los costes específicos del paciente se resumieron como costes promedio por instalación.Resultados:  El coste social promedio asociado a un episodio de neumonía con manejo ambulatorio era de $18.98, con rangos entre $14.33 en Nausori y $23.67 en Suva. Los gastos para el hogar representan una proporción significativa de los costes sociales (29% en Nausori y 45% en Suva), siendo los costes de transporte el ítem más importante para los hogares. Los gastos del sector salud estaban dominados por los costes de personal en ambos lugares. Tanto el promedio total de gastos del hogar como el promedio total de los gastos del sector salud eran significativamente mayores en Suva que en Nausori.Conclusiones:  Un solo episodio de neumonía con manejo ambulatorio representa un coste significativo tanto para el sector gubernamental como para los hogares afectados. Por la alta incidencia que tiene esta enfermedad en Fiyi, la carga social para la sociedad es considerable .</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02898.x" xmlns="http://purl.org/rss/1.0/"><title>ARVs and cash too: caring and supporting people living with HIV/AIDS with the Malawi Social Cash TransferARV et des sous aussi: Prise en charge et soutien aux personnes vivant avec le VIH/SIDA dans le Schéma de Transfert Social d’Argent au MalawiAntirretrovirales y dinero en efectivo: Cuidando y apoyando a las personas que viven con VIH/SIDA en la Malawi Social Cash Transfer</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02898.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">ARVs and cash too: caring and supporting people living with HIV/AIDS with the Malawi Social Cash TransferARV et des sous aussi: Prise en charge et soutien aux personnes vivant avec le VIH/SIDA dans le Schéma de Transfert Social d’Argent au MalawiAntirretrovirales y dinero en efectivo: Cuidando y apoyando a las personas que viven con VIH/SIDA en la Malawi Social Cash Transfer</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Miller</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. G. Tsoka</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02898.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02898.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02898.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">204</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">210</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> The Malawian Social Cash Transfer Scheme (SCT) is a social protection programme for ultra poor and labour-constrained households, including people living with HIV/AIDS (PLWHA). We aimed to gain insight into respondents’ circumstances prior to becoming transfer beneficiaries and to examine how PLWHA used transfers to support themselves and their families.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> We conducted 24 semi-structured qualitative interviews with PLWHA who were also SCT beneficiaries and living in villages where the scheme was operational in 2008.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Respondents were destitute and lacked food and basic necessities prior to the transfer. As cash recipients, the majority of respondents reported positive impacts on health, food security and economic well-being as well as an improved ability to care for their families.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Important unanswered programmatic questions persist, such as ‘What is the appropriate transfer level?’ And ‘Should recipients graduate from the scheme?’ Moreover, the scheme’s long-term sustainability is still unclear. Nevertheless, this analysis presents evidence describing how PLWHA used cash transfers to improve their situation and mitigate the impact of HIV/AIDS on families.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectifs: </b> Le Schéma Malawien de Transfert Social d’Argent (TSA) est un programme de protection sociale pour les personnes ultra pauvres et les ménages contraints par le travail, y compris ceux des personnes vivant avec le VIH/SIDA (PVVS). Nous avons cherchéà mieux comprendre les circonstances des répondants avant qu’ils ne deviennent bénéficiaires des transferts et à examiner comment les PVVS utilisent les transferts pour leur soutien et celui de leurs familles.</p></div><div class="para"><p><b>Méthodes: </b> Nous avons effectué 24 entretiens qualitatifs semi-structurés avec les PVVS qui étaient également des bénéficiaires du TSA et vivaient dans des villages où le schéma était opérationnel en 2008.</p></div><div class="para"><p><b>Résultats: </b> Les répondants étaient démunis et manquaient de nourriture et des nécessités de base avant le transfert. En tant que bénéficiaires d’argent, la majorité des répondants ont rapporté des effets positifs sur la santé, la sécurité alimentaire et le bien-être économique ainsi qu’une capacité améliorée pour prendre soin de leurs familles.</p></div><div class="para"><p><b>Conclusion: </b> D’importantes questions programmatiques persistent tel que «Quel est le niveau de transfert approprié ?” et “Les bénéficiaires devraient-ils évoluer du schéma ?”. En outre, le maintien du schéma à long terme est encore incertain. Néanmoins, cette analyse présente des preuves décrivant comment les PVVS utilisent les transferts d’argent pour améliorer leur situation et faire face à l’impact du VIH/SIDA sur les familles.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivos: </b> El programa de transferencia de efectivo, el <em>Malawian Social Cash Transfer Scheme</em> (SCT) es un programa de protección social para hogares ultra pobres y desempleadas, incluyendo aquellas personas viviendo con VIH/SIDA (PVCVS). Nuestro objetivo era buscar entender las circunstancias de quienes respondían antes de convertirse en beneficiarios de las transferencias de efectivo, y examinar como las PVCVS utilizan las transferencias para sostenerse a ellos mismos y a sus familias.</p></div><div class="para"><p><b>Métodos: </b> Hemos realizado 24 entrevistas cualitativas semi-estructuradas a PVCVS que eran también beneficiarios del SCT y vivían en poblaciones en las que el programa estaba operativo en el 2008.</p></div><div class="para"><p><b>Resultados: </b> Quienes respondían estaban desempleados y no tenían ni comida ni sus necesidades básicas cubiertas antes de recibir la transferencia. Como receptores de efectivo, la mayoría de los que respondieron reportaron impactos positivos sobre la salud, la seguridad alimentaria, y el bienestar económico, al igual que una habilidad mejorada para cuidar a sus familias.</p></div><div class="para"><p><b>Conclusión: </b> Persisten preguntas programáticas importantes sin resolver, tales como “¿Cual es el nivel de transferencia apropiado?” y “¿Deberían los receptores “graduarse” del programa?” Más aún, la sostenibilidad del esquema a largo plazo no está clara. Sin embargo, este análisis presenta evidencia que describe como las PVCVS utilizan las transferencias de dinero para mejorar su situación y mitigar el impacto del VIH/SIDA en sus familias.</p></div></div>]]></content:encoded><description>Objectives  The Malawian Social Cash Transfer Scheme (SCT) is a social protection programme for ultra poor and labour-constrained households, including people living with HIV/AIDS (PLWHA). We aimed to gain insight into respondents’ circumstances prior to becoming transfer beneficiaries and to examine how PLWHA used transfers to support themselves and their families.Methods  We conducted 24 semi-structured qualitative interviews with PLWHA who were also SCT beneficiaries and living in villages where the scheme was operational in 2008.Results  Respondents were destitute and lacked food and basic necessities prior to the transfer. As cash recipients, the majority of respondents reported positive impacts on health, food security and economic well-being as well as an improved ability to care for their families.Conclusion  Important unanswered programmatic questions persist, such as ‘What is the appropriate transfer level?’ And ‘Should recipients graduate from the scheme?’ Moreover, the scheme’s long-term sustainability is still unclear. Nevertheless, this analysis presents evidence describing how PLWHA used cash transfers to improve their situation and mitigate the impact of HIV/AIDS on families.Objectifs:  Le Schéma Malawien de Transfert Social d’Argent (TSA) est un programme de protection sociale pour les personnes ultra pauvres et les ménages contraints par le travail, y compris ceux des personnes vivant avec le VIH/SIDA (PVVS). Nous avons cherchéà mieux comprendre les circonstances des répondants avant qu’ils ne deviennent bénéficiaires des transferts et à examiner comment les PVVS utilisent les transferts pour leur soutien et celui de leurs familles.Méthodes:  Nous avons effectué 24 entretiens qualitatifs semi-structurés avec les PVVS qui étaient également des bénéficiaires du TSA et vivaient dans des villages où le schéma était opérationnel en 2008.Résultats:  Les répondants étaient démunis et manquaient de nourriture et des nécessités de base avant le transfert. En tant que bénéficiaires d’argent, la majorité des répondants ont rapporté des effets positifs sur la santé, la sécurité alimentaire et le bien-être économique ainsi qu’une capacité améliorée pour prendre soin de leurs familles.Conclusion:  D’importantes questions programmatiques persistent tel que «Quel est le niveau de transfert approprié ?” et “Les bénéficiaires devraient-ils évoluer du schéma ?”. En outre, le maintien du schéma à long terme est encore incertain. Néanmoins, cette analyse présente des preuves décrivant comment les PVVS utilisent les transferts d’argent pour améliorer leur situation et faire face à l’impact du VIH/SIDA sur les familles.Objetivos:  El programa de transferencia de efectivo, el Malawian Social Cash Transfer Scheme (SCT) es un programa de protección social para hogares ultra pobres y desempleadas, incluyendo aquellas personas viviendo con VIH/SIDA (PVCVS). Nuestro objetivo era buscar entender las circunstancias de quienes respondían antes de convertirse en beneficiarios de las transferencias de efectivo, y examinar como las PVCVS utilizan las transferencias para sostenerse a ellos mismos y a sus familias.Métodos:  Hemos realizado 24 entrevistas cualitativas semi-estructuradas a PVCVS que eran también beneficiarios del SCT y vivían en poblaciones en las que el programa estaba operativo en el 2008.Resultados:  Quienes respondían estaban desempleados y no tenían ni comida ni sus necesidades básicas cubiertas antes de recibir la transferencia. Como receptores de efectivo, la mayoría de los que respondieron reportaron impactos positivos sobre la salud, la seguridad alimentaria, y el bienestar económico, al igual que una habilidad mejorada para cuidar a sus familias.Conclusión:  Persisten preguntas programáticas importantes sin resolver, tales como “¿Cual es el nivel de transferencia apropiado?” y “¿Deberían los receptores “graduarse” del programa?” Más aún, la sostenibilidad del esquema a largo plazo no está clara. Sin embargo, este análisis presenta evidencia que describe como las PVCVS utilizan las transferencias de dinero para mejorar su situación y mitigar el impacto del VIH/SIDA en sus familias.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02895.x" xmlns="http://purl.org/rss/1.0/"><title>Predictors of antibiotic use in African communities: evidence from medicines household surveys in five countriesFacteurs prédictifs de l’utilisation des antibiotiques dans les communautés africaines: résultats d’enquêtes sur les médicaments auprès des ménages dans cinq paysVaticinadores del uso de antibióticos en comunidades africanas: Evidencia de las encuestas nacionales de hogares sobre medicamentos realizadas en cinco países</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02895.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Predictors of antibiotic use in African communities: evidence from medicines household surveys in five countriesFacteurs prédictifs de l’utilisation des antibiotiques dans les communautés africaines: résultats d’enquêtes sur les médicaments auprès des ménages dans cinq paysVaticinadores del uso de antibióticos en comunidades africanas: Evidencia de las encuestas nacionales de hogares sobre medicamentos realizadas en cinco países</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. E. Vialle-Valentin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. F. LeCates</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. Zhang</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. T. Desta</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Ross-Degnan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02895.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02895.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02895.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">211</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">222</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> To investigate antibiotic use in five national household surveys conducted with the WHO methodology to identify key determinants of antibiotic use in the community.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Data from The Gambia, Ghana, Kenya, Nigeria and Uganda surveys were combined. We used logistic regression models that accounted for the clustered survey design to identify the determinants of care seeking outside the home and antibiotic use for 2914 cases of recent acute illness.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Overall, 95% of individuals with acute illness took medicines, 90% sought care outside their homes and 36% took antibiotics. In multivariate analyses, illness severity was a strong predictor of seeking care outside the home. Among those who sought outside care, the strongest predictor of antibiotic use was the presence of upper respiratory symptoms (OR: 3.02, CI: 2.36–3.86, <em>P</em> &lt; 0.001), followed by gastrointestinal symptoms or difficulty breathing, and antibiotics use was less likely if they had fever. The odds of receiving antibiotics were higher when visiting a public hospital or more than one healthcare facility.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> The nature and severity of symptoms and patterns of care seeking had the greatest influence on decisions to take antibiotics. Antibiotics were widely available and inappropriately used in all settings. Policies to regulate antibiotics distribution as well as interventions to educate prescribers, dispensers and consumers are needed to improve antibiotic use.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectifs: </b> Investiguer l’utilisation des antibiotiques dans cinq enquêtes nationales auprès des ménages, menées avec la méthode OMS pour identifier les principaux déterminants de l’utilisation des antibiotiques dans la communauté.</p></div><div class="para"><p><b>Méthodes: </b> Les données d’enquêtes en Gambie, au Ghana, au Kenya, au Nigeria et en Ouganda ont été combinées. Nous avons utilisé des modèles de régression logistique qui ont tenu compte de la conception du sondage par grappes afin d’identifier les déterminants du recours aux soins à l’extérieur du domicile et l’utilisation des antibiotiques pour 2914 cas de maladie aiguë récente.</p></div><div class="para"><p><b>Résultats: </b> Au total, 95% des personnes atteintes de maladie aiguë ont pris des médicaments, 90% ont fait recours à des soins à l’extérieur de leurs foyers et 36% ont pris des antibiotiques. Dans des analyses multivariées, la sévérité de la maladie était un facteur prédictif important du recours à des soins à l’extérieur du foyer. Parmi ceux qui ont recherché des soins à l’extérieur, le plus important facteur prédictif de l’utilisation d’antibiotiques était la présence de symptômes respiratoires supérieurs (OR: 3,02, IC: 2,36 à 3,86; p &lt; 0,001), suivi par les symptômes gastro-intestinaux ou la difficultéà respirer. Les antibiotiques ont été moins probablement utilisés dans les cas de fièvre. Les chances de recevoir des antibiotiques étaient plus élevées lors de la visite dans un hôpital public ou dans plus d’un établissement de santé.</p></div><div class="para"><p><b>Conclusion: </b> La nature et la sévérité des symptômes, ainsi que les modes de recours aux soins avaient le plus d’influence sur les décisions à prendre des antibiotiques. Les antibiotiques étaient largement disponibles et utilisés de façon inappropriée dans tous les contextes. Des politiques visant à réglementer la distribution des antibiotiques ainsi que des interventions visant àéduquer les prescripteurs, les distributeurs et les utilisateurs, sont nécessaires pour améliorer l’usage des antibiotiques.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivos: </b> Investigar el uso de antibióticos en cinco encuestas nacionales de hogares realizadas con el método de la OMS para identificar determinantes claves del uso de antibióticos en la comunidad.</p></div><div class="para"><p><b>Métodos: </b> Se combinaron datos de las encuestas de Gambia, Ghana, Kenia, Nigeria y Uganda. Utilizamos modelos de regresión logística que justificaban el diseño por conglomerados del estudio para identificar los determinantes de búsqueda de cuidados fuera del hogar y del uso de antibióticos para 2914 casos de enfermedad aguda reciente.</p></div><div class="para"><p><b>Resultados: </b> En general, un 95% de los individuos con enfermedad aguda tomó medicamentos, un 90% buscó cuidados fuera de sus hogares, y un 36% tomó antibióticos. En análisis multivariables, la severidad de la enfermedad era un fuerte vaticinador de la búsqueda de cuidados fuera del hogar. Entre aquellos que buscaron cuidados externos, el vaticinador más fuerte del uso de antibióticos era la presencia de síntomas de compromiso del aparato respiratorio superior (OR: 3.02, IC: 2.36–3.86, p &lt; 0.001), seguido por síntomas gastrointestinales o dificultad respiratoria, el uso de antibióticos era menos probable si tenían fiebre. La probabilidad de recibir antibióticos era mayor cuando se visitaba un hospital público o más de un centro sanitario.</p></div><div class="para"><p><b>Conclusiones: </b> La naturaleza y la severidad de los síntomas y patrones de búsqueda de cuidados tenían la mayor influencia sobre la decisión de tomar antibióticos. Los antibióticos estaban ampliamente disponibles y su uso era inapropiado en todos los emplazamientos. Con el fin de mejorar el uso de los antibióticos, se requieren políticas para regular la distribución de antibióticos al igual que intervenciones para educar a quienes los prescriben, los dispensan y a los consumidores.</p></div></div>]]></content:encoded><description>Objectives  To investigate antibiotic use in five national household surveys conducted with the WHO methodology to identify key determinants of antibiotic use in the community.Methods  Data from The Gambia, Ghana, Kenya, Nigeria and Uganda surveys were combined. We used logistic regression models that accounted for the clustered survey design to identify the determinants of care seeking outside the home and antibiotic use for 2914 cases of recent acute illness.Results  Overall, 95% of individuals with acute illness took medicines, 90% sought care outside their homes and 36% took antibiotics. In multivariate analyses, illness severity was a strong predictor of seeking care outside the home. Among those who sought outside care, the strongest predictor of antibiotic use was the presence of upper respiratory symptoms (OR: 3.02, CI: 2.36–3.86, P &lt; 0.001), followed by gastrointestinal symptoms or difficulty breathing, and antibiotics use was less likely if they had fever. The odds of receiving antibiotics were higher when visiting a public hospital or more than one healthcare facility.Conclusions  The nature and severity of symptoms and patterns of care seeking had the greatest influence on decisions to take antibiotics. Antibiotics were widely available and inappropriately used in all settings. Policies to regulate antibiotics distribution as well as interventions to educate prescribers, dispensers and consumers are needed to improve antibiotic use.Objectifs:  Investiguer l’utilisation des antibiotiques dans cinq enquêtes nationales auprès des ménages, menées avec la méthode OMS pour identifier les principaux déterminants de l’utilisation des antibiotiques dans la communauté.Méthodes:  Les données d’enquêtes en Gambie, au Ghana, au Kenya, au Nigeria et en Ouganda ont été combinées. Nous avons utilisé des modèles de régression logistique qui ont tenu compte de la conception du sondage par grappes afin d’identifier les déterminants du recours aux soins à l’extérieur du domicile et l’utilisation des antibiotiques pour 2914 cas de maladie aiguë récente.Résultats:  Au total, 95% des personnes atteintes de maladie aiguë ont pris des médicaments, 90% ont fait recours à des soins à l’extérieur de leurs foyers et 36% ont pris des antibiotiques. Dans des analyses multivariées, la sévérité de la maladie était un facteur prédictif important du recours à des soins à l’extérieur du foyer. Parmi ceux qui ont recherché des soins à l’extérieur, le plus important facteur prédictif de l’utilisation d’antibiotiques était la présence de symptômes respiratoires supérieurs (OR: 3,02, IC: 2,36 à 3,86; p &lt; 0,001), suivi par les symptômes gastro-intestinaux ou la difficultéà respirer. Les antibiotiques ont été moins probablement utilisés dans les cas de fièvre. Les chances de recevoir des antibiotiques étaient plus élevées lors de la visite dans un hôpital public ou dans plus d’un établissement de santé.Conclusion:  La nature et la sévérité des symptômes, ainsi que les modes de recours aux soins avaient le plus d’influence sur les décisions à prendre des antibiotiques. Les antibiotiques étaient largement disponibles et utilisés de façon inappropriée dans tous les contextes. Des politiques visant à réglementer la distribution des antibiotiques ainsi que des interventions visant àéduquer les prescripteurs, les distributeurs et les utilisateurs, sont nécessaires pour améliorer l’usage des antibiotiques.Objetivos:  Investigar el uso de antibióticos en cinco encuestas nacionales de hogares realizadas con el método de la OMS para identificar determinantes claves del uso de antibióticos en la comunidad.Métodos:  Se combinaron datos de las encuestas de Gambia, Ghana, Kenia, Nigeria y Uganda. Utilizamos modelos de regresión logística que justificaban el diseño por conglomerados del estudio para identificar los determinantes de búsqueda de cuidados fuera del hogar y del uso de antibióticos para 2914 casos de enfermedad aguda reciente.Resultados:  En general, un 95% de los individuos con enfermedad aguda tomó medicamentos, un 90% buscó cuidados fuera de sus hogares, y un 36% tomó antibióticos. En análisis multivariables, la severidad de la enfermedad era un fuerte vaticinador de la búsqueda de cuidados fuera del hogar. Entre aquellos que buscaron cuidados externos, el vaticinador más fuerte del uso de antibióticos era la presencia de síntomas de compromiso del aparato respiratorio superior (OR: 3.02, IC: 2.36–3.86, p &lt; 0.001), seguido por síntomas gastrointestinales o dificultad respiratoria, el uso de antibióticos era menos probable si tenían fiebre. La probabilidad de recibir antibióticos era mayor cuando se visitaba un hospital público o más de un centro sanitario.Conclusiones:  La naturaleza y la severidad de los síntomas y patrones de búsqueda de cuidados tenían la mayor influencia sobre la decisión de tomar antibióticos. Los antibióticos estaban ampliamente disponibles y su uso era inapropiado en todos los emplazamientos. Con el fin de mejorar el uso de los antibióticos, se requieren políticas para regular la distribución de antibióticos al igual que intervenciones para educar a quienes los prescriben, los dispensan y a los consumidores.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02901.x" xmlns="http://purl.org/rss/1.0/"><title>Mortality from infectious diseases among refugees and immigrants compared to native Danes: a historical prospective cohort studyMortalité par maladies infectieuses chez les réfugiés et immigrants comparés aux Danois de souche: une étude prospective de cohorte historiqueMortalidad por enfermedades infecciosas entre refugiados e inmigrantes comparados con Daneses nativos: estudio histórico-prospectivo de cohortes</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02901.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Mortality from infectious diseases among refugees and immigrants compared to native Danes: a historical prospective cohort studyMortalité par maladies infectieuses chez les réfugiés et immigrants comparés aux Danois de souche: une étude prospective de cohorte historiqueMortalidad por enfermedades infecciosas entre refugiados e inmigrantes comparados con Daneses nativos: estudio histórico-prospectivo de cohortes</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Norredam</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Olsbjerg</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. H. Petersen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. Bygbjerg</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Krasnik</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02901.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02901.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02901.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">223</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">230</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> Refugees and immigrants are likely to be vulnerable to mortality from infectious diseases as a result of high prevalences in their countries of origin and barriers in access to healthcare in the recipient countries. Consequently, we aimed to compare and investigate differences in mortality from infectious diseases among refugees and immigrants and native Danes.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> A register-based, historical prospective cohort design. All refugees (<em>n</em> = 29 139) and family-reunited immigrants (<em>n</em> = 27 134) who, between 1 January1993 and 31 December1999, were granted the right to reside in Denmark were included and matched 1:4 on age and sex with native Danes. Civil registration numbers were cross-linked to the Register of Causes of Death, and fatalities owing to infectious diseases (based on ICD-10 diagnosis) were identified. Mortality ratios were estimated separately for men and women by migrant status and region of birth; adjusting for age and income; using a Cox regression model, after a mean follow-up of 10–12 years after arrival.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Female [hazard ratio (HR) = 4.15; 95% CI: 2.38, 7.25] and male (HR = 2.05; 95% CI: 1.27, 3.33) refugees experienced significantly higher mortality risks from infectious diseases than did native Danes, as was the case for male immigrants (HR = 2.39; 95% CI: 1.20, 4.76) but less so for female immigrants (HR = 1.23; 95% CI: 0. 50-3.01). Mortality by region of origin was notably higher for individuals from North Africa and sub-Saharan Africa.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Higher mortality among refugees and immigrants than among the native population should lead to reflections on medical reception systems in recipient countries and subsequent possibilities of access to specialised diagnostic and curative healthcare.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectifs: </b> Les réfugiés et les immigrants sont susceptibles d’être vulnérables à la mortalité due aux maladies infectieuses en raison de la prévalence élevée dans leur pays d’origine et des obstacles à l’accès aux soins de santé dans les pays hôtes. Par conséquent, nous avons cherchéà comparer et à enquêter sur les différences de mortalité par maladies infectieuses chez les réfugiés/immigrés et les Danois de souche.</p></div><div class="para"><p><b>Méthodes: </b> Une étude prospective de cohorte historique basée sur les registres. Tous les réfugiés (n = 29.139) et immigrés de familles réunies (n = 27.134) qui, entre le 1<sup>er</sup> janvier 1993 et le 31 décembre 1999 ont obtenu le droit de résidence au Danemark ont été inclus et appariés dans un rapport ¼ pour l’âge et le sexe avec des Danois de souche. Les numéros d’immatriculation civile croisés au registre des causes de décès et les décès dus aux maladies infectieuses (sur base du diagnostic ICD-10) ont été identifiés. Les taux de mortalité ont été estimés séparément pour les hommes et les femmes selon le statut de migrant et la région de naissance, avec ajustement pour l’âge et le revenu, en utilisant un modèle de régression de Cox, après un suivi moyen de 10 à 12 ans après l’arrivée.</p></div><div class="para"><p><b>Résultats: </b> Les réfugiés féminins (RR = 4,15; IC95%: 2,38–7,25) et masculins (RR = 2,05; IC95%: 1,27–3,33) avaient un risque de mortalité par maladies infectieuses significativement plus élevé que les Danois de souche de même que les immigrés masculins (RR = 2,39; IC95%: 1,20–4,76) mais moins pour les immigrés féminins (RR = 1,23; IC95%: 0,50 – 3,01). La mortalité par région d’origine était notablement plus élevée pour les ressortissants d’Afrique du Nord et subsaharienne.</p></div><div class="para"><p><b>Conclusions: </b> La mortalité plus élevée chez les réfugiés et les immigrés que chez les autochtones devrait conduire à des réflexions sur les systèmes d’offre médicale dans les pays hôtes et les possibilités d’accès aux soins diagnostiques et curatifs spécialisés.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivos: </b> Los refugiados e inmigrantes suelen ser vulnerables a la mortalidad por enfermedades infecciosas como resultado de la alta prevalencia en sus países de origen y de las barreras al acceso de cuidados sanitarios en los hogares que les acogen. En consecuencia, buscábamos comparar e investigar las diferencias en mortalidad por enfermedades infecciosas entre refugiados e inmigrantes y Daneses nativos.</p></div><div class="para"><p><b>Métodos: </b> Diseño histórico-prospectivo de cohortes, basado en registros. Se incluyeron todos los refugiados (n = 29,139) e inmigrantes reunidos con sus familias (n = 27,134) que obtuvieron la residencia en Dinamarca entre el 1 de Enero de 1993 y el 31 de Diciembre de 1999, y se les pareó 1:4 por edad y sexo con Daneses nativos. Los números de registro civil se cruzaron con los del Registro de Causas de Muerte, y se identificaron las muertes por enfermedades infecciosas (basándose en el diagnóstico ICD-10). Se calcularon las tasas de mortalidad para hombres y mujeres de forma separada, según estatus migratorio y lugar de nacimiento; ajustando para edad e ingresos; utilizando un modelo de regresión de Cox, después de una media de seguimiento de 10–12 años después de su llegada.</p></div><div class="para"><p><b>Resultados: </b> Los refugiados, tanto mujeres (RR = 4.15; 95%CI: 2.38; 7.25) como hombres, (RR = 2.05; 95%CI: 1.27;3.33) experimentaron un riesgo de mortalidad por enfermedades infecciosas significativamente mayor que los Daneses nativos, al igual que los inmigrantes hombres (RR = 2.39; 95%CI: 1.20; 4.76), pero era menor para inmigrantes mujeres (RR = 1.23; 95%CI:0. 50–3.01). La mortalidad por región de origen era notablemente más alta para individuos del Norte de África y África sub-Sahariana.</p></div><div class="para"><p><b>Conclusiones: </b> Una mayor mortalidad entre refugiados e inmigrantes que entre la población nativa debería conllevar a una reflección sobre los sistemas sanitarios de acogida en países receptores, y las subsecuentes posibilidades de acceso a pruebas diagnósticas especializadas y cuidados curativos.</p></div></div>]]></content:encoded><description>Objectives  Refugees and immigrants are likely to be vulnerable to mortality from infectious diseases as a result of high prevalences in their countries of origin and barriers in access to healthcare in the recipient countries. Consequently, we aimed to compare and investigate differences in mortality from infectious diseases among refugees and immigrants and native Danes.Methods  A register-based, historical prospective cohort design. All refugees (n = 29 139) and family-reunited immigrants (n = 27 134) who, between 1 January1993 and 31 December1999, were granted the right to reside in Denmark were included and matched 1:4 on age and sex with native Danes. Civil registration numbers were cross-linked to the Register of Causes of Death, and fatalities owing to infectious diseases (based on ICD-10 diagnosis) were identified. Mortality ratios were estimated separately for men and women by migrant status and region of birth; adjusting for age and income; using a Cox regression model, after a mean follow-up of 10–12 years after arrival.Results  Female [hazard ratio (HR) = 4.15; 95% CI: 2.38, 7.25] and male (HR = 2.05; 95% CI: 1.27, 3.33) refugees experienced significantly higher mortality risks from infectious diseases than did native Danes, as was the case for male immigrants (HR = 2.39; 95% CI: 1.20, 4.76) but less so for female immigrants (HR = 1.23; 95% CI: 0. 50-3.01). Mortality by region of origin was notably higher for individuals from North Africa and sub-Saharan Africa.Conclusions  Higher mortality among refugees and immigrants than among the native population should lead to reflections on medical reception systems in recipient countries and subsequent possibilities of access to specialised diagnostic and curative healthcare.Objectifs:  Les réfugiés et les immigrants sont susceptibles d’être vulnérables à la mortalité due aux maladies infectieuses en raison de la prévalence élevée dans leur pays d’origine et des obstacles à l’accès aux soins de santé dans les pays hôtes. Par conséquent, nous avons cherchéà comparer et à enquêter sur les différences de mortalité par maladies infectieuses chez les réfugiés/immigrés et les Danois de souche.Méthodes:  Une étude prospective de cohorte historique basée sur les registres. Tous les réfugiés (n = 29.139) et immigrés de familles réunies (n = 27.134) qui, entre le 1er janvier 1993 et le 31 décembre 1999 ont obtenu le droit de résidence au Danemark ont été inclus et appariés dans un rapport ¼ pour l’âge et le sexe avec des Danois de souche. Les numéros d’immatriculation civile croisés au registre des causes de décès et les décès dus aux maladies infectieuses (sur base du diagnostic ICD-10) ont été identifiés. Les taux de mortalité ont été estimés séparément pour les hommes et les femmes selon le statut de migrant et la région de naissance, avec ajustement pour l’âge et le revenu, en utilisant un modèle de régression de Cox, après un suivi moyen de 10 à 12 ans après l’arrivée.Résultats:  Les réfugiés féminins (RR = 4,15; IC95%: 2,38–7,25) et masculins (RR = 2,05; IC95%: 1,27–3,33) avaient un risque de mortalité par maladies infectieuses significativement plus élevé que les Danois de souche de même que les immigrés masculins (RR = 2,39; IC95%: 1,20–4,76) mais moins pour les immigrés féminins (RR = 1,23; IC95%: 0,50 – 3,01). La mortalité par région d’origine était notablement plus élevée pour les ressortissants d’Afrique du Nord et subsaharienne.Conclusions:  La mortalité plus élevée chez les réfugiés et les immigrés que chez les autochtones devrait conduire à des réflexions sur les systèmes d’offre médicale dans les pays hôtes et les possibilités d’accès aux soins diagnostiques et curatifs spécialisés.Objetivos:  Los refugiados e inmigrantes suelen ser vulnerables a la mortalidad por enfermedades infecciosas como resultado de la alta prevalencia en sus países de origen y de las barreras al acceso de cuidados sanitarios en los hogares que les acogen. En consecuencia, buscábamos comparar e investigar las diferencias en mortalidad por enfermedades infecciosas entre refugiados e inmigrantes y Daneses nativos.Métodos:  Diseño histórico-prospectivo de cohortes, basado en registros. Se incluyeron todos los refugiados (n = 29,139) e inmigrantes reunidos con sus familias (n = 27,134) que obtuvieron la residencia en Dinamarca entre el 1 de Enero de 1993 y el 31 de Diciembre de 1999, y se les pareó 1:4 por edad y sexo con Daneses nativos. Los números de registro civil se cruzaron con los del Registro de Causas de Muerte, y se identificaron las muertes por enfermedades infecciosas (basándose en el diagnóstico ICD-10). Se calcularon las tasas de mortalidad para hombres y mujeres de forma separada, según estatus migratorio y lugar de nacimiento; ajustando para edad e ingresos; utilizando un modelo de regresión de Cox, después de una media de seguimiento de 10–12 años después de su llegada.Resultados:  Los refugiados, tanto mujeres (RR = 4.15; 95%CI: 2.38; 7.25) como hombres, (RR = 2.05; 95%CI: 1.27;3.33) experimentaron un riesgo de mortalidad por enfermedades infecciosas significativamente mayor que los Daneses nativos, al igual que los inmigrantes hombres (RR = 2.39; 95%CI: 1.20; 4.76), pero era menor para inmigrantes mujeres (RR = 1.23; 95%CI:0. 50–3.01). La mortalidad por región de origen era notablemente más alta para individuos del Norte de África y África sub-Sahariana.Conclusiones:  Una mayor mortalidad entre refugiados e inmigrantes que entre la población nativa debería conllevar a una reflección sobre los sistemas sanitarios de acogida en países receptores, y las subsecuentes posibilidades de acceso a pruebas diagnósticas especializadas y cuidados curativos.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02905.x" xmlns="http://purl.org/rss/1.0/"><title>Can sputum collection practices for tuberculosis improve laboratory diagnosis of pneumonic plague in developing countries?Communication brève: Les pratiques de collecte des crachats pour la tuberculose peuvent-elles améliorer le diagnostic de laboratoire de la peste pneumonique dans les pays en développement?Comunicación corta:¿Pueden las prácticas de recolección de esputo para tuberculosis mejorar el diagnóstico de laboratorio de la plaga neumónica en países en vías de desarrollo?</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02905.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Can sputum collection practices for tuberculosis improve laboratory diagnosis of pneumonic plague in developing countries?Communication brève: Les pratiques de collecte des crachats pour la tuberculose peuvent-elles améliorer le diagnostic de laboratoire de la peste pneumonique dans les pays en développement?Comunicación corta:¿Pueden las prácticas de recolección de esputo para tuberculosis mejorar el diagnóstico de laboratorio de la plaga neumónica en países en vías de desarrollo?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Boothby</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. C. Shako</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Bertherat</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02905.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02905.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02905.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Communication</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">231</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">234</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Africa reports 90% of human plague cases yet no guidelines currently exist for the safe and accurate collection of sputum from patients with suspected pneumonic plague. Using existing tuberculosis guidelines as a model and in conjunction with epidemiological and clinical features of pneumonic plague, the authors describe the importance of formal guidelines to enhance sputum collection practices and improve safety in developing countries. A model for suggested guidelines is given.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>L’Afrique rapporte 90% des cas de peste humaine. Cependant, il n’existe toujours pas de directives pour la collecte sûre et précise des crachats de patients suspects de peste pneumonique. En utilisant les directives existantes pour la tuberculose comme modèle et en conjonction avec les caractéristiques épidémiologiques et cliniques de la peste pneumonique, les auteurs décrivent l’importance des directives officielles pour améliorer les pratiques de collecte des crachats et améliorer la sécurité dans les pays en développement. Un modèle de directive est suggéré.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>África reporta un 90% de los casos de plagas humanas y sin embargo aún no existen guías para la recolección de esputo de pacientes con sospecha de plaga neumónica. Utilizando las guías existentes para tuberculosis como modelo, en conjunción con características clínicas y epidemiológicas de plaga neumónica, los autores describen la importancia de guías formales para mejorar las prácticas de recolección de esputo y mejorar la seguridad en países en vías de desarrollo. Se presenta un modelo para guías sugeridas.</p></div>]]></content:encoded><description>Africa reports 90% of human plague cases yet no guidelines currently exist for the safe and accurate collection of sputum from patients with suspected pneumonic plague. Using existing tuberculosis guidelines as a model and in conjunction with epidemiological and clinical features of pneumonic plague, the authors describe the importance of formal guidelines to enhance sputum collection practices and improve safety in developing countries. A model for suggested guidelines is given.L’Afrique rapporte 90% des cas de peste humaine. Cependant, il n’existe toujours pas de directives pour la collecte sûre et précise des crachats de patients suspects de peste pneumonique. En utilisant les directives existantes pour la tuberculose comme modèle et en conjonction avec les caractéristiques épidémiologiques et cliniques de la peste pneumonique, les auteurs décrivent l’importance des directives officielles pour améliorer les pratiques de collecte des crachats et améliorer la sécurité dans les pays en développement. Un modèle de directive est suggéré.África reporta un 90% de los casos de plagas humanas y sin embargo aún no existen guías para la recolección de esputo de pacientes con sospecha de plaga neumónica. Utilizando las guías existentes para tuberculosis como modelo, en conjunción con características clínicas y epidemiológicas de plaga neumónica, los autores describen la importancia de guías formales para mejorar las prácticas de recolección de esputo y mejorar la seguridad en países en vías de desarrollo. Se presenta un modelo para guías sugeridas.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02899.x" xmlns="http://purl.org/rss/1.0/"><title>Development and evaluation of a single-step multiplex PCR to differentiate the aquatic stages of morphologically similar Aedes (subgenus: Stegomyia) speciesDéveloppement et évaluation d’une PCR multiplex àétape unique pour différencier les stades aquatiques morphologiquement semblables des espèces du moustique Aedes (sous-genre: Stegomyia)Desarrollo y evaluación de una PCR multiplex realizada en un solo paso, para diferenciar estadíos acuáticos de la especie Aedes (Subgenus: Stegomyia) morfológicamente similares</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02899.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Development and evaluation of a single-step multiplex PCR to differentiate the aquatic stages of morphologically similar Aedes (subgenus: Stegomyia) speciesDéveloppement et évaluation d’une PCR multiplex àétape unique pour différencier les stades aquatiques morphologiquement semblables des espèces du moustique Aedes (sous-genre: Stegomyia)Desarrollo y evaluación de una PCR multiplex realizada en un solo paso, para diferenciar estadíos acuáticos de la especie Aedes (Subgenus: Stegomyia) morfológicamente similares</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Biswadeep Das</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sunita Swain</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aparna Patra</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mumani Das</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hari Kishen Tripathy</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Namita Mohapatra</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Santanu K. Kar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rupenangshu K. Hazra</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02899.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02899.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02899.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">235</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">243</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To develop a single-step multiplex PCR to differentiate the aquatic stages of <em>Aedes aegypti</em>, <em>Aedes albopictus</em> and <em>Aedes vittatus</em> collected from different breeding spots in arbovirus endemic/epidemic areas and to detect the most abundant species by the multiplex PCR.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> Aquatic stages of different mosquito species were sampled by inspecting artificial and natural breeding sites in domestic and peridomestic areas. DNA was isolated from different stages of the three <em>Aedes</em> species. Using novel primers based on 18S rDNA sequence, a single-step multiplex PCR was developed to clearly distinguish the three <em>Aedes</em> species. It was then evaluated in the aquatic stages of <em>Aedes</em> species collected from different areas.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> A total of 1150 aquatic stages were collected from 294 breeding spots, of which 156 contained <em>Aedes</em> species. Discarded tires were the major breeding spots of <em>Aedes</em> species. The aquatic stages were clustered into 230 pools; <em>Ae. albopictus</em> was detected in the largest number of pools, followed by <em>Ae. aegypti</em> and <em>Ae. vittatus</em>.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> The Multiplex PCR clearly differentiated the aquatic stages of the three <em>Aedes</em> species and detected that <em>Ae. albopictus</em> was most profuse in different breeding spots surveyed, hence indicating to be the main vector in this region. So control measures can be designed against <em>Ae. albopictus</em> at an early stage to prevent any arboviral outbreak. This method is a convenient tool for precise identification of <em>Aedes</em> vectors during entomological surveys in arbovirus endemic/epidemic areas where several species coexist.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectif: </b> Développer une PCR multiplex àétape unique pour différencier les stades aquatiques des espèces <em>Aedes aegypti</em>, <em>Aedes albopictus</em> et <em>Aedes vittatus</em>, collectés dans différents endroits de reproduction dans des zones endémiques/épidémiques pour arbovirus et détecter les espèces les plus abondantes par PCR multiplex.</p></div><div class="para"><p><b>Méthodes: </b> Les stades aquatiques de différentes espèces de moustiques ont étééchantillonnés en inspectant les sites de reproduction artificiels et naturels dans les zones domestiques et péri domestiques. L’ADN a été isolé des différents stades des trois espèces d’<em>Aedes</em>. En utilisant des amorces basées sur la séquence d’ADNr 18S, une PCR multiplex àétape unique a été développée pour distinguer clairement les trois espèces du genre <em>Aedes</em>. Elle a ensuite étéévaluée sur les stades aquatiques des espèces d’<em>Aedes</em> recueillies dans différents endroits.</p></div><div class="para"><p><b>Résultats: </b> 1150 stades aquatiques ont été recueillis dans 294 endroits de reproduction dont 156 contenaient des espèces <em>Aedes</em>. Les pneus usagés étaient les principaux points de reproduction des espèces du genre <em>Aedes</em>. Les stades aquatiques ont été regroupés en 230 pools. <em>Ae. albopictus</em> a été détecté dans le plus grand nombre de pools, suivie par <em>Ae. aegypti</em> et <em>Ae. vittatus</em>.</p></div><div class="para"><p><b>Conclusions: </b> La PCR multiplex différencie clairement les stades aquatiques des trois espèces <em>Aedes</em> et a trouvé qu’<em>Ae. albopictus</em>était la plus abondante dans les différentes zones de reproduction sondées étant par conséquent, le principal vecteur dans cette région. Ainsi, les mesures de contrôle pourraient être conçues contre <em>Ae. albopictus</em>à un stade précoce afin de prévenir toute épidémie à arbovirus. Cette méthode est un outil pratique pour l’identification précise des vecteurs <em>Aedes</em> lors des enquêtes entomologiques dans des zones endémiques/épidémiques pour arbovirus où plusieurs espèces cohabitent.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivo: </b> Desarrollar una PCR multiplex realizada en un solo paso para diferenciar estadios acuáticos de <em>Aedes aegypti, Aedes albopictus</em> y <em>Aedes vittatus</em> recolectados de diferentes focos de reproducción en áreas endémicas / epidémicas para arbovirus y detectar las especies más abundantes mediante PCR multiplex.</p></div><div class="para"><p><b>Métodos: </b> Los estadíos acuáticos de diferentes especies de mosquito se muestrearon inspeccionando focos de reproducción artificiales y naturales en áreas domésticas y peridomésticas. Se aisló el ADN de diferentes estadíos de las tres especies de <em>Aedes</em>. Utilizando cebadores basados en la secuencia del ADNr 18S, se desarrolló una PCR multiplex de un solo paso para distinguir claramente entre las tres especies de <em>Aedes</em>. Después se evaluó en los estadíos acuáticos de especies de <em>Aedes</em> recolectados de diferentes áreas.</p></div><div class="para"><p><b>Resultados: </b> Se recolectaron 1150 estadíos acuáticos de 294 focos de reproducción, de los cuales 156 contenían la especie <em>Aedes</em>. Las ruedas abandonadas eran los principales focos de reproducción de la especie <em>Aedes</em>. Los estadíos acuáticos estaban agrupados en 230 charcos; <em>Ae. albopictus</em> fue la especie detectada en un mayor número de charcos, seguido por <em>Ae. aegypti y Ae. vittatus</em>.</p></div><div class="para"><p><b>Conclusiones: </b> La PCR multiplex diferencia claramente los estadíos acuáticos de las tres especies de Aedes. Se detectó que <em>Ae. albopictus</em> era la especie más abundante en los diferentes focos de reproducción estudiados, indicando que se trata del principal vector en esta región. Por lo tanto, podrían diseñarse medidas de control frente a <em>Ae. albopictus</em> en un estadío temprano para prevenir un brote de arbovirus. Este método es una herramienta convencional para la identificación precisa de vectores de Aedes durante estudios entomológicos en áreas endémicas / epidémicas para arbovirus en donde coexisten varias especies.</p></div></div>]]></content:encoded><description>Objective  To develop a single-step multiplex PCR to differentiate the aquatic stages of Aedes aegypti, Aedes albopictus and Aedes vittatus collected from different breeding spots in arbovirus endemic/epidemic areas and to detect the most abundant species by the multiplex PCR.Methods  Aquatic stages of different mosquito species were sampled by inspecting artificial and natural breeding sites in domestic and peridomestic areas. DNA was isolated from different stages of the three Aedes species. Using novel primers based on 18S rDNA sequence, a single-step multiplex PCR was developed to clearly distinguish the three Aedes species. It was then evaluated in the aquatic stages of Aedes species collected from different areas.Results  A total of 1150 aquatic stages were collected from 294 breeding spots, of which 156 contained Aedes species. Discarded tires were the major breeding spots of Aedes species. The aquatic stages were clustered into 230 pools; Ae. albopictus was detected in the largest number of pools, followed by Ae. aegypti and Ae. vittatus.Conclusions  The Multiplex PCR clearly differentiated the aquatic stages of the three Aedes species and detected that Ae. albopictus was most profuse in different breeding spots surveyed, hence indicating to be the main vector in this region. So control measures can be designed against Ae. albopictus at an early stage to prevent any arboviral outbreak. This method is a convenient tool for precise identification of Aedes vectors during entomological surveys in arbovirus endemic/epidemic areas where several species coexist.Objectif:  Développer une PCR multiplex àétape unique pour différencier les stades aquatiques des espèces Aedes aegypti, Aedes albopictus et Aedes vittatus, collectés dans différents endroits de reproduction dans des zones endémiques/épidémiques pour arbovirus et détecter les espèces les plus abondantes par PCR multiplex.Méthodes:  Les stades aquatiques de différentes espèces de moustiques ont étééchantillonnés en inspectant les sites de reproduction artificiels et naturels dans les zones domestiques et péri domestiques. L’ADN a été isolé des différents stades des trois espèces d’Aedes. En utilisant des amorces basées sur la séquence d’ADNr 18S, une PCR multiplex àétape unique a été développée pour distinguer clairement les trois espèces du genre Aedes. Elle a ensuite étéévaluée sur les stades aquatiques des espèces d’Aedes recueillies dans différents endroits.Résultats:  1150 stades aquatiques ont été recueillis dans 294 endroits de reproduction dont 156 contenaient des espèces Aedes. Les pneus usagés étaient les principaux points de reproduction des espèces du genre Aedes. Les stades aquatiques ont été regroupés en 230 pools. Ae. albopictus a été détecté dans le plus grand nombre de pools, suivie par Ae. aegypti et Ae. vittatus.Conclusions:  La PCR multiplex différencie clairement les stades aquatiques des trois espèces Aedes et a trouvé qu’Ae. albopictusétait la plus abondante dans les différentes zones de reproduction sondées étant par conséquent, le principal vecteur dans cette région. Ainsi, les mesures de contrôle pourraient être conçues contre Ae. albopictusà un stade précoce afin de prévenir toute épidémie à arbovirus. Cette méthode est un outil pratique pour l’identification précise des vecteurs Aedes lors des enquêtes entomologiques dans des zones endémiques/épidémiques pour arbovirus où plusieurs espèces cohabitent.Objetivo:  Desarrollar una PCR multiplex realizada en un solo paso para diferenciar estadios acuáticos de Aedes aegypti, Aedes albopictus y Aedes vittatus recolectados de diferentes focos de reproducción en áreas endémicas / epidémicas para arbovirus y detectar las especies más abundantes mediante PCR multiplex.Métodos:  Los estadíos acuáticos de diferentes especies de mosquito se muestrearon inspeccionando focos de reproducción artificiales y naturales en áreas domésticas y peridomésticas. Se aisló el ADN de diferentes estadíos de las tres especies de Aedes. Utilizando cebadores basados en la secuencia del ADNr 18S, se desarrolló una PCR multiplex de un solo paso para distinguir claramente entre las tres especies de Aedes. Después se evaluó en los estadíos acuáticos de especies de Aedes recolectados de diferentes áreas.Resultados:  Se recolectaron 1150 estadíos acuáticos de 294 focos de reproducción, de los cuales 156 contenían la especie Aedes. Las ruedas abandonadas eran los principales focos de reproducción de la especie Aedes. Los estadíos acuáticos estaban agrupados en 230 charcos; Ae. albopictus fue la especie detectada en un mayor número de charcos, seguido por Ae. aegypti y Ae. vittatus.Conclusiones:  La PCR multiplex diferencia claramente los estadíos acuáticos de las tres especies de Aedes. Se detectó que Ae. albopictus era la especie más abundante en los diferentes focos de reproducción estudiados, indicando que se trata del principal vector en esta región. Por lo tanto, podrían diseñarse medidas de control frente a Ae. albopictus en un estadío temprano para prevenir un brote de arbovirus. Este método es una herramienta convencional para la identificación precisa de vectores de Aedes durante estudios entomológicos en áreas endémicas / epidémicas para arbovirus en donde coexisten varias especies.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02900.x" xmlns="http://purl.org/rss/1.0/"><title>Leprosy decline in Amazonas State, BrazilCommunication brève: Recul de la lèpre dans l’Etat d’Amazonas, au BrésilComunicación corta: El declive de la lepra en el estado del Amazonas, Brasil</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02900.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Leprosy decline in Amazonas State, BrazilCommunication brève: Recul de la lèpre dans l’Etat d’Amazonas, au BrésilComunicación corta: El declive de la lepra en el estado del Amazonas, Brasil</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Maria Lucia Fernandes Penna</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Valderiza Lourenço Pedrosa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Emília dos Santos Pereira</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02900.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02900.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02900.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Communication</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">244</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">246</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective </b> To analyse the leprosy case detection rates in Amazonas State, Brazil, by age group from 1980 to 2009.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method </b> The historical data series of leprosy cases by age group from 1980 to 2009 were fitted as a function of time using Poisson regression models. Relative annual reduction in the detection rate (RAR) by age group was estimated as one minus the exponential of the estimated regression coefficient for time. To compare the regression coefficients, we used their 95% confidence interval.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> The relative annual reduction varied from 9% in the age group of 0–4 years to 1% in the age group of 60–69 years. There was a declining trend of the RAR in the younger age groups that disappeared after 29 years of age. The detection rate in people &gt;29 years old declined very little over time, with no statistically significant difference between age groups.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> Our findings show a reduction in the infection risk in the last 30 years and a birth cohort effect: cohorts born in more recent years faced smaller risks of leprosy infection than older cohorts.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectif: </b> Analyser les taux de détection des cas de lèpre dans l’Etat d’Amazonas, au Brésil, par groupe d’âge, de 1980 à 2009.</p></div><div class="para"><p><b>Méthode: </b> Les séries de données historiques de cas de lèpre par groupe d’âge de 1980 à 2009 ont été déterminées en fonction du temps en utilisant des modèles de régression de Poisson. La réduction relative annuelle du taux de détection (RAR) par groupe d’âge a été estimée comme étant 1 moins l’exponentielle du coefficient de régression estimé pour le temps. Pour comparer les coefficients de régression, nous avons utilisé leur intervalle de confiance à 95%.</p></div><div class="para"><p><b>Résultats: </b> La réduction relative annuelle variait de 9% dans le groupe d’âge des 0 à 4 ans à 1% dans le groupe d’âge des 60 à 69 ans. Il y avait une tendance à la baisse du RAR dans les groupes d’âge plus jeunes qui disparaissait après l’âge de 29 ans. Le taux de détection chez les personnes &gt; 29 ans a très peu diminué au fil du temps, sans différence statistique significative entre les groupes d’âge.</p></div><div class="para"><p><b>Conclusion: </b> Nos résultats montrent une réduction du risque d’infection au cours des 30 dernières années et un effet de cohorte de naissance; les cohortes nées plus récemment ont des risques d’infection pour la lèpre, moins élevées que les cohortes plus âgées.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivo: </b> Analizar las tasas de detección de casos de lepra, por grupo de edad, en el estado de Amazonas, Brasil, entre 1980 y 2009.</p></div><div class="para"><p><b>Método: </b> Las series históricas de datos de casos de lepra por grupo de edad de 1980 al 2009 se ajustaron como una función del tiempo utilizando modelos de regresión de Poisson. La reducción anual relativa (RAR) de la tasa de detección por grupo de edad se calculó como uno menos el exponencial del coeficiente de regresión estimado para el tiempo. Para comparar los coeficientes de regresión, utilizamos un intervalo de confianza del 95%.</p></div><div class="para"><p><b>Resultados: </b> La reducción anual relativa varió del 9% en el grupo de edad de 0 a 4 años, al 1% en el grupo de edad de 60 a 69 años. Había una tendencia al declive en el RAR en los grupos de edad más jóvenes que desaparecía después de los 29 años de edad. La tasa de detección en personas &gt;29 años declinaba muy poco a lo largo del tiempo, sin una diferencia estadística significativa entre los grupos de edad.</p></div><div class="para"><p><b>Conclusión: </b> Nuestros hallazgos muestran una reducción del riesgo de infección en los últimos 30 años y el efecto de la cohorte de nacimiento: las cohortes nacidas en años recientes tenían un menor riesgo de infección por lepra que las cohortes mayores.</p></div></div>]]></content:encoded><description>Objective  To analyse the leprosy case detection rates in Amazonas State, Brazil, by age group from 1980 to 2009.Method  The historical data series of leprosy cases by age group from 1980 to 2009 were fitted as a function of time using Poisson regression models. Relative annual reduction in the detection rate (RAR) by age group was estimated as one minus the exponential of the estimated regression coefficient for time. To compare the regression coefficients, we used their 95% confidence interval.Results  The relative annual reduction varied from 9% in the age group of 0–4 years to 1% in the age group of 60–69 years. There was a declining trend of the RAR in the younger age groups that disappeared after 29 years of age. The detection rate in people &gt;29 years old declined very little over time, with no statistically significant difference between age groups.Conclusion  Our findings show a reduction in the infection risk in the last 30 years and a birth cohort effect: cohorts born in more recent years faced smaller risks of leprosy infection than older cohorts.Objectif:  Analyser les taux de détection des cas de lèpre dans l’Etat d’Amazonas, au Brésil, par groupe d’âge, de 1980 à 2009.Méthode:  Les séries de données historiques de cas de lèpre par groupe d’âge de 1980 à 2009 ont été déterminées en fonction du temps en utilisant des modèles de régression de Poisson. La réduction relative annuelle du taux de détection (RAR) par groupe d’âge a été estimée comme étant 1 moins l’exponentielle du coefficient de régression estimé pour le temps. Pour comparer les coefficients de régression, nous avons utilisé leur intervalle de confiance à 95%.Résultats:  La réduction relative annuelle variait de 9% dans le groupe d’âge des 0 à 4 ans à 1% dans le groupe d’âge des 60 à 69 ans. Il y avait une tendance à la baisse du RAR dans les groupes d’âge plus jeunes qui disparaissait après l’âge de 29 ans. Le taux de détection chez les personnes &gt; 29 ans a très peu diminué au fil du temps, sans différence statistique significative entre les groupes d’âge.Conclusion:  Nos résultats montrent une réduction du risque d’infection au cours des 30 dernières années et un effet de cohorte de naissance; les cohortes nées plus récemment ont des risques d’infection pour la lèpre, moins élevées que les cohortes plus âgées.Objetivo:  Analizar las tasas de detección de casos de lepra, por grupo de edad, en el estado de Amazonas, Brasil, entre 1980 y 2009.Método:  Las series históricas de datos de casos de lepra por grupo de edad de 1980 al 2009 se ajustaron como una función del tiempo utilizando modelos de regresión de Poisson. La reducción anual relativa (RAR) de la tasa de detección por grupo de edad se calculó como uno menos el exponencial del coeficiente de regresión estimado para el tiempo. Para comparar los coeficientes de regresión, utilizamos un intervalo de confianza del 95%.Resultados:  La reducción anual relativa varió del 9% en el grupo de edad de 0 a 4 años, al 1% en el grupo de edad de 60 a 69 años. Había una tendencia al declive en el RAR en los grupos de edad más jóvenes que desaparecía después de los 29 años de edad. La tasa de detección en personas &gt;29 años declinaba muy poco a lo largo del tiempo, sin una diferencia estadística significativa entre los grupos de edad.Conclusión:  Nuestros hallazgos muestran una reducción del riesgo de infección en los últimos 30 años y el efecto de la cohorte de nacimiento: las cohortes nacidas en años recientes tenían un menor riesgo de infección por lepra que las cohortes mayores.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02902.x" xmlns="http://purl.org/rss/1.0/"><title>Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West AfricaSéroprévalence et incidence des maladies infectieuses transmises par la transfusion chez les donneurs de sang dans les centres régionaux de transfusion sanguine au Burkina-Faso, Afrique de l’OuestSeroprevalencia e incidencia de enfermedades infecciosas transmitidas mediante transfusión entre donantes de sangre de los centros regionales de transfusión en Burkina Faso, África del Oeste</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02902.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West AfricaSéroprévalence et incidence des maladies infectieuses transmises par la transfusion chez les donneurs de sang dans les centres régionaux de transfusion sanguine au Burkina-Faso, Afrique de l’OuestSeroprevalencia e incidencia de enfermedades infecciosas transmitidas mediante transfusión entre donantes de sangre de los centros regionales de transfusión en Burkina Faso, África del Oeste</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bolni Marius Nagalo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cyrille Bisseye</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mahamoudou Sanou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kisito Kienou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yacouba K. Nebié</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alice Kiba</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Honorine Dahourou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Siaka Ouattara</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jean Baptiste Nikiema</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rémy Moret</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jean Didier Zongo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jacques Simpore</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02902.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02902.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02902.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">247</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">253</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background and objective </b> The high prevalence of numerous transfusion-transmitted infectious diseases such as HIV, HBV, HCV and syphilis in sub-Saharan Africa affects blood safety for transfusion recipients. The aim of this study was to evaluate the prevalence and incidence of transfusion-transmissible infectious diseases among blood donors in Burkina Faso.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> A retrospective study of blood donors’ records from January to December 2009 was conducted. Prevalence and incidence of viral infections were calculated among repeat and first-time blood donors.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> Of the total of 31 405 first-time volunteer blood donors in 2009, 24.0% were infected with at least one pathogen and 1.8% had serological evidence of multiple infections. The seroprevalence of HIV, HBV, HCV and syphilis in first-time volunteer donors was 1.8%, 13.4%, 6.3% and 2.1%, respectively. In 3981 repeat donors, the incidence rate was 3270.2, 5874.1 and 6784.6 per 100 000 donations for anti-HIV-1, HBsAg and anti-HCV, respectively. These numbers varied significantly according to populations where blood is collected and blood centres in Burkina Faso.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion </b> The relatively high prevalence of viral markers in first-time volunteers and remarkably high incidence of infections in repeat donors raise concerns regarding the safety of these donors and suggest that implementation of NAT might significantly improve the situation.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Contexte et objectif: </b> La prévalence élevée de nombreuses maladies infectieuses transmises par la transfusion comme le VIH, le VHB, le VHC et la syphilis en Afrique subsaharienne affecte la sécurité du sang pour les receveurs de transfusions sanguines. Le but de cette étude était d’évaluer la prévalence et l’incidence des maladies infectieuses transmissibles par la transfusion chez les donneurs de sang au Burkina-Faso.</p></div><div class="para"><p><b>Méthodes: </b> Une étude rétrospective des dossiers des donneurs de sang de janvier à décembre 2009 a été menée. La prévalence et l’incidence des infections virales ont été calculées chez les donneurs de sang répétitifs et les tout nouveaux donneurs.</p></div><div class="para"><p><b>Résultats: </b> Sur un total de 31405 nouveaux donneurs de sang bénévoles en 2009, 24,0%étaient infectés par au moins un pathogène et 1,8% présentaient des preuves sérologiques d’infections multiples. La séroprévalence du VIH, VHB, VHC et la syphilis chez les tout nouveaux donneurs bénévoles était de 1,8%, 13,4%, 6,3% et 2,1% respectivement. Chez 3981 donneurs réguliers, le taux d’incidence était de 3270,2; 5874,1 et 6784,6 pour 100.000 dons pour l’anti-VIH-1, l’HBsAg et l’anti-VHC, respectivement. Ces chiffres varient considérablement selon les populations chez qui le sang est collecté et selon les centres de transfusion sanguine au Burkina-Faso.</p></div><div class="para"><p><b>Conclusion: </b> La prévalence relativement élevée des marqueurs viraux chez les tout nouveaux volontaires et l’incidence remarquablement élevée des infections chez les donneurs répétitifs soulèvent des préoccupations concernant la sécurité de ces donneurs et suggèrent que l’implémentation de tests nucléotidiques pourrait améliorer considérablement la situation.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Antecedentes y Objetivos: </b> La alta prevalencia, en África sub-Sahariana, de numerosas enfermedades infecciosas transmitidas mediante transfusión, tales con el VIH, el VHB, el VHC y la sífilis, afecta la seguridad de la sangre destinada a receptores de una transfusión. El objetivo de este estudio era evaluar la prevalencia e incidencia de enfermedades infecciosas transmisibles en sangre entre donantes de sangre en Burkina Faso.</p></div><div class="para"><p><b>Métodos: </b> Estudio retrospectivo de los registros de donantes de sangre entre Enero y Diciembre 2009. Se calcularon la prevalencia e incidencia de las infecciones virales entre los donantes de sangre que repetían y los que lo hacían por primera vez.</p></div><div class="para"><p><b>Resultados: </b> De un total de 31,405 donantes de sangre voluntarios de primera vez en 2009, 24.0% estaban infectados con al menos un patógeno y 1.8% tenían evidencia serológica de infecciones múltiples. La seroprevalencia del VIH, VHB, VHC y sífilis en los donantes voluntarios de primera vez era del 1.8%, 13.4%, 6.3% y 2.1%, respectivamente. En 3,981 donantes repetidores, la tasa de incidencia era de 3270.2, 5874.1 y 6784.6 por 100,000 donaciones para anti-VIH-1, AgHBs y anti-VHC, respectivamente. Estos números variaban significativamente según la población donante y el centro de recolección de la sangre en Burkina Faso.</p></div><div class="para"><p><b>Conclusión: </b> La relativamente alta prevalencia de marcadores virales entre los voluntarios de primera vez y la extraordinariamente alta incidencia de infecciones en donantes repetidores plantea una preocupación legítima sobre de la seguridad de estos donantes, y sugiere que la implementación del NAT puede mejorar significativamente la situación.</p></div></div>]]></content:encoded><description>Background and objective  The high prevalence of numerous transfusion-transmitted infectious diseases such as HIV, HBV, HCV and syphilis in sub-Saharan Africa affects blood safety for transfusion recipients. The aim of this study was to evaluate the prevalence and incidence of transfusion-transmissible infectious diseases among blood donors in Burkina Faso.Methods  A retrospective study of blood donors’ records from January to December 2009 was conducted. Prevalence and incidence of viral infections were calculated among repeat and first-time blood donors.Results  Of the total of 31 405 first-time volunteer blood donors in 2009, 24.0% were infected with at least one pathogen and 1.8% had serological evidence of multiple infections. The seroprevalence of HIV, HBV, HCV and syphilis in first-time volunteer donors was 1.8%, 13.4%, 6.3% and 2.1%, respectively. In 3981 repeat donors, the incidence rate was 3270.2, 5874.1 and 6784.6 per 100 000 donations for anti-HIV-1, HBsAg and anti-HCV, respectively. These numbers varied significantly according to populations where blood is collected and blood centres in Burkina Faso.Conclusion  The relatively high prevalence of viral markers in first-time volunteers and remarkably high incidence of infections in repeat donors raise concerns regarding the safety of these donors and suggest that implementation of NAT might significantly improve the situation.Contexte et objectif:  La prévalence élevée de nombreuses maladies infectieuses transmises par la transfusion comme le VIH, le VHB, le VHC et la syphilis en Afrique subsaharienne affecte la sécurité du sang pour les receveurs de transfusions sanguines. Le but de cette étude était d’évaluer la prévalence et l’incidence des maladies infectieuses transmissibles par la transfusion chez les donneurs de sang au Burkina-Faso.Méthodes:  Une étude rétrospective des dossiers des donneurs de sang de janvier à décembre 2009 a été menée. La prévalence et l’incidence des infections virales ont été calculées chez les donneurs de sang répétitifs et les tout nouveaux donneurs.Résultats:  Sur un total de 31405 nouveaux donneurs de sang bénévoles en 2009, 24,0%étaient infectés par au moins un pathogène et 1,8% présentaient des preuves sérologiques d’infections multiples. La séroprévalence du VIH, VHB, VHC et la syphilis chez les tout nouveaux donneurs bénévoles était de 1,8%, 13,4%, 6,3% et 2,1% respectivement. Chez 3981 donneurs réguliers, le taux d’incidence était de 3270,2; 5874,1 et 6784,6 pour 100.000 dons pour l’anti-VIH-1, l’HBsAg et l’anti-VHC, respectivement. Ces chiffres varient considérablement selon les populations chez qui le sang est collecté et selon les centres de transfusion sanguine au Burkina-Faso.Conclusion:  La prévalence relativement élevée des marqueurs viraux chez les tout nouveaux volontaires et l’incidence remarquablement élevée des infections chez les donneurs répétitifs soulèvent des préoccupations concernant la sécurité de ces donneurs et suggèrent que l’implémentation de tests nucléotidiques pourrait améliorer considérablement la situation.Antecedentes y Objetivos:  La alta prevalencia, en África sub-Sahariana, de numerosas enfermedades infecciosas transmitidas mediante transfusión, tales con el VIH, el VHB, el VHC y la sífilis, afecta la seguridad de la sangre destinada a receptores de una transfusión. El objetivo de este estudio era evaluar la prevalencia e incidencia de enfermedades infecciosas transmisibles en sangre entre donantes de sangre en Burkina Faso.Métodos:  Estudio retrospectivo de los registros de donantes de sangre entre Enero y Diciembre 2009. Se calcularon la prevalencia e incidencia de las infecciones virales entre los donantes de sangre que repetían y los que lo hacían por primera vez.Resultados:  De un total de 31,405 donantes de sangre voluntarios de primera vez en 2009, 24.0% estaban infectados con al menos un patógeno y 1.8% tenían evidencia serológica de infecciones múltiples. La seroprevalencia del VIH, VHB, VHC y sífilis en los donantes voluntarios de primera vez era del 1.8%, 13.4%, 6.3% y 2.1%, respectivamente. En 3,981 donantes repetidores, la tasa de incidencia era de 3270.2, 5874.1 y 6784.6 por 100,000 donaciones para anti-VIH-1, AgHBs y anti-VHC, respectivamente. Estos números variaban significativamente según la población donante y el centro de recolección de la sangre en Burkina Faso.Conclusión:  La relativamente alta prevalencia de marcadores virales entre los voluntarios de primera vez y la extraordinariamente alta incidencia de infecciones en donantes repetidores plantea una preocupación legítima sobre de la seguridad de estos donantes, y sugiere que la implementación del NAT puede mejorar significativamente la situación.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02911.x" xmlns="http://purl.org/rss/1.0/"><title>Rotavirus disease burden among children &lt;5 years of age – Santa Rosa, Guatemala, 2007–2009Charge des maladies à rotavirus chez les enfants de moins de 5 ans à Santa Rosa, au Guatemala, de 2007 à 2009Carga de enfermedad por Rotavirus entre niños &lt;5 años – Santa Rosa, Guatemala, 2007–2009</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02911.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Rotavirus disease burden among children &lt;5 years of age – Santa Rosa, Guatemala, 2007–2009Charge des maladies à rotavirus chez les enfants de moins de 5 ans à Santa Rosa, au Guatemala, de 2007 à 2009Carga de enfermedad por Rotavirus entre niños &lt;5 años – Santa Rosa, Guatemala, 2007–2009</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jennifer Cortes</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wences Arvelo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Beatriz Lopez</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lissette Reyes</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tara Kerin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rashi Gautam</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Manish Patel</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Umesh Parashar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kim A. Lindblade</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02911.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02911.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02911.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">254</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">259</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives </b> To assess the burden of rotavirus disease in Guatemala, in view of the recent introduction of a national rotavirus vaccination programme.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods </b> We examined data from an active, facility-based surveillance system in Santa Rosa, Guatemala, from October 2007 through September 2009 among children &lt;5 years of age presenting to the hospital or ambulatory clinics with diarrhoea (≥3 loose stools in 24 h during the last 7 days). Demographic and epidemiological data were collected, and specimens were tested for rotavirus via enzyme immunoassay. Genotyping was performed via reverse transcriptase polymerase chain reaction.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results </b> We enrolled 347 hospitalized patients &lt;5 years of age with diarrhoea and 1215 from ambulatory clinics. Specimens from 275 (79%) hospitalized children and 662 (54%) from ambulatory visits were tested for rotavirus. Rotavirus accounted for 32% of hospitalizations and 9% of ambulatory visits for diarrhoea, resulting in adjusted annual rates of 36 hospitalizations and 372 ambulatory visits per 10 000 children. Ninety-one per cent of hospitalizations and 81% of ambulatory visits for rotavirus diarrhoea occurred in children &lt;2 years. G1P8 represented 71% and 95% of rotavirus genotypes for 2007–2008 and 2008–2009 rotavirus seasons, respectively.</p></div><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions </b> Rotavirus is a major cause of diarrhoea in children &lt;5 years of age in Santa Rosa, Guatemala, highlighting the potential health benefits of vaccination and the need for continued surveillance to assess impact and effectiveness of the rotavirus vaccination programme in Guatemala.</p></div><div class="section" id="sec-sum-2" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objectifs: </b> Evaluer la charge des maladies à rotavirus au Guatemala, au vu de l’introduction récente d’un programme national de vaccination contre le rotavirus.</p></div><div class="para"><p><b>Méthodes: </b> Nous avons examiné les données d’un système de surveillance actif basé sur les établissements de santéà Santa Rosa, au Guatemala, d’octobre 2007 à septembre 2009 chez les enfants &lt;5 ans présentés à l’hôpital ou dans des cliniques ambulatoires et souffrant de diarrhée (≥3 selles liquides en 24 heures au cours des sept derniers jours). Les données démographiques et épidémiologiques ont été recueillies et des spécimens ont été testés pour le rotavirus par dosage immunoenzymatique. Le génotypage à l’aide de la réaction en chaine de la polymérase et de la transcriptase inverse a été effectué.</p></div><div class="para"><p><b>Résultats: </b> Nous avons recruté 347 patients &lt;5 ans hospitalisés souffrant de diarrhée et 1215 dans les cliniques de soins ambulatoires. Des spécimens de 275 (79%) enfants hospitalisés et 662 (54%) en visites ambulatoires ont été testés pour le rotavirus. Le rotavirus représentait 32% des hospitalisations et 9% des visites ambulatoires pour la diarrhée, résultant en des taux annuels ajustés de 36 hospitalisations et 372 visites ambulatoires par 10.000 enfants. 91% des hospitalisations et 81% des visites ambulatoires pour les diarrhées à rotavirus survenaient chez des enfants &lt;2 ans. G1P8 représentait 71% et 95% des génotypes de rotavirus pour les saisons à rotavirus de 2007–2008 et 2008–2009, respectivement.</p></div><div class="para"><p><b>Conclusions: </b> Le rotavirus est une cause majeure de diarrhée chez les enfants &lt;5 ans à Santa Rosa, au Guatemala, soulignant les avantages potentiels de la vaccination pour la santé et la nécessité d’une surveillance continue pour évaluer l’impact et l’efficacité du programme de vaccination contre le rotavirus au Guatemala.</p></div></div><div class="section" id="sec-sum-3" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><b>Objetivos: </b> Evaluar la carga de la enfermedad por rotavirus en Guatemala, en vista de la reciente introducción de un programa nacional de vacunación para rotavirus.</p></div><div class="para"><p><b>Métodos: </b> Hemos analizado datos provenientes de un sistema de vigilancia activo en instalaciones de Santa Rosa, Guatemala, entre Octubre del 2007 y Septiembre 2009, de niños &lt;5 años de edad que se presentaban en el hospital o ambulatorios con diarrea (≥3 heces blandas en 24 horas durante los últimos siete días). Se recolectaron datos demográficos y epidemiológicos, y a los especímenes se les realizaron pruebas para rotavirus mediante inmunoensayo enzimático. Se realizó el genotipaje mediante PCR.</p></div><div class="para"><p><b>Resultados: </b> Se incluyeron 347 pacientes &lt;5 años hospitalizados con diarrea y 1215 de clínicas ambulatorias. Los especímenes de 275 (79%) niños hospitalizados y 662 (54%) de visitas ambulatorias se examinaron para rotavirus. El rotavirus era responsable de un 32% de las hospitalizaciones y un 9% de las visitas a ambulatorios por diarrea, resultando en tasas anuales ajustadas de 36 hospitalizaciones y 372 visitas ambulatorias por 10,000 niños. Un 91% de las hospitalizaciones y un 81% de las visitas ambulatorias por diarrea por rotavirus sucedió en niños &lt;2 años. G1P8 representó un 71% y 95% de los genotipos de rotavirus durante los periodos de 2007–2008 y 2008–2009, respectivamente.</p></div><div class="para"><p><b>Conclusiones: </b> El rotavirus es la principal causa de diarrea en niños &lt;5 años en Santa Rosa, Guatemala, enfatizando los beneficios potenciales en la salud de la vacunación y la necesidad de una vigilancia continuada para evaluar el impacto y la efectividad del programa de vacunación para rotavirus en Guatemala.</p></div></div>]]></content:encoded><description>Objectives  To assess the burden of rotavirus disease in Guatemala, in view of the recent introduction of a national rotavirus vaccination programme.Methods  We examined data from an active, facility-based surveillance system in Santa Rosa, Guatemala, from October 2007 through September 2009 among children &lt;5 years of age presenting to the hospital or ambulatory clinics with diarrhoea (≥3 loose stools in 24 h during the last 7 days). Demographic and epidemiological data were collected, and specimens were tested for rotavirus via enzyme immunoassay. Genotyping was performed via reverse transcriptase polymerase chain reaction.Results  We enrolled 347 hospitalized patients &lt;5 years of age with diarrhoea and 1215 from ambulatory clinics. Specimens from 275 (79%) hospitalized children and 662 (54%) from ambulatory visits were tested for rotavirus. Rotavirus accounted for 32% of hospitalizations and 9% of ambulatory visits for diarrhoea, resulting in adjusted annual rates of 36 hospitalizations and 372 ambulatory visits per 10 000 children. Ninety-one per cent of hospitalizations and 81% of ambulatory visits for rotavirus diarrhoea occurred in children &lt;2 years. G1P8 represented 71% and 95% of rotavirus genotypes for 2007–2008 and 2008–2009 rotavirus seasons, respectively.Conclusions  Rotavirus is a major cause of diarrhoea in children &lt;5 years of age in Santa Rosa, Guatemala, highlighting the potential health benefits of vaccination and the need for continued surveillance to assess impact and effectiveness of the rotavirus vaccination programme in Guatemala.Objectifs:  Evaluer la charge des maladies à rotavirus au Guatemala, au vu de l’introduction récente d’un programme national de vaccination contre le rotavirus.Méthodes:  Nous avons examiné les données d’un système de surveillance actif basé sur les établissements de santéà Santa Rosa, au Guatemala, d’octobre 2007 à septembre 2009 chez les enfants &lt;5 ans présentés à l’hôpital ou dans des cliniques ambulatoires et souffrant de diarrhée (≥3 selles liquides en 24 heures au cours des sept derniers jours). Les données démographiques et épidémiologiques ont été recueillies et des spécimens ont été testés pour le rotavirus par dosage immunoenzymatique. Le génotypage à l’aide de la réaction en chaine de la polymérase et de la transcriptase inverse a été effectué.Résultats:  Nous avons recruté 347 patients &lt;5 ans hospitalisés souffrant de diarrhée et 1215 dans les cliniques de soins ambulatoires. Des spécimens de 275 (79%) enfants hospitalisés et 662 (54%) en visites ambulatoires ont été testés pour le rotavirus. Le rotavirus représentait 32% des hospitalisations et 9% des visites ambulatoires pour la diarrhée, résultant en des taux annuels ajustés de 36 hospitalisations et 372 visites ambulatoires par 10.000 enfants. 91% des hospitalisations et 81% des visites ambulatoires pour les diarrhées à rotavirus survenaient chez des enfants &lt;2 ans. G1P8 représentait 71% et 95% des génotypes de rotavirus pour les saisons à rotavirus de 2007–2008 et 2008–2009, respectivement.Conclusions:  Le rotavirus est une cause majeure de diarrhée chez les enfants &lt;5 ans à Santa Rosa, au Guatemala, soulignant les avantages potentiels de la vaccination pour la santé et la nécessité d’une surveillance continue pour évaluer l’impact et l’efficacité du programme de vaccination contre le rotavirus au Guatemala.Objetivos:  Evaluar la carga de la enfermedad por rotavirus en Guatemala, en vista de la reciente introducción de un programa nacional de vacunación para rotavirus.Métodos:  Hemos analizado datos provenientes de un sistema de vigilancia activo en instalaciones de Santa Rosa, Guatemala, entre Octubre del 2007 y Septiembre 2009, de niños &lt;5 años de edad que se presentaban en el hospital o ambulatorios con diarrea (≥3 heces blandas en 24 horas durante los últimos siete días). Se recolectaron datos demográficos y epidemiológicos, y a los especímenes se les realizaron pruebas para rotavirus mediante inmunoensayo enzimático. Se realizó el genotipaje mediante PCR.Resultados:  Se incluyeron 347 pacientes &lt;5 años hospitalizados con diarrea y 1215 de clínicas ambulatorias. Los especímenes de 275 (79%) niños hospitalizados y 662 (54%) de visitas ambulatorias se examinaron para rotavirus. El rotavirus era responsable de un 32% de las hospitalizaciones y un 9% de las visitas a ambulatorios por diarrea, resultando en tasas anuales ajustadas de 36 hospitalizaciones y 372 visitas ambulatorias por 10,000 niños. Un 91% de las hospitalizaciones y un 81% de las visitas ambulatorias por diarrea por rotavirus sucedió en niños &lt;2 años. G1P8 representó un 71% y 95% de los genotipos de rotavirus durante los periodos de 2007–2008 y 2008–2009, respectivamente.Conclusiones:  El rotavirus es la principal causa de diarrea en niños &lt;5 años en Santa Rosa, Guatemala, enfatizando los beneficios potenciales en la salud de la vacunación y la necesidad de una vigilancia continuada para evaluar el impacto y la efectividad del programa de vacunación para rotavirus en Guatemala.</description></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02908_1.x" xmlns="http://purl.org/rss/1.0/"><title>Neonatal meningitis and the developing world</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02908_1.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Neonatal meningitis and the developing world</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rashmi R. Das</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02908_1.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02908_1.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02908_1.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editors</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">260</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">260</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02908_2.x" xmlns="http://purl.org/rss/1.0/"><title>Authors’ Reply</title><link>http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02908_2.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Authors’ Reply</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">O. Swann</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. S. Furyk</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1365-3156.2011.02908_2.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1365-3156.2011.02908_2.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1111%2Fj.1365-3156.2011.02908_2.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editors</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">261</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">261</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item></rdf:RDF>
